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Abstract
MicroRNAs (miRNAs) play an important role in biomarker research.
Identifying their targets and inferring their functions have been of a
great importance to developing our understanding of many biologi-
cal processes and fundamental novel anti-cancer and viral therapies.
Since the discovery and validation of true miRNA-messengerRNA
(mRNA) bindings is a laborious and expensive process, computational
tools for the prediction of miRNA targets are essential in this re-
search area. Advanced tools of miRNA target prediction incorporate
knowledge about secondary structures of mRNA sequences, usually
the 3’UTR into the evaluation and assessment of putative miRNA-
mRNA bindings. The default secondary RNA structure in most target
prediction tools of this type is the minimum free energy conformation
or a representative of the ensemble of all possible RNA structures. A
key indicator of putative miRNA-mRNA bindings is the energy re-
quired to open base pairs that are present in the potential binding
site within the conformation. However, mRNAs as well as miRNAs
are present in a single cell in multiple copies, where the number of
copies may range from several tens up to several hundreds of copies,
each of them transcribed from DNA at different points of time and
therefore, potentially, being present in different folding stages, most
likely in metastable conformations. In this thesis we have addressed
the problem of miRNA bindings to metastable RNA secondary struc-
tures in the context of Single Nucleotide Polymorphisms (SNPs). To
this end, we first searched the recent literature for disease-related
triples [mRNA/3’UTR; SNP; miRNA] that have been analysed by
methods including PCR and/or luciferase reporter assays. We next
compared results of two major computational approaches to miRNA
target ranking prediction: conservation feature using TargetScan tool
and target site accessibility feature using PITA and STarMir tools. We
showed that site accessibility may be a better ranking criterion. We
then studied the problem of miRNA bindings to metastable secondary
structures in the context of SNPs and mRNA concentration levels
i.e. whether features of miRNA bindings to metastable conforma-
tions could provide additional information supporting the differences
in expression levels of the two sequences defined by a SNP. We showed
that among the different parameters we introduced and analyzed, we
found that three of them, related to the average depth and average
opening energy of metastable conformations, may provide supporting
information for a stronger separation between miRNA bindings to the
two alleles defined by a given SNP. These findings were a trigger to
devise a novel target prediction tool that incorporates metastable sec-
ondary structures with low energy levels into predictions. We present,
RNAStrucTar, a miRNA target prediction tool that analyses putative
mRNA binding sites within 3’UTR secondary structures represent-
ing metastable conformations. The first stage consists of generating
conformations that can be classified as deep local minima. The sec-
ond stage incorporates duplex structure prediction through sequence
alignment and energy computation. Target site accessibility related
to different sets of metastable conformations is also taken into ac-
count. An overall interaction score computed from multiple binding
sites is returned. The approach is discussed in the context of SNPs
where our manually curated [mRNA;SNP;miRNA] dataset is utilised.
RNAStrucTar predictions are in favour of the allele with the stronger
miRNA binding stated in the underlying literature in 22 instances,
while the resulting scores are indifferent in ten cases. For the two
other cases (HTR3E and FGF20), the score is in favour of the weaker
allele. In this respect, RNAStrucTar results are better than PITA and
STarMir, with a positive prediction for RAD51 and MSLN (STarMir
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In February 2001, the Human Genome Project (HGP) published the first draft
of human genome [1]. Since then, many other whole-genome sequencing projects
have been completed which have elucidated the complexity of the human genome
and subsequently the human proteome. Building on the work of the HGP, the
Encyclopedia Of DNA Elements (ENCODE) project was carried out to catalog
and describe all the functional elements in the human genome [2]. The completion
of other projects, such as the SNP Consortium [3] and the HapMap Project [4],
has also impacted the field of RNA research in profound ways. In this chapter,
we first introduce the biological aspects of RNA folding and then we discuss the
microRNA target prediction problem by explaining the associated computational
principles and reviewing state of the art prediction tools. We conclude the chapter
with an overall organisation of the thesis.
1.1 RNA Folding Concepts
1.1.1 RNA Biogenesis
The central dogma of molecular biology explains the flow of genetic information,
from DNA to RNA, to make a functional product, a protein. The nucleic acids,
i.e. DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) serve as stor-
age for genetic information. RNA and DNA are polymers of repeating units of
monomers called nucleotides, made from three distinct modules that are a sin-
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gle sugar, a single base and up to three phosphate groups. Each nucleotide has
one of four types of bases, namely Adenine (A), Uridine (U) (Thymine (T) in
the case of DNA), Guanine (G) and Cytosine(C). Several forms of RNAs include
messenger RNA (mRNA), ribosomal RNA (rRNA) and transfer RNA (tRNA).
mRNAs are short-lived protein-coding RNAs that carry information from DNA
to the ribosome sites to generate protein.
Figure 1.1: The central dogma of molecular biology.
Figure 1.1 illustrates the different biological steps from DNA to protein. The
transcription, splicing and translation are the main processes that account for
gene expression of protein coding genes. Transcription is the copying of DNA
(template strand) to RNA (pre-RNA). Pre-RNA consists of two types of sub-
sequences: exons and introns. Introns are sub-sequences between exons that are
removed by splicing; the remaining exons form the RNA sequence, where one
distinguishes between two main types: messenger RNA (mRNA) that carries
information about proteins (encodes protein information), and non-coding RNA.
Messenger RNA is transformed into protein by a process called translation (within
the coding region of mRNA, three consecutive nucleotides - called codons - define
a single amino acid in the protein). After splicing, the mRNA consists of the
central coding region (CDS) and a flanking region (in most cases) on either side
of the coding region, which are called untranslated regions (UTRs). Thus, the
untranslated regions are sections of the mRNA located before the start codon
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and after the stop codon of the coding region, termed the five prime untranslated
region (5’ UTR) and three prime untranslated region (3’ UTR), respectively.
Figure 1.2 illustrates a typical mature mRNA. The mRNA also contains two
other special regions: the 5’ cap added to the 5’ end which provides stability
during translation and the 3’ poly (A) tail added to the 3’end which protects the
mRNA from degradation.
Figure 1.2: The structure of a typical mature Messenger RNA.
1.1.2 RNA Folded Structure
An RNA molecule can be described as a hierarchical structure in which the pri-
mary sequence determines the secondary structure which, in turn, determines its
tertiary folding, whose formation alters only minimally the secondary structure
[5]. The secondary structure is the folded form of the nucleotide chain that is a
2-dimensional structure where certain substructures such as hairpins or loops are
formed through base pairing. It provides an ideal model to study RNA folding,
provides a biochemically useful structure description, mathematically and com-
putationally easy to handle, and uses energy models based on carefully measured
parameters. RNA molecules are also able to fold into tertiary shapes which can
bind to other molecules very tightly and specifically. It is this 3-dimensional
conformation that determines RNA function. Figure 1.3 illustrates the different
structural levels of an RNA sequence, where the secondary structure drawing was
produced by Varna visualization tool [6] and the tertiary structure generated by
RNAcomposer [7].
A secondary structure consists of a number of substructures or motifs e.g.
single-stranded regions, stacked base pairs, hairpin loops, multiple loops, interior
loops, and bulge loops (see Figure 1.4). Hairpins (or stemloops) are the most
common element of RNA secondary structure [8; 9]. The foundation of the RNA
structure formation is a continuous base pairing, resulting in helical regions or










(a) Primary sequence (b) Secondary structure (c) Tertiary structure
Figure 1.3: The RNA structure hierarchy.
a single stranded region which folds back on itself. When the parts of the RNA
sequence spanned by two base pairs are neither disjoint, nor have one contained
in the other, the two base pairs form a pseudoknot. A bulge loop occurs when a
duplex is interrupted by one or more unpaired nucleotides in one of the strands.
The objective of RNA folding in bioinformatics is to accurately model the struc-
ture of the RNA from its given sequence, where the most likely RNA structure
to form is predicted by computational programs.




We give in this section the well-known mathematical formulation of the secondary
structure problem. The primary sequence of RNA is represented as a string s of
n characters, R = r1, r2, . . . , rn where ri ∈ {A,C,G, U}. The secondary structure
of a sequence R is the set of base pairs (ri, rj) such that the following properties
are satisfied:
• For each pair is (i, j), 1 ≤ i < j ≤ n i.e. each base of a pair must be from
different locations.
• Each pair (i, j) is either a Watson-Crick pair (ri, rj) ∈
(A,U), (U,A), (C,G), (G,C)}, or a wobble pair (ri, rj) ∈ {(G,U), (U,G)}.
• Each index k = 1, . . . , n can only occur at most once in a pair.
• Sharp folds in the sequence are prohibited, that is j − i > p , where p is a
positive constant. For example, a hairpin loop should have at least three
unpaired nucleotides [10].
A pseudoknot occurs when two pairs, between nucleotides i and j and between
nucleotides i’ and j’, exist with i < i′ < j < j′.
Several representations of the secondary structure have been utilized. While
the graph representation shown in Figure 1.3 gives an idea of the shape of the
RNA sequence, the string notation known as the dot bracket notation is a machine
readable representation. It is defined by the following rules:
• If a base i is unpaired, then it is represented as Si =′ .′ in the string
• If (p, q)is a base pair and p < q, then Sp =′ (′ and Sq =′)′.
The first rule applies to all loop and bulge substructures. The second rule ap-
plies to helix or stacked stem substructures. For example, the string ((((.....))))
corresponds to a stacked helix of length 4 and a hairpin loop of length 5.
Figure 1.5 shows the dot bracket and the circular representations where nu-
cleotides of a secondary structure are represented by a circle and arcs are drawn




(a) Dot Bracket representation of MFE structure
(b) Circular representation
Figure 1.5: Different RNA representations of the RNA sequence and secondary
structure from Figure 1.3.
representation was produced by RNAfold [11] and the circular representation gen-
erated by mfold [12].
1.1.4 Secondary Structure Prediction
Research on RNA secondary structure prediction dates back to around 1960 [13].
Further progress was published in [14; 15; 16]. The method by Tumanyan et al.
[16], published in 1966, comprises already the essential ingredients of a dynamic
programming approach for RNA secondary structure prediction [17]. The algo-
rithm was implemented with a potential of handling sequences of length up to n
= 600 with the then available hardware. A more formal application of dynamic
programming to RNA secondary structure prediction was carried out in 1978 by
Nussinov et al. [18] and Waterman and Smith [19]. Nussinov algorithm compares
a sequence against itself and finds the maximum of the scores for the possible
structures at a particular position. Base pair maximization will not necessarily
generate the most stable structure and may have scattered matches which are
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not biologically reasonable. It may create a structure with many interior loops or
hairpins which are energetically unfavorable. Therefore this algorithm does not
give accurate structure predictions [20; 21].
Later on, the application of dynamic programming to secondary structure
prediction by energy minimization, with various refinements and energy functions,
eventually resulted in the design of powerful tools for folding simulations and
associated program packages, such as RNAfold by Hofacker and co-workers [11; 22]
and mfold by Zuker and co-workers [20; 23; 24].
Different secondary structures could be shaped from the same RNA sequence.
Each structure has its specific free energy change ∆G introduced as the Gibbs
free energy change of folding and expressed in KiloJoules/Mole (Kj/mol). These
algorithms are used to search for a single secondary structure with the lowest
free energy change named the minimum free energy(MFE) conformation. The
Turner nearest neighbor energy model, where free energies are assigned to loops
rather than to base pairs, using loop dependant energy rules, is widely used for
free energy calculation [25; 26]. The key idea of this algorithm is that a secondary
structure can be decomposed into a number of separate loop structures such that
the total free energy of the structure is the sum of these parts. As an example,
stacking pairs are the dominant stabilizing force as they contribute to the negative
free energy while unpaired bases, such as interior loops, hairpin loops, bulges
and multi-loops, form destabilizing loops, thus contributing with a positive free
energy.
There is a great diversity in recent research on secondary structure predic-
tions, including attempts to tackle the problem of folding simulations for struc-
tures with pseudoknots, which is known to be NP complete [27]. Kinetic folding
simulations and modeling of co-transcriptional folding are an important consid-
eration. Furthermore, sampling techniques focusing on approximations of the
partition function over all secondary structures or specifically for metastable con-
formations have also been of major interest.
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1.1.5 Kinetic folding
Kinetic folding simulations provide valuable information about transition rates
at different folding stages and the stability of substructures such as helices, hair-
pins, various types of loops, and pseudoknots. Flamm and Hofacker provide an
overview of methods for kinetic folding simulations in [28], see also the detailed
summary by Schuster [29].
While basic kinetic moves are addition and deletion of single base pairs,
Flamm et al. [30] introduced the shift move, which is a combination of a base
pair removal and a base pair addition where one position remains invariant. The
shift move aims at the simulation of ‘defect diffusion’ reported in [31], which
tries to capture the process where the position of a bulge in a helix may move
along a helix as the result of rapid base pair formation and dissociation. Geis et
al. present the Kinwalker tool in [32], along with simulation results on twelve
RNA sequences with a length ranging from 115 nt to 1492 nt. The underlying
method generates secondary structures by combining building blocks represent-
ing thermodynamically optimal substructures. The optimal substructures are
calculated by standard dynamic programming. Finding the energy barrier be-
tween two locally optimal conformations is an important step in the execution of
Kinwalker. The sub-routine employs a modification of the Morgan-Higgs heuris-
tic [33], which is designed to find a direct folding pathway of minimum height
between two secondary structures. Most of the total run-time of Kinwalker is
spent on this particular task. The authors report a good agreement of folding
simulations with experimentally verified folding pathways, and the same applies
to calculated folding times and corresponding values predicted in the literature.
Co-transcriptional folding is generally acknowledged as describing the process
of how RNA folding happens in vivo [34]. As pointed out in [28] and [35], RNA
is transcribed at a rate of only ≈ 30-40 nucleotides per second, where the nascent
chain starts folding as soon as it leaves the ribosome. Since helices formed by
the incomplete chain may be too stable to refold later on, co-transcriptional
folding may drive the folding process to a well-defined folded state that is different
from a MFE conformation. In a recent experimental study, Solomatin et al.
[36] argue in favor of multiple RNA folding pathways to different biologically
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active conformations (where the authors include the wider perspective of protein
folding). Therefore, metastable structures have become the subject of recent
research due to the new insights into co-transcriptional folding and interactions
between different types of RNA sequences.
Studies on RNA folding kinetics may provide interesting insights into the
kinetic mechanism of RNA functions. However, analyzing the underlying folding
energy landscape, which will be defined in the following section, presents a simpler
alternative.
1.1.6 Energy Landscapes
We briefly recall the main features of energy landscapes induced by RNA sec-
ondary structures. Given an RNA sequence R, we denote by L(R) = [C,N, E] the
energy landscape defined by the set of secondary structures C, the neighborhood
relation N and the energy function E : C → R. The conformation space C con-
sists of secondary structures with standard settings as provided, for example, by
the RNAfold tool [11], i.e. no isolated base pairs and at least three nucleotides in
loops.
Given a secondary structure S of sequence R, the neighborhood NS is defined
by two types of single-step transitions S → S ′ ∈ NS:
(1) Addition of one or two base pairs: a single base pair is added, if an existing
helix is extended; two base pairs are added, if an unpaired position admits
such an extension without extending a helix by two base pairs; the addition
must ensure that the condition for the minimum loop size is not violated.
(2) Deletion of one or two base pairs: a single base pair is deleted as part of a
helix, if at least two adjoined base pairs remain; otherwise, two base pairs
are deleted.
The neighborhood NS covers all conformations that can be generated by a single
application of one of the transitions, where by definition the secondary structure
S itself belongs to NS.
The RNAsubopt tool by Wuchty et al. [37] is an algorithm that generates all
suboptimal folds of a sequence in a partial energy landscape, which is within a
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desired energy range from the MFE. The idea underlying the algorithm is taken
from Waterman and Byers [38] who developed it in the context of suboptimal
solutions to the shortest path problem in networks. A more detailed investigation
of the energy landscape of RNA is possible and defines the following particular
features:
• A local minimum is a structure with an energy lower than the energy of all
neighboring structures.
• A local maximum is a structure with an energy higher than the energies of
all legal neighboring structures.
• A saddle point is a structure from where at least two local minima can be
reached by a downhill walk starting with this structure.
Methods to elucidate the basin structure of landscapes by means of trees that
represent local minima and their connecting saddle points have been developed.
This includes the Barriers program [39], a tool that inputs an energy sorted
list of conformations of a landscape, and computes local minima and energy bar-
riers of the landscape. An example of a barrier tree is given in the Figure 1.6.
Lorenz and Clote introduce in [40] the RNAlocopt tool for sampling and approx-
imating the total number of metastable conformations (local minima) using the
partition function. However, currently the RNAlocopt tool has only been imple-
mented using the older Turner 1999 energy model without dangling ends. RNA
energy landscape analysis in the context of metastable conformations has also
been presented in [41] ,[42] ,[43] and [44].
1.2 MicroRNA Regulatory Targets
One of the most significant recent advances in Cell Biology is the discovery of
small non coding RNAs, known to possess regulatory functions at the trans-
lational level in cells of various species. The term non-coding RNA (ncRNA)
is commonly used for RNA that is not translated into a protein. It has been
assumed that genes generally code for proteins [45]. However, recent evidence
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Figure 1.6: An example of a Barriers output tree where local minima are labeled
with numbers and the height of the energy barrier to their connecting saddle
points is given. The global minimum is marked as local minimum 1.
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suggests that the majority of the genomes in mammals and other complex organ-
isms is in fact transcribed into ncRNAs, many of which are alternatively spliced
and/or processed into smaller products [46]. ncRNAs are involved in a varied
number of cellular processes. Among other roles, they regulate gene expression
at the levels of transcription, RNA processing, and translation. ncRNAs are di-
vided into two main groups: the short ncRNAs (< 30 nts) and the long ncRNAs
(> 200 nts). The three major classes of short non-coding RNAs are microRNAs
(miRNAs), short interfering RNAs (siRNAs), and piwi-interacting RNAs (piR-
NAs). A detailed review of classes of ncRNAs and their functions is given in
[47].
1.2.1 MicroRNA Biogenesis
MicroRNAs are short, 17 to 24 nucleotides long, non-coding RNAs encoded by
a significant proportion of genes [48]. They are produced from either their own
genes or from introns and rarely from exons [49]. The first report of a miRNA,
lin-4, that regulates the development of Caenorhabditis elegans (C. elegans), dates
back to 1993 [50; 51]. However, it was not until later, with the discovery of the
let-7 miRNA and its conservation from worms to humans, that the functional im-
portance of miRNA-dependant gene regulation emerged [52; 53]. In the following
years, hundreds of miRNAs were identified in a wide range of species.
The current molecular framework for the mammalian miRNA biogenesis is
shown in Figure 1.7. MicroRNA genes are transcribed by either RNA poly-
merase II or RNA polymerase III into long primary miRNA transcripts (pri-
miRNA) [54; 55]. The precursor (pre-miRNAs) of ≈ 65 nucleotides in length
[48] with a stem loop structure is next released from pri-miRNA by a cleavage
event, which is catalysed by the nuclear microprocessor complex Drosha-DGCR8
(Pasha) in the nucleus [56]. The resulting precursor hairpin, the pre-miRNA, is
then processed by another RNase III enzyme, Dicer and this causes the release
of a double-stranded RNA duplex of ≈ 22 base-pair RNA that is composed of
the eventual mature miRNA, base-paired to a complementary miRNA* strand,
or the passenger strand [57]. Subsequently, one of the strands, designated as
miRNA or the guide strand, is preferentially selected for maturation whereas the
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Figure 1.7: MicroRNA biogenesis.
13
passenger strand is degraded [58]. However, recent reports have indicated that
in some cases, the two strands often co-exist and are both functional. In these
cases, the mature miRNA species may be derived from both the 5’ and 3’ arms of
the precursor duplex, and are called the miRNA-5p and -3p species, respectively
[59; 60]. The mature miRNA is then loaded into an Argonaute (Ago) family pro-
tein inside the RNA-Induced Silencing Complex (RISC) , where it guides RISC
for gene regulation [61]. The diverse pathways in miRNA processing have been
reviewed in depth in [62] and [48].
MicroRNAs have been found to possess important post-transcriptional regula-
tory roles in many biological processes and diseases. They bind predominantly to
mRNAs that contain partially or fully complementary target sequences [58]. As
a consequence, they silence targets through RNA degradation as well as blocking
the mRNA translation into proteins. Initially miRNAs were thought to repress
protein output with little or no influence on mRNA levels. However, mRNA-array
experiments showed that miRNAs decrease the levels of many targeted mRNAs
[63]. Perfect pairing of a miRNA with its target site may lead to the destruc-
tion of the targeted mRNA through Argonaute-catalysed mRNA cleavage. While
this mode of repression dominates in plants, it is extremely rare in mammalian
miRNA targets [63].
It is estimated that at least 60% of coding genes are repressed by miRNAs
in humans [64]. The miRBase database is a searchable database of published
miRNA sequences and annotations. The current release (version 21) [65] reports
about 1881 precursors and 2588 mature human miRNAs and reports thousands of
others across 223 species. However, several studies show that many more miRNAs
remain to be discovered, both in well-studied model organisms and in human [66]
and therefore the number of published miRNAs is constantly increasing. As
an example, the number of miRNA loci annotated in miRBase has grown by
approximately two-thirds, from 15 172 loci in 142 species (release 16, October
2010) to 24 521 loci in 206 species (release 20, June 2013) [65]. To illustrate the
rapid pace of miRNA-related studies, we carried out a keyword search to retrieve
publications relevant to miRNA research. We show in Figure 1.8 three indicators
of the research status in terms of the number of entries representing hairpin
precursor miRNAs stored in miRBase, the number of publications reported in
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PubMed regarding miRNAs and the number of publications in PubMed with specific
reference to miRNA targets.
Figure 1.8: MiRNA research timeline showing the annual growth of miRNA-
related publications in PubMed and the number of entries in miRBase database.
1.2.2 microRNA and Human Diseases
Although miRNAs have an important role in healthy individuals, increasing work
have shown that miRNAs are also implicated in a wide range of human diseases.
In fact, miRNAs are now recognized to be involved in different types of cancer,
cardiovascular diseases and neurological disorders, where they play a significant
role in the disease development, progression and its prognosis [67]. Consequently,
miRNAs are becoming a novel class of biomarkers or targets for disease diagno-
sis and therapy [68]. Experimental approaches have shown that dysregulation of
miRNAs is linked to the development of various human cancer [69]. According to
[70] and [71], miRNA expression profiles may uniquely identify cancer types while
gain or loss of specific miRNAs may function as an oncogene or tumor suppressor.
All these evidences commonly suggest that finding miRNA target sites (miRTSs)
is expected to be fundamental for novel anti-cancer and viral therapies [72]. Thus,
miRNA drugs are currently being tested in clinical trials. However, limits still
exist that may prevent miRNA-therapy immediate large-scale exploitation. See
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[73] for a detailed review of the personalized medicine field. In the past few
years, a number of databases, that provide experimentally supported miRNA-
disease associations, have been implemented. A manually curated database en-
titled miR2Disease provides a comprehensive resource of miRNA deregulation
in various human diseases [74]. The Human microRNA Disease Database (HMDD
v2.0) is also a database for experimentally supported human miRNA and disease
associations [68].
1.2.3 Experimental Strategies for microRNA Target
Identification
MicroRNA targets can be experimentally verified with gene-specific, as well as
high-throughput techniques. In gene-specific experiments, by measuring the ex-
pression level of the reporter protein or target mRNA, it is possible to draw
conclusions whether the miRNA is directly targeting the 3’UTR by translational
repression or target degradation respectively, since an inverse relationship be-
tween the levels of expression of a miRNA and its target is anticipated.
In vitro reporter gene assays are universally used to confirm a direct regula-
tion of gene expression by a miRNA. To this end, the 3’ UTR of the transcript
of interest is sub-cloned immediately downstream of the reporter gene luciferase
(Photinus or Renilla) or green fluorescent protein (GFP) open reading frame se-
quence. The construct is then introduced into the cell line expressing the targeting
miRNA and the amount of light produced by the luciferase enzyme catalyzing
its substrate is measured. A reduction in light output is interpreted as repres-
sion of luciferase activity that is induced by the miRNA [75]. Firefly and Renilla
luciferases are the most commonly used reporter genes. Alternatively, individual
miRNAs can be successively transfected into a cell line that expresses a luciferase
reporter containing the 3’UTR of the target mRNA of interest and the expression
of reporter gene is measured before and after the introduction of the miRNA to
the cell [75]. Such a procedure can provide direct support but fails to identify
the specific site of interaction. In fact, to demonstrate a direct miRNA-target
interaction in a specific target site, one can measure the gain or loss of miRNA
regulation in different constructs with mutated miRTSs [76].
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Additionally, gene expression changes can also be experimentally quantified
using real time PCR (qRT-PCR). However, miRNAs regulate not only mRNA
expression but also protein levels. Therefore, monitoring miRNA effect at the
mRNA level may identify targets regulated by target degradation and may leave
out targets regulated by translational repression. Thus, the analysis of the effect
on target gene expression can also be done at the protein level using western
blot to compare protein expression given the presence or absence of the miRNA
[76]. Alternatively, the more time-consuming northern blot analysis can be used
in the cases where different isoforms of the target are expressed. The disadvan-
tages of these last measures is that they fail to distinguish between direct targets
(structural interaction) and targets indirectly down-regulated if they are a part
of a miRNA-mediated regulatory module controlled by the direct miRNA targets
(indirect targets) [76; 77].
These gene specific experiments are still time consuming and with the in-
creasing number of new miRNAs and their potential targets, high-throughput
experimental strategies were developed for large-scale analysis of miRNA targets
and their biological function. In fact, since miRNAs act by inhibiting trans-
lation and/or promoting degradation of their targets, the approach consists of
transfection of specific miRNA mimics or inhibitors into the cells followed by
high-throughput analysis of mRNA expression by microarray or high-throughput
sequencing or proteomics [78]. As an example, the pSILAC (pulsed Stable Isotope
Labelling with Amino acids in Cell culture) method directly measures proteins
level changes induced by overexpression of miRNAs using miRNA transfection
or endogenous miRNA knockdown [79]. The same technique is used to mea-
sure mRNA level changes in microarray experiments [80]. However, none of these
high-throughput techniques allows distinction between direct and indirect targets
and only gives indirect evidence about specific miRNA-target interactions. HITS-
CLIP (HIgh Throughput Sequencing by CrossLinking and ImmunoPrecipitation)
is a powerful technique capable of providing an extensive insight to the location
of miRNA targeting within an mRNA. However, this technique can only identify
a targeted region (≈ 100 nt) as opposed to a specific target site [76]. This tech-
nique was improved with the later version called PAR-CLIP (PhotoActivatable-
Ribonucleoside-enhanced CrossLinking and ImmunoPrecipitation). Although the
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sites of miRNA-mRNA interaction are determined, these approaches can’t iden-
tify the specific miRNA-mRNA association experimentally. However, this may
be estimated using features commonly found in experimental samples such as the
seed complementarity feature.
1.2.4 Problem Formulation
The problem of discovering the targeting genes that miRNAs regulate is of a
great importance to developing our understanding of many diseases and viruses.
The number of discovered miRNAs is increasing and each miRNA is thought to
regulate a few hundred target mRNAs [79; 81]. Moreover, experimental based
predictions are time consuming and expensive while most of the real targets are
yet to be discovered. Consequently, efficient and reliable computational methods
for target prediction are required to generate clues and hypotheses for experi-
mental studies.
In plants, an almost perfect base pair complementarity of the whole miRNA
to the mRNA is required, making target identification a simple task [82]. In
animals, on the other hand, miRNAs are only partially complementary to their
mRNA target sequences [83]. Therefore, computationally identifying miRNA
target genes is a challenging problem in bioinformatics. Alkan et al. studied the
general RNA-RNA interaction prediction problem under different models and
proved that it is an NP hard problem [84]. Hence predicted structures need to
be simplified by removing pseudo-knots such that secondary structures have no
crossed base pairs.
1.3 Important Features in microRNA Target
Prediction
Common characteristics found in data with strong experimental support are being
identified. In fact, empirical evidences are examined carefully to extract the
principles of miRNA target recognition. Computational methods perform the
predictions based on these features. In this section, we discuss a few important
principles applied in the prediction algorithms.
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1.3.1 Seed Match Requirement
Some methods require the target sequence to have a perfect complementarity to
a region in the mature miRNA sequence named seed. The seed of a miRNA is
defined as the sequence between the second base and the 8th nucleotide of the
5’ end. This requirement is justified by the fact that the seed region is believed
to be the most evolutionary conserved region of miRNA [85] and that most of
the experimentally validated targets have been observed to have a high degree of
complementarity to the seed sequence of the miRNA. The importance of the seed
match is further emphasized by a study of the crystal structure of the silencing
complex RISC that shows that the seed region is tightly bound to the complex
[86] and also by the observation that miRNAs with almost identical sequences at
their 5’ ends, which form miRNA seed families, share targets [87]. The existing
methods which use the seed match, require as few as 6-nucleotide matching at
the seed region [88]. There are possible 6-mers (positions 1–6, 2–7, and 3–8 from
the 5’ end of the miRNA), 7-mers (positions 2–8 and 1–7 from the 5’ end of the
miRNA), and 8-mer (position 1–8 from the 5’ end of the miRNA) matches in
the seed. Otherwise, a 6-mer match to position 3–8 is called an ”offset 6-mer
seed” because of its position and a marginal effect on repression [88]. Prediction
methods with seed-pairing criteria have their false positive rate and their time
complexity reduced [89]. Nevertheless, some experimentally validated miRNA
targets that do not have a perfect seed match have been identified. Pairing to
the 3’ region of the miRNA can sometimes supplement seed matches to enhance
target recognition, or it can compensate for mismatches in the seed. Such sites are
known as ’3’-supplementary sites’ and ’3’-compensatory sites’ respectively [88].
Moreover, a class of ’centered sites’ described as 11-12 contiguous base pairs to
the center of the miRNA can compensate for the weaker seed complementarity
leading to the assumption that non-seed nucleotides may have a significant free
energy contribution [90]. Therefore in order to avoid missing true targets, some




The miRNA and its targets are shown to be widely conserved across a wide
range of species [64]. Therefore, some computational approaches applied to pre-
dict miRNA targets rely on sequence search similarity between different species,
considering binding site evolutionary conservation. The conservation criteria can
be incorporated into predictions in a variety of ways. While some tools require
target sites to appear at the same position in a cross-species UTR alignment [89],
others require the binding to only occur at overlapping positions in the alignment
of the 3’UTR sequences [91]. Moreover, the number of species involved in UTR
alignment differs with some computational tools requiring only conservation be-
tween human and rodent while others allow extensive conservation involving more
than two species [92]. Considering binding site evolutionary conservation allows
high prediction accuracy [93]. However, further studies have shown that not all
target sites are necessarily conserved. For example, in [92], the analysis of 84 ex-
perimentally verified interactions provided by the DIANA-TarBase database gives
23 interactions with no conserved target sites. Thus, using the conservation cri-
teria may come at the expense of missing real targets. Additionally, binding site
conservation evaluation involves multiple sequence alignments over the different
species and this can be computationally heavy.
1.3.3 Thermodynamics
Similar to the secondary structure prediction problem, early tools used a base
pair counting model to predict interactions between mRNA and miRNA. The
drawback of using this model is that base pairs maximizations do not necessarily
lead to the most stable structure as it may create a structure with many interior
loops or hairpins, which are energetically unfavorable. Therefore, the main focus
of our study will be on methods that are based on thermodynamic stability of the
duplex structure, considering free energy minimization. In fact, the most popular
miRNA target prediction tools rely on traditional RNA secondary structure pre-
diction, where the change in Gibbs free energy ∆Gduplex of the miRNA-mRNA
duplex structure is calculated and used as a determinant component for evalu-
ating their interaction. The lower the free energy of the two paired RNAs, the
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stronger is the binding and the more energy is needed to disrupt this duplex for-
mation. Consequently, a miRNA has a strong affinity to a target mRNA when
the corresponding duplex has a low ∆Gduplex.
1.3.4 Target Site Accessibility
Some tools avoid intra-molecular base pairing by omitting the computation of
folded structures within the monomers and rely almost exclusively on the free en-
ergy change of the duplex formation ∆Gduplex. This assumption that the mRNA
is in linear form certainly reduces the computational complexity. However, recent
studies suggest that this assumption describes only part of the binding process
and that prediction tools can be improved by incorporating the folded struc-
ture of the mRNA into the prediction algorithm [24; 94]. In reality, either the
binding site must not be involved in any base pairing with other parts of the
same mRNA or there should be an energetic penalty ∆Gopen for freeing base
pairing interactions within the mRNA in order to make the target accessible for
the binding. This energetic cost has to be considered in the total hybridization
energy [24; 95]. Methods considering the accessibility of the binding site in-
stead of its conservation provided an alternative way of increasing precision [24].
This feature is used in a variety of ways. The standard assumption in miRNA
target predictions is that the functional state of the mRNA is the MFE struc-
ture. However, recent literature argues in favor of the existence of multiple active
RNA conformations instead of a unique MFE conformation as the single biolog-
ically active state [96]. Long et al. [97] overcame the limitation of using a single
MFE structure in predictions, by averaging over 1,000 structures sampled from
a statistically representative sample from the Boltzmann-weighted ensemble of
RNA secondary structures by using the stochastic sampling method Sfold [98].
In [24], the authors compute the accessibility in relation to the probability that
the target region is unpaired in thermodynamic equilibrium and, additionally,
based on the ensemble of all possible structures in thermodynamic equilibrium,
where RNAfold [22] is utilized. Mar´ın and J. Van´ıcˇek [99] argue that consider-
ing only the MFE structure neglects the possibility that the miRNA binds to a
3’UTR structure with a slightly higher energy than the MFE structure, but with
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better accessibility. The authors compute pair probabilities from the canonical
ensemble of secondary structures generated by RNAplfold [100] in order to find
accessible stretches of nucleotides in the seed matches. They achieve comparable
or better results obtained with MFE structures only. A few other computational
approaches compute the local accessibilities i.e. the probabilities that sequence
intervals are single-stranded in thermodynamic equilibrium. RNAup tool [101] uses
the local folding algorithm RNAplfold [102] to compute the accessibilities of all
intervals of an RNA molecule. RNAplfold algorithm has later been rewritten to
use a more efficient version, which has the same complexity as Sfold (requires
cubic time) [103].
1.3.5 Expression Levels of RNAs
Within the past few years, analyzing concentration levels of miRNAs and their
putative targets has become a major topic in miRNA research. In [104], the
authors provide experimental evidence that the typical number of gene copies
present in a single cell lies between 5–20, with most genes having less than a
100 copies. Individual miRNAs are likewise considered to vary widely, with a
few tissue-specific species present more than 10,000 copies per cell [105]. Conse-
quently, miRNAs are more abundant than mRNAs with an average of 500 copies
per cell. Therefore, the miRNA abundance can help to explain the co-regulation
of a target mRNA by several miRNAs, and the regulation of multiple mRNAs by a
single miRNA. Ragan et al. [106] published results on miRNA target predictions
that utilize information about miRNA and mRNA concentration levels. For the
miRNA target prediction tool TargetScan, Garcia et al. [107] demonstrate how
predictions may improve if target abundance is accounted for in binding scores.
Other implementations such as Sylamer have explored the combined analysis
of miRNA and mRNA expression data to increase the accuracy of miRNA tar-
get prediction and to uncover miRNAs that actively regulate mRNA expression
following a miRNA experiment [108].
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1.3.6 Location of Binding Region
Although functional miRNA sites are thought to be predominantly located in
the 3’UTR of mRNAs, studies where miRNAs have been reported to regulate
gene expression through their binding to the 5’UTR region of target genes have
emerged [109; 110]. Seed sites located in the coding sequence of mRNAs can
also cause downregulation [111]. However, the implication of these interactions
remains obscure due to their smaller impact on mRNA stability compared to
miRNA-target interactions that involve 3’UTRs [112].
1.4 Overview of Computational Methods for
microRNA Target Prediction
The first miRNA target prediction method was published in 2003 by Stark et
al. [113]. This early algorithm for miRNA targets was based on the few known
miRNA-target pairs, comparison of Drosophila melanogaster and Drosophila pseu-
doobscura, and minimal assumptions regarding miRNA-target interaction. The
algorithm successfully predicted new targets that the authors validated experi-
mentally. Since then, several other computational methods have been published
and made available to users. The prediction algorithms are mainly divided into
two main groups: data-driven and rule-based approaches [114]. Data driven
tools collect different types of features and use machine learning techniques to
find the feature patterns shared by true miRNA-target interactions. Such tools
are affected by shortage of reliable training data and the lack of published works
related to thoroughly experimentally refuted targets limits the validity of their
results. On the other hand, rule based algorithms consist of a set of rules tested
according to a particular order, considered as filtered steps [114]. In this section,
some of the most commonly used algorithms for human miRNA target predic-
tion are reviewed. Our review will be mainly focused on rule based algorithms,
although some of the machine learning approaches will be discussed.
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1.4.1 miRanda/miRanda-mirSVR/microRNA.org
miRanda is one of the earliest developed target prediction tools implemented in
2003 [115]. The algorithm consists of a three-step analysis. It first calculates a
score using a position weighted dynamic programming algorithm to assess the
complementarity between miRNA and its target. The scoring method favors
complementarity between the 5’end of the miRNA i.e. the seed region and the
3’end of the mRNA. However this tool does not require perfect seed complemen-
tarity. As a second step, miRanda estimates the free energy of the duplex by using
RNAfold [11] from the Vienna package. To comply with the input of RNAfold,
the miRNA is concatenated with the potential binding site, inserting an artificial
8-bit linker sequence between them formed by the character ’X’. Finally, conser-
vation in related genomes is used in order to validate predicted target sites and
to reduce false positives. However, this tool also allows looking for non-conserved
target sites. As a final outcome, this tool classifies a site as a real binding site if
its free energy is less than a cut-off value. Although the algorithm was originally
used to identify targets in Drosophila, subsequent versions were applied to pre-
dict miRNA-target in humans [116]. miRanda provides a searchable precompiled
dataset and the latest release from 2010 includes the human, mouse, rat, fruit
fly and Nematode species. It also provides a freely downloadable version of their
sourcecode in order for the user to run it locally with their own pairs of miRNA
and target sequences. Later on, Betel et al. [117] designed a new algorithm called
mirSVR for scoring and ranking the efficiency of miRanda-predicted miRTSs by
using supervised learning on mRNA expression changes following miRNA trans-
fections. This machine learning method combines target site information and
contextual features into a single integrated model, and uses support vector re-
gression (SVR) to train on a wide range of features, including secondary structure
accessibility of the site and conservation. Similar to miRanda, miRanda-mirSVR
provides a searchable precompiled dataset. However, the program’s results and
data resources are not always updated and therefore the latest version of miRBase
is not used for the predictions.
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1.4.2 TargetScan
TargetScan is one of the earliest developed target prediction tools, implemented
in 2003 [85]. The algorithm primarily takes the perfect complementarity rule of
the seed region to the putative target sequence into account as a first filtering
step. It also mainly uses the conservation criteria for filtering. Predicted binding
sites are then evaluated thermodynamically using RNAfold [11] from Vienna RNA
folding package and a final score is computed. TargetScanS [89] is an improved
and simplified version of this tool that does not consider free energy and limits
the miRNA complementarity to a six-nucleotide seed match and a match at posi-
tion 1 of 3’end. Conservation is finally required between five species in order for
the binding site to be valid. However, non-conserved sites can also be predicted
as an option. Later versions relaxed the seed match requirement and identify
sites with mismatches in the seed region that are compensated by conserved 3’
pairing [64] and centered sites [90]. Furthermore, a number of additional features
have also been integrated. In particular, a multiple linear regression, trained
on 74 filtered datasets, was used to integrate determinants such as seed-pairing
stability (SPS) and target-site abundance (TA) [107]. TargetScan web interface
allows the user to search by miRNA name, gene name, or from broadly con-
served, conserved, or poorly conserved miRNA families across several species.
The latest release 7 dates from 2015 [118] and includes searchable lists for hu-
man (TargetScanHuman), mouse (TargetScanMouse), worms (TargetScanWorm)
, fruit fly (TargetScanFly) and fish (TargetScanFish) species. TargetScanHuman
considers matches to human 3’ UTRs and their orthologs, as defined by UCSC
whole-genome alignments [119]. TargetScan Perl scripts are also available to
download, the last version dates from 2015.
1.4.3 MicroCosm
MicroCosm Targets (previously known as miRBase Targets) is a web resource
containing computationally predicted targets for miRNAs across many species
[115; 120]. MicroCosm uses the miRanda algorithm to identify potential binding
sites. The current version 5 uses dynamic programming alignment to identify
highly complementary sites, which are scored between 0 and 100, where 0 repre-
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sents no complementarity and 100 complete complementary. Strict complemen-
tarity to the 5’ seed region is required by the algorithm. Furthermore, target sites
selected by miRanda are passed through the Vienna RNA folding routines [11] to
evaluate their thermodynamic property. Finally every potential target site is
checked to see whether the site is conserved in orthologous transcripts from other
species. The last release of the database (v5) dates from 2008.
1.4.4 RNAHybrid
RNAHybrid [121] directly predicts optimal and suboptimal secondary structures
for the hybridization of miRNA and a large target RNA. The algorithm finds
the energetically most favorable hybridizations of a small RNA to a large RNA.
The calculation is simplified by allowing only inter-molecular base pairs. Using
dynamic programming technique, bulge loops and internal loops are restricted
to a maximum length. RNAhybrid uses perfect seed match by default (although
this can be user defined) to find all possible binding structures and picks the
structure which gives the MFE. This MFE along with its p-value are compared
to user-defined cut-offs in order to classify the given 3’UTR as a target to the
input miRNA. The energy model used in RNAhybrid is essentially equivalent to
the classic RNA folding algorithm of Zuker [12] where only interior loops are
allowed. In case of long sequences, it is possible that many hybridization sites
reach significant interaction energy and therefore RNAhybrid reports suboptimal
hits. A later version of the tool have been implemented, where a few features, such
as the possibility to disallow G:U base pairs in the seed region, and a seed-match
speed-up, which accelerates the program by a factor of 8, have been included [122].
RNAhybrid was originally available through a web command line downloadable
tool. However, the program can now also be used as a web service for remote
calls, thus eliminating the need for a local installation.
1.4.5 PicTar/doRiNA
The Probabilistic Identification of Combinations of Target sites (PicTar) method,
first implemented in 2005, allows the identification of targets for both single
miRNAs and combinations of miRNAs. Input to PicTar consists of a fixed search
26
set of co-expressed miRNAs and multiple alignments of RNA sequences (typically
3’ UTRs). Outputs are scores that rank genes by their likelihood of being a
common target of members (subsets) of the search set and probabilities for the
predicted binding sites in each UTR [91]. As a first step, the algorithm looks at
perfect seed matches, perfectly Watson-Crick base paired stretches of ≈ 7 nt, to
the given miRNA among a group of 3’UTRs. In the case of imperfect matches, the
free energy is computed and compared to a threshold binding energy. Once the
probabilities for each subsequence of the RNA sequence to be a binding site for
the miRNA are fixed, a score is computed based on the previous steps, taking into
account the conservation across species. This tool is represented as a searchable
precompiled dataset available via the novel database DoRiNA [123], where the
most recent PicTar predictions for all species date from 2014 [124].
1.4.6 PITA
Probability of Interaction by Target Accessibility (PITA) [24] uses target-site ac-
cessibility as the major feature for miRNA target prediction. The algorithm first
scans the mRNA sequence for potential target sites by searching near perfect seed
matches. Then for each binding site within the mRNA, a thermodynamic model
is used to compute the accessibility energy score ∆∆G = ∆Gduplex − ∆Gopen,
that is the difference between the energy of the duplex ∆Gduplex and the energy
required for making the target region accessible for miRNA binding ∆Gopen. The
tool RNAduplex [125] from the Vienna package is used to predict the MFE struc-
ture of the duplex ∆Gduplex. Computing the accessibility is directly related to the
probability that the target region is unpaired in thermodynamic equilibrium and
is based on the ensemble of all possible structures in thermodynamic equilibrium
rather than a single MFE structure, using the RNAfold tool[22]. The disruption
energy ∆Gopen is determined by computing the free energy difference between the
native mRNA secondary structures and the same structures with the target re-
gion, including additional nucleotides upstream and downstream, required to be
unpaired. As a final step and in the case of multiple sites for a single miRNA, the
energy scores are appropriately summed to form a score for the total interaction
energy of the duplex. PITA is available as an online user interface, where the user
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can choose between the fly, worm, mouse and human organisms and can enter
any seed match parameters. Additionally, PITA webpage provides precompiled
dataset and the latest update of PITA Catalog version 6 dates from 2008. Users
have also the option to download PITA executable in order to run the tool on the
command line.
1.4.7 STarMir
STarMir[97] RNA target prediction tool is based on a two-step nucleation ex-
pansion model. In the two-step model, hybridization nucleates at an accessible
target site, and then the binding elongates to form the complete miRNA-target
duplex. To overcome the limitations of using a single MFE structure in predic-
tions, Sfold algorithm [98] is used to get a sample of 1,000 secondary structures
from the entire Boltzmann ensemble to compute target accessibility profiles for
the putative target sites.
• Nucleation stage
This stage is related to the assumption that nucleation requires a gain in
free energy from base-pairing at the nucleation site that is greater than
the energy cost for the translational and rotational entropy loss when two
RNA strands are fixed in a conformation by intermolecular base-pairing.
The energy cost for the translational and rotational entropy loss is called
initiation energy ∆Ginitiation. The standard setting in STarMir is ∆Ginitiation
= 4.09 kcal/mol. The first step in this stage is to find potential target sites.
With the help of a window of length four nucleotides, the accessibility profile
shows the probability that the four consecutive nucleotides starting at the
indicated nucleotide are all single stranded. A potential site is a block that
has a probability of 0.5 or greater of being unpaired. As a second step,
for each potential site, the best binding with the miRNA is computed. For
each secondary structure i, 1 ≤ i ≤ 1, 000, compute the nucleation potential
∆GN,i over all structures from the sample structures and then the average
is calculated. In fact, the algorithm checks for each structure in the sample
how many four consecutive nucleotides are free within the binding site and
then calculates the binding of these four nucleotides and takes the smallest
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of all, i.e. the strongest binding. This energy value will represent the
structure and finally, an average of these values is computed and given as
a nucleation potential ∆GN . The requirement for further processing of the
particular miRNA-mRNA interaction is given by:
∆GN + ∆Ginitiation < 0kcal/mol.
• Elongation stage
Once a target site has passed the nucleation threshold, the total interaction
energy between the miRNA and the mRNA is computed, using a similar
method to the model used in PITA. The tool RNAhybrid [121] is used to
compute the MFE structure of duplex ∆Ghybrid which is required to be
less than a threshold of -14 kcal/mol. The difference between the free
energy of the duplex ∆Ghybrid and the free energy needed to disrupt the
structure of the target site ∆Gopen is computed and gives the main score
for this potential binding site similar to the ∆∆G score for PITA. ∆Gopen is
computed as a difference between the native mRNA structure free energy
and the free energy of the same structure with the target site unpaired. The
average over all the structures is computed.
In the case of multiple sites, the scores are linearly summed and compared
to a threshold (-10 kcal/mol). STarMir adds the extension to the coding region
and 5’UTR to predict the secondary structure as an option. Moreover, there is
no requirement for a seed match in contrast to most other prediction methods.
Therefore, this tool is generic and not specific to the miRNA target prediction.
A later version, implemented in 2013, introduced logistic prediction models de-
veloped with miRNA binding data from CrossLinking and ImmunoPrecipitation
(CLIP) experiments [126]. The model is also utilizing evolutionary conservation
information for predictions if the user specifies the sequence using the RefSeq
ID. STarMirDB [127], a web searchable database currently including all predicted
binding sites by the models for miRNAs and mRNAs in the HITS-CLIP and V-
CLIP studies, with an indicator showing whether a site is supported by the CLIP
study, has also been developed, for human mouse and worm species. STarMir
web server [128] allows users to submit their own miRNA and mRNA sequences
for prediction of binding sites by the models.
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1.4.8 DIANA-microT/DIANA-microT-CDS
DIANA-microT [129] is one of the most widely used tools since its initial launch
in 2009. The initial algorithm is based on the dynamic programming to predict
potential binding sites and uses a 38-nucleotide window that progressively moves
across the 3’UTR sequence one nucleotide at a time. The putative pair are
first assessed whether there were at least three consecutive canonical pairings
between the two sequences and then the MFE of the potential site is calculated.
Finally, the algorithm filters weaker bindings based on specific rules focusing on
the number of consecutive base pairs towards the 5’ end region of the miRNA as
well as the 3’end and the size of allowable bulges in the miRNA or its cognate
mRNA. In [130], a later version was implemented with a change in the binding
rules, focusing more on the alignment between the seed region of the miRNA
and the target sequence. Target sites are then scored according to their binding
category and degree of conservation in other species and an overall miRNA-
target gene (miTG) score is calculated through the weighted sum of all target
sites’ scores lying on the 3’UTR. The algorithm also allows looking for non-
conserved target sites. Later on, a new machine-learning version of the microT
algorithm, DIANA-microT-CDS, has been specifically designed to identify miRNA
targets both in 3’UTRs and in coding sequences (CDS) [131]. DIANA-microT web
server v5.0 hosts the most recent version of DIANA-microT-CDS algorithm [132]
implemented in 2013, and is using data from Ensembl version 69 and miRBase
version 18, and currently hosts miRNA target predictions for Homo sapiens, Mus
musculus, Drosophila melanogaster and C. elegans.
1.4.9 Sylamer/SylArray
Sylamer is a prediction method for detecting microRNA target from expres-
sion data [108]. The algorithm quantifies the over or under representation of
miRNA seed matches in a sorted list of genes from an expression experiment.
The significance of enriched binding sites is calculated using hypergeometric p-
values. SylArray [133] provides a database and a user interface to the Sylamer
algorithm. It allows the user to upload an ordered gene list obtained from a
microarray or other high-throughput miRNA experiment. SylArray utilizes cu-
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rated sets of 3’UTRs to attach sequences to these genes and then applies the
Sylamer algorithm for detection of miRNA signatures in those sequences. The
graphical output is a landscape plot of the enrichment p-values for miRNA seed
complementary sites in 3’UTRs, calculated in incremental parts of the submitted
ranked gene list [133].
1.5 Online Resources for microRNA Research
In this section we present a brief overview of the most widely used databases
and repositories, which offer fundamental data resources to any miRNA research
process. Some prediction tools provide precompiled predictions on their website
such as PITA, TargetScan and Pictar. Others provide web interfaces such as
STarMir or allow users to download a version of their program such as miRanda.
To accurately measure the performance of a prediction tool, it is important to
have a sufficient number of experimentally validated and refuted miRNA-target
interactions. An important source of experimentally validated miRNA-target in-
teractions is the DIANA-TarBase database provided by the Diana lab. The latest
version v7.0 from 2014 includes more than half a million miRNA:gene interac-
tions, curated from published experiments implemented utilizing 356 different cell
types from 24 species [134]. For each interaction, it provides a detailed descrip-
tion of the gene and the miRNA, its related publications and the experiments
used for its validation. Another resource for experimentally validated miRNA
targets is the miRecords database. The latest version, dated from 2013, hosts
2705 records of interactions between 644 miRNAs and 1901 target genes in 9
animal species. Among these records, 2028 were curated from low-throughput
experiments [135]. The miRTarBase provides the most updated collection by com-
paring with other similar, previously developed databases [136]. The starBase
database [137] collects data provided by high-throughput CLIP-seq (PAR-CLIP,
HITS-CLIP, iCLIP, CLASH). This type of data consists of sites of interaction for
the mRNA-miRNA-Argonaute complex on a transcriptome-wide scale. The last
version v2.0 [138] identifies RNA-RNA and protein-RNA interaction data from
108 CLIP-Seq generated by 37 independent studies.
Furthermore, several human genome annotation databases have been devel-
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oped. These include RefGene (RefSeq Gene [139]), Ensembl [140], and the UCSC
annotation database [141]. For most cases the data is the same between these
different repositories. However, in [142], the authors demonstrate that the choice
of a gene model may have a dramatic effect on both gene quantification and differ-
ential analysis. miRBase database [65] is the main used repository for published
miRNA annotation and nomenclature. microRNA.org [143] provides a collection
of miRNA expression profiles in various tissues and cell lines while the Expres-
sion Atlas [144] provides information on gene expression patterns under different
biological conditions.
1.6 Comparison of Prediction Methods
Target prediction tools certainly facilitate target identification as they are used
to pre-select the putative targets of a given miRNA. However, biologists are fac-
ing the problem of how to select the best tool to use based on the needs of a
particular experiment. Moreover, the vast number of predicted targets makes
it a challenge for scientists to choose which interactions are worthy to validate
experimentally, and which ones will have a major impact in a given biological
pathway under study. Some miRNA target computational methods are available
as web servers allowing users to search precomputed prediction results. These
tools are convenient and usually easy to use. However, the annotation databases
are updated frequently and especially for miRNAs, the differences between ver-
sions are significant and therefore the available predictions should be updated
regularly. Furthermore, some web servers do allow predicting for novel mRNA
and miRNA sequences, allowing users to provide mRNA and miRNA sequences.
These include STarMir and PITA web servers. Other computational methods are
available as stand-alone packages, allowing the user to run their own predictions
on their local machine. This is particularly useful when predicting for a large
number of mRNAs and miRNAs. When predicting the target site, the methods
that can only predict target genes cannot be used. The performance of compu-
tational tools can be measured by standard measures like sensitivity also called
true positive rate (TPR), specificity and false positive rate (FPR).
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Sensitivity = TPR = TP
TP+FN
TP (true positives) is the number of predicted miRNA-target interactions that
really exist. FN (false negatives) is the number of miRNA-target interactions that
do exist but are not predicted. Thus, sensitivity is the percentage of correctly






FP (false positives) are the experimentally rejected miRNA-mRNA interac-
tions that are wrongly predicted by the tool. TN (true negatives) are also im-
portant, that is is the number of non-existing miRNA-target interactions that
are correctly not included in the predictions. Subsequently, specificity is the re-
lation of the number of correctly not predicted interactions that do not exist
to the number of all experimentally refuted interactions. Both sensitivity and
specificity have to be maximized to achieve a good performance and the FPR
should be minimized. A suitable method to evaluate the relation between the
sensitivity and the specificity is a Receiver Operating Characteristic (ROC) anal-
ysis. The ROC curve is a plot of the sensitivity versus the FPR, which helps
to find the optimal balance between these two measures. The area under the
curve (AUC) is a comparable value for the overall performance and it ranges
between 0 for a method that does not predict TP and 1 for a perfect predic-
tor, with 0.5 denoting a meaningless result. Several computational methods were
benchmarked using datasets identified by high-throughput experiments. In [117],
Betel et al. compared mirSVR against a number of existing target prediction al-
gorithms using a large panel of independent miRNA transfection and inhibition
experiments as test data. Their results show that mirSVR strongly outperforms
the alignment-based (miRanda) and energy-based (PITA) scores for the task of
ranking single-site genes by their downregulation (upregulation) in response to
microRNA transfection (inhibition). However, these methods were not trained
on genome-wide expression data and therefore were not expected to perform as
33
well as supervised approaches such as mirSVR. On the other hand, mirSVR per-
forms better than TargetScan’s context score in 21 out of the 25 test sets, which
constitutes a statistically significant improvement. In [127], the performance of
STarMir’s CLIP-based logistic model was tested by both intra-dataset valida-
tion and inter-dataset validation. Liu et al. compared STarMir predictions with
predictions available from TargetScan, mirSVR, PITA and RNA22 [145]. Logistic
models trained on five different CLIP datasets all have substantially higher TPR
than TargetScan and mirSVR, RNA22 with comparable FPR, and lower FPR than
PITA, RNA22 with comparable TPR. Additionally, for inter-dataset validation, the
authors noticed an improvement in predictions. In [118], Agarwale et al. com-
pared predictions of TargetScan7 to several miRNA target prediction tools, in-
cluding DIANA-microT-CDS, miRanda-MicroCosm v5, mirSVR, PicTar2 and PITA
Catalog v6, using the results of seven microarray datasets. The authors tested
how well each of the methods predicted the repression of mRNAs with at least
one canonical 7-8 nt 3’ UTR site and found that TargetScan’s context++ model,
DIANA-microT-CDS and miRanda-miRSVR were among the most predictive tools.
In [131], the prediction sensitivity and precision for several methods is tested on a
dataset identified by the pSILAC method [79]. The DIANA-microT-CDS program
exhibits the highest sensitivity at any level of specificity in comparison with six
other programs including miRanda, Pictar and TargetScan 5.0.
Additionally, several surveys were proposed to analyse and compare compu-
tational methods using independent datasets. In [146], to test the sensitivity of
target prediction algorithms, the authors used HITS-CLIP datasets for human,
mouse and C. elegans downloaded from the starBase database. miRanda algo-
rithm (applied on 3’ UTR sequences) shows the maximum coverage of miRTSs
(66%) followed by PITA, TargetScan and Pictar. In [147], the authors give a
recent comprehensive overview and assessment of computational prediction of
miRNA targets in animals. The authors compared the performance of seven pre-
dictors on four benchmark datasets and found that although certain methods, like
TargetScan and miRmap [148], offer high overall predictive quality, there is no a
universally best predictor. For instance, PicTar and MirTarget2 [149] provide
predictions with high specificity and low number of FP.
It is important to highlight that none of the existing tools could capture all
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true targets and the FPR is still relatively high. Moreover, the performance of a
method is not consistent across different datasets. Thus, how to obtain reliable
and comprehensive results is a long-standing challenge for miRNA target predic-
tion. As a result, several tools have been integrated into one body of information
to form either a database such as miRecords’ Predicted Targets component [135],
an integration of predicted miRNA targets produced by 11 established miRNA
target prediction programs, or into a single miRNA target prediction algorithm
such as the SMILE tool [150], which integrates the outcomes of individual predic-
tion tools with the aim of surpassing the performance of the individual tools. A
detailed review of some of the existing integrated data resources can be found in
[151].
1.7 miRNA-related Polymorphisms as
Biomarkers
Polymorphisms are DNA sequence variations that may exist in several forms. The
most common forms are Single Nucleotide Polymorphisms (SNPs) which involve
a change in one single nucleotide. SNPs typically have two alleles at the specific
base position in the genome i.e. within a population there are two commonly
occuring nucleotide variations [152]. For a given SNP, the allele that was either
first discovered or is the most common is considered the reference against which
all other forms are compared. This reference form is called the wild-type allele
[153]. The allele that is observed to have the lowest frequency at a locus in a
particular population, is called the minor allele.
miRNA-related polymorphisms include SNPs located within miRNA sequence
or miRNA-binding target sites. These are defined as miRSNPs and are typ-
ically located at the seed sequence and the 3’UTR of mRNAs, respectively.
Small insertions and deletions (INDELS) in miRNA sequences and miRTSs are
also considered as the second largest class of genetic variants after SNPs [154].
miRNA-related polymorphisms are increasingly thought to play a significant role
in pathological dysregulation of gene expression. In fact, these polymorphisms
have been associated with many human diseases, including cancer [155], diabetes
35
[156], inflammatory diseases [157], Parkinsons disease [158] and many other dis-
eases. Consequently, identifying functional miRNA-related SNPs are of interest
for disease-related studies.
A genome-wide association study (GWAS) is an approach that involves scan-
ning markers across complete sets of genomes of many individuals to find genetic
variations associated with a particular disease. GWASs have successfully discov-
ered hundreds of novel genomic loci that influence human disease susceptibility
and therefore helped identify genetic risk factors for common diseases in the pop-
ulation [152]. Alleles that are associated with higher risk of a particular human
disease are called risk alleles. The current build 144 of dbSNP database [159] in-
clude around 100 millions validated human SNPs. GWASs are based upon the
principle of linkage disequilibrium (LD) at the population level. LD describes the
degree to which alleles at two or more nearby loci are correlated to each other
within a population [152]. The LD structure was investigated in the HapMap
project [4] and the outcome was a list of SNPs that captured most of the com-
mon genomic variation in a number of human populations. A brief introduction
to the the early history of GWASs is given in [160], where the authors list some
of the first discoveries made through this experimental design.
A recent review of miRSNPs as biomarkers in cancer management and re-
search is given in [155]. miRNA dysregulation in cancer was first reported in
2002 when miR-15 and miR-16 were shown to be involved in Chronic Lympho-
cytic Leukemia (CLL) pathogenesis [161]. A subsequent study demonstrated that
a variation in the primary sequence of the miRNA cluster encoding miR-16-1 and
miR-15a results in reduced mature expression of miR-16-1 and miR-15 in vitro
and in vivo, and is associated with deletion of the chromosome region containing
this miRNA cluster [162]. This DNA variant was found in 11 of 75 patients with
CLL but not observed in 160 subjects without cancer [162].
miRNA-related SNPs were first reported to affect phenotype in 2005 when a
mutation in a miR-189 binding site of SLITRK1 was found to be associated with
Tourette’s syndrome [163]. The authors showed that the 3’UTR SNP destroys
a target site for miR-189, making this work the first evidence that a 3’UTR
SNP could inhibit miRNA binding [163]. The first work to report that a 3’UTR
SNP could create an illegitimate miRNA target site was published in 2006 [164].
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The authors showed that a SNP in the 3’UTR of myostatin caused muscular
hypertrophy in Texel sheep [164]. The SNP creates an illegitimate target site for
miR-1 and miR-206, which are highly expressed in skeletal muscle and specifically
target the variant allele.
Since these initial observations, a number of studies have used systematic
sequencing and in silico approaches to identify SNPs in miRNA target genes. As
an example, it has been shown that a SNP in the 3’UTR of KRAS gene, located
in the binding site of miRNA let-7, weakens its inhibition and increases the risk
of non small cell lung cancer [165].
Polymorphisms within miRNA genes have been reported to be relatively rare,
with only approximately 10% of human pre-miRNAs having documented SNPs,
and less than 1% of miRNAs having SNPs in the functional seed region [166].
As a consequence, the information about miRNA seed region polymorphisms has
received much less attention compared to the SNPs that occur in the miRNA
target site [167]. As an example, a study discovered that a mutation in the seed
region of human miR-96 was responsible for nonsyndromic progressive hearing
loss [168]. A detailed review listing some of these disease-associated mutations
and their effect on miRNA regulation is given in [169].
Several online databases have been developed storing SNPs in miRTSs and/or
miRNA sequences. mirdSNP database [170] is a database including disease-
associated SNPs (dSNPs) on the 3’UTRs of human genes manually curated from
PubMed. PolymiRTS (Polymorphism in microRNAs and their Target Sites) is
a database of naturally occurring DNA variations in miRNA seed regions and
miRTSs [171]. There also exist two other databases with a similar purpose to
PolymiRTS: MicroSNiPer [172] and Patrocles [173], which integrate SNPs, phe-
notype, and expression data. However, the number of discovered SNPs is still
increasing following the same pace as the rapidly growing genomic data and
therefore these databases should be updated on a regular basis. Sethupathy
and Collins [174] critically assess several genetic association studies related to
miRNA bindings and the potential impact of SNPs in bindings regions. The au-
thors highlight the importance of follow-up functional experiments for a deeper
understanding of the real effect miRNA target site variations may have on the
development of various human diseases.
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1.8 Organisation of the Thesis
The present work is an investigation into the impact of disease-associated SNPs
on the thermodynamics of the mRNA-miRNA interaction and accessibility of
the target and the role of computational methods in predicting this impact. We
are particularly interested in exploring how these SNP-effect predictions could
be more accurate if accessibility features related to RNA secondary structures
different from MFE conformations are taken into account. Chapter 2 introduces
our manually curated dataset and the main motivation of our work. The rest of
the thesis is organized as follows. The problem of miRNA bindings to metastable
secondary structures in the context of SNPs and mRNA expression levels will be
studied in chapter 3. We showed that the number of metastable structures and the
features of miRNA bindings to metastable conformations can provide additional
information supporting the differences in expression levels of mRNAs and their
corresponding SNP-infected variants. In chapter 4, a novel target prediction tool
that incorporates metastable secondary structures with low energy levels into
predictions is introduced. The algorithm of the proposed method is discussed
and a summary of the test results is given. In the last chapter, we summarize the





miRNA Target Sites Dataset
The aim of this chapter is to introduce the main motivation of our work on
how to improve detecting the effects of the miRSNPs on miRNA bindings. We
first introduce the dataset that will be used throughout our work. This dataset
includes 34, manually curated, disease associated SNPs within miRNA target
site cases. We analyzed the relevant publications and we extracted the common
framework followed in most of these studies and listed the most frequently used
miRNA target prediction tools. We then tested the performance of the avail-
able databases on our dataset of 34 disease associated SNPs. Three categories
of miRNA-target gene related research databases were of particular interest: the
databases which offer repositories for experimentally validated miRNA-target in-
teractions, the databases which provide direct access to miRNA-target predictions
from several well established tools and finally databases offering SNP-effect pre-
dictions. A comparison between these databases is given for each category. We
finally compared results of two major computational approaches to miRNA tar-
get ranking prediction: conservation feature using TargetScan tool and target
site accessibility feature using PITA and STarMir tools.
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2.1 Background
miRNAs are short non-coding RNAs known to possess important post- transcrip-
tional regulatory roles. They bind to mRNAs that contain specific complementary
target sub-sequences, and this way blocking the mRNA translation into proteins
[58]. Hundreds of targeted genes associated with cancer, cardiovascular disease,
viral infections and other diseases have been experimentally verified [136; 175].
However, the number of discovered miRNAs is increasing [65], and each miRNA
is thought to regulate a few hundred targeted genes in mammals [176]. Therefore,
the problem of finding genes that are regulated by miRNAs is of a great impor-
tance to a better understanding of biological processes. Identifying experimen-
tally miRNA targets is a laborious process with time-consuming and expensive
experiments, and therefore computational methods for miRNA target prediction
are applied for narrowing down potential candidates for experimental validation.
The first computational target prediction tools were published and made available
in 2003 [85; 115], and over the past decade a variety of computational methods
has been developed for identifying putative targets of miRNAs. Besides other
features, accessibility, conservation and thermodynamics are important factors
for miRNA-target interaction.
It has been shown that the regulation of gene expression by miRNAs is a
complex process and that dysregulation of miRNA networks has been implicated
in several diseases. Different regulatory mechanisms can control miRNA expres-
sion and cause its alteration in human diseases [177]. miRNA expression can be
modulated as a consequence of defects in the miRNA biogenesis machinery. A
deregulation of miRNA expression can also be a result of increased or decreased
transcription due to an altered transcription factor activity [177]. Another rea-
son for disturbed miRNA-mediated gene regulation are polymorphisms within
miRNA-binding target sites, commonly called miRSNPs.
The impact of SNPs on minimum free energy mRNA conformations has been
comprehensively studied in [178]. The authors analyzed a total number of 34 557
SNPs in 12 450 genes. The minimum free energy conformations were calculated by
using RNAfold. The authors provide a great variety of data about the distribution
of SNPs within mRNA transcripts and their effect on minimum free energy values
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of secondary structures as well as on the profile of the ensemble of suboptimal
structures and structures with high Boltzmann probabilities, see also [36; 96; 179]
for the impact of SNPs on the ensemble of secondary structures. The study [178]
also includes the analysis of various subsets of transcripts and SNPs, e.g. with
respect to the transcript length and different SNP types.
Martin et al. [179] study structural changes induced by SNPs in the 5’UTR
of the human FTL gene in conjunction with associated SNPs that restore the
overall wild-type ensemble of secondary structures, thus leading to the notion of
structure-stabilizing haplotypes. The authors also analyzed the stabilizing effect
of multiple structure-stabilizing haplotypes on binding sites of miRNAs and RNA
binding proteins (nine cases of 3’UTRs and one case of 5’UTR). As pointed out
by the authors, the findings suggest that certain SNP pairs are conserved in the
human population because they stabilize ensembles of mRNA conformations.
In [180], the authors used SNPs cases to either cause a destabilization of the
interaction due to changes in the free binding energy or a change in target acces-
sibility due to alterations in the RNA secondary/tertiary structure. Their results
suggest to not only consider the influence of a SNP on the miRNA target in-
teraction through introduced mismatches but also on miRNA target accessibility
through secondary structure alterations caused by SNPs inside or in the vicinity
of miRNA target sites (miRTSs) when searching for a possible disease association.
Consequently, the aim of our work is to analyze the impact of SNPs on the
thermodynamics of the mRNA-miRNA interaction and accessibility of the tar-
get and the role of computational methods in predicting this impact. To this
end, we researched the recent literature for experimental studies on the impact
of SNPs on miRNA bindings. We carried out a keyword search in the PubMed
database using the search terms ”miRNA”, ”target”, ”polymorphism/variant”,
”disease” and ”3’UTR”. Moreover, some of the publications were sourced from
the Human microRNA Disease Database (HMDD) [181]. All miRSNP-disease asso-
ciation studies were included in the present work if they met the following three
conditions:
• (i) The expression levels of both alleles involved are analyzed experimentally
by SNP genotyping (for some instances, a combination of clinical associa-
tion studies and strong in silico results) or related methods involving PCR
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experiments.
• (ii) The underlying allele information can be extracted as consistent data
from the NCBI database, the dbSNP database and the Ensembl database
(3’UTR transcripts from BioMart).
• (iii) Identifying all metastable conformations within an energy offset δE
above MFE conformations is computationally feasible (3’UTR length .
1100 nt).
Meeting all three conditions at least to a certain extent reduced the number of
case studies we found to a set of 34 RNA instances.
The sequence IDs were retrieved the NCBI Single Nucleotide Polymorphism
Database (dbSNP) of nucleotide sequence variation. We also utilized miRdSNP
[170] and mirTarbase [136] for retrieving information related to wild type and
variant alleles, ensuring this way a maximum consistency between the publication
and the different databases. A detailed description of all instances in terms of
Ensembl ID codes is provided in Supplementary Material in Section .1, where for
each case, we explain how the UTR is retrieved from the relevant publication and
how the differences in the UTR annotation are resolved. The sequence length
refers to data directly obtained from the NCBI database together with transcript
information provided by the Ensembl Biomart database, and the length ranges
between 124 nt and 1177 nt.
Subsequently, we analyzed the corresponding publications to retrieve informa-
tion about the common followed framework and more importantly the in-silico
analysis carried out in most of these studies.
2.2 Disease-associated miRSNPs Dataset
The selection of our dataset was governed by the need of having miRNA-mRNA
interactions with a high level of experimental validation. We extracted 34 in-
stances of [mRNA/3’UTR;SNP;miRNA] interactions, from comprehensive stud-
ies based upon PCR and/or luciferase reporter assays, considered to be the best
evidence of direct regulation. The data are sourced from the following publica-
tions:
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[LIG3;rs4796030;miR-221]: The case is analyzed in [182]. The SNP rs4796030
is defined by A↔C at 3’UTR position 83 of NM 002311.4. The 3’UTR length
is 124 nt. The authors studied bladder cancer cases by using genotyping assays.
The authors conjecture a stronger inhibitory effect of miR-221 for the C-allele.
[MSLN;rs1057147;miR-611]: The case is analyzed in [183]. The SNP rs1057147
is defined by G↔A at 3’UTR position 69 of NM 001177355. The 3’UTR length is
132 nt. Dual-luciferase assays showed a significantly lower reporter activity when
the vector harbored the G allele as compared to the A allele. miR-611 mimic
caused a reduced reporter activity of vectors harboring the G allele, concluding
a stronger inhibitory effect of miR-611 for the G allele.
[CGA;rs6631;miR-1302]: The case is analyzed in [184]. The SNP rs6631 is
defined by T↔A at 3’UTR position 215 of NM 000735. The 3’UTR length is
258 nt. Results of dual-luciferase reporter assays reveal that miR-1302 negatively
regulates CGA, and the substitution of T by A at rs6631 within the binding site
disrupts its regulation. The authors observe a stronger inhibitory effect of miR-
1302 for the A-allele.
[CBR1;rs9024;miR-574-5p]: The case is analyzed in [185]. The SNP rs9024
is defined by G↔A at 3’UTR position 133 of NM 001757.2. The 3’UTR length
is 284 nt. The authors employed dual-luciferase assays to evaluate the miRNA
binding to both alleles and observed a stronger inhibitory effect of miR-574-5p
for the A-allele.
[HTR3E;rs56109847;miR-510-5p]: The case is analyzed in [186], see also
[174]. The SNP rs56109847 (rs62625044) is defined by G↔A at 3’UTR position
76 of NM 001256614.1. The 3’UTR length is 302 nt. The authors measure lu-
ciferase activity to evaluate the miRNA binding to both alleles and observe a
stronger inhibitory effect of miR-510-5p for the G-allele, see Figure 1B in [186].
[KRT81;rs3660;miR-17]: [KRT81;rs3660;miR-20b]: The case is analyzed
in [187]. The SNP rs3660 is defined by G↔C at 3’UTR position 102 of NM 002281.
The 3’UTR length is 342 nt. An increased expression of the reporter gene for the
C allele of rs3660 compared with the G allele was observed by luciferase assay.
The G to C change reduced binding efficiency of miR-20b and miR-17-5p to
KRT81 mRNA, leading to decreased translational repression, thereby increased
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KRT81 expression in rs3660C allele compared with rs3660G allele.
[SPI1;rs1057233;miR-569]: The case is analyzed in [188]. The SNP rs1057233
is defined by C↔T at 3’UTR position 330 of NM 003120. The 3’UTR length
is 369 nt. The authors investigate a possible association between SPI1 poly-
morphisms and systemic lupus erythematosus(SLE). Transfection experiments
demonstrated that miR-569 can inhibit the expression of a reporter construct
containing the non-risk allele (C), but not the risk allele (T), suggesting that the
loss of microRNA-mediated regulation of expression could be a potential molecu-
lar mechanism of overexpression of SPI1 that might contribute to the occurrence
of SLE.
[HLA-G;rs1063320;miR-148a-3p]: The case is analyzed in [189]. The SNP
rs1063320 is defined by C↔G at 3’UTR position 233 of NM 002127.5. The 3’UTR
length is 386 nt. The study aims at exploring factors affecting the asthma risk.
The authors used real-time PCR and luciferase assays for measuring expression
levels of miRNAs and C/G-alleles and found evidence for a stronger inhibitory
effect of miR-148a-3p for the G-allele.
[MTHFD1L;rs7646;miR-197]: The case is analyzed in [190]. The SNP rs7646
is defined by A↔G at 3’UTR position 120 of NM 015440. The 3’UTR length
is 393 nt. The authors study polymorphisms in the mitochondrial folate gene
MTHFD1L associated with the risk of neural tube defects (NTDs). Their results
indicate that miR-9 and miR-197 specifically downregulate MTHFD1L levels in
HEK293 and MCF-7 cells and that SNP rs7646 significantly affects miR-197 bind-
ing affinity to the MTHFD1L 3’UTR, causing more efficient post-transcriptional
gene repression in the presence of the allele that is associated with increased risk
of NTDs. These findings were verified in vitro using the luciferase reporter assays.
[NFKBIA;rs696;miR-449a]: The case is analyzed in [191]. The SNP rs696 is
defined by G↔A at 3’UTR position 126 of NM 020529. The 3’UTR length is
502 nt. Experiments showed that miR-449a reduced the relative luciferase ac-
tivities via the NFkBIA 3’UTR target site created by the A allele. The results
indicate that A allele strengthens the binding of miR-449a with 3’UTR of NFk-
BIA, which in turn inhibits the expression of NFkBIA.
[TYMS;rs2790;miR-1248]: The case is analyzed in [192]. The SNP rs2790
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is defined by A↔G at 3’UTR position 89 of NM 001071. The 3’UTR length is
502 nt. In vitro functional study for TYMS rs2790 was carried out. Luciferase
assays showed a lower expression level for rs2790 G allele as compared with A
allele, and the hsa-miR-1248 had an effect on modulation of TYMS gene. The
authors conclude a stronger inhibitory effect of miR-1248 for the G allele.
[CCNE1;rs3218073;miR-151a]: The case is analyzed in [193]. The SNP
rs3218073 is defined by C↔T at 3’UTR position 332 of NM 001238. The 3’UTR
length is 531 nt. Luciferase reporter assays were used to indicate that CCNE1
was a direct target of miR-151, and the rs3218073 T to C change resulted in
altered regulation of CCNE1 expression. These findings support the hypothesis
that miR-151 directly targets CCNE1 expression, and the variant T allele alters
the dependence of CCNE1 3’UTR, thus allowing increased CCNE1 expression in
the presence of this variant allele.
[NPM1;rs34351976;miR-337]: The case is analyzed in [194]. The SNP
rs34351976 is defined by a delT mutation at 3’UTR position 165 of NM 002520.
The 3’UTR length is 572 nt. Bioinformatics analysis combined with luciferase
reporter assay demonstrated that the delT polymorphism creates an illegitimate
binding site for miR-337-5p, which results in decreased protein levels.
[AGT;rs7079;miR-31]: [AGT;rs7079;miR-584]: The case is analyzed in
[195]. The SNP rs7079 is defined by C↔A at 3’UTR position 556 of NM 000029.
The 3’UTR length is 618 nt. For AGT gene, results of the experiments showed
that miR-31 and miR-584 bind to the C allele of the hAGT gene and downregu-
late the luciferase gene expression either in human kidney or human liver cells.
[NCSTN;rs141849450;miR-455]: The case is analyzed in [196]. The SNP
rs141849450 is defined by delCA at 3’UTR position 515 of NM 001290184. The
3’UTR length is 681 nt. Using luciferase-based assays, the authors demonstrated
that rs113810300 and rs141849450 SNPs affected miRNA-mediated repression of
Nicastrin. Notably, rs141849450 completely abolished the miR-455-mediated re-
pression of Nicastrin. On the other hand, the seed region SNP delCA515-516
reduced miR-455-mediated repression. The authors observe a stronger inhibitory
effect of miR-455 for the wild-type allele.
[SMUG1;rs2233921;miR-770]: The case is analyzed in [197]. The SNP
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rs2233921 is defined by G↔T at 3’UTR position 80 of NM 001243787. The
3’UTR length is 628 nt. An in vitro assay was used to investigate whether
rs2233921 alleles were associated with differential gene expression. The G to
T point mutation resulted in a reduction of the expression of luciferase in all the
experiments performed. Although not a particular miRNA was selected, miR-770
was selected as a candidate miRNA suggested by a review paper citing the work
[198].
[PARP1;rs8679;miR-145-5p]: The case is analyzed in [182]. The SNP rs8679
is defined by T↔C at 3’UTR position 607 of NM 001618.3. The 3’UTR length is
769 nt. The methodology is the same as for [LIG3;rs4796030;miR-221], and the
authors presume an additive effect of both instances on bladder cancer risk. For
PARP1/rs8679, the authors conjecture a stronger inhibitory effect of miR-145-5p
for the T-allele.
[WFS1;rs1046322;miR-668-3p]: The case is analyzed in [199]. The SNP
rs1046322 is defined by G↔A at 3’UTR position 253 of NM 001145853.1. The
3’UTR length is 779 nt. Expression levels of luciferase assays are measured for
both alleles, with a stronger inhibitory effect of miR-668-3p for the G-allele.
[MSX1;rs12532;miR-3649]: The case is analyzed in [200]. The SNP rs12532
is defined by A↔G at 3’UTR position 276 of NM 002448. The 3’UTR length is
790 nt. The sequence analysis indicated that SNP rs12532 might alter the binding
ability of miR-3649, confirmed by luciferase activity assay showing a lower ex-
pression level of rs12532 A allele compared with that of the G allele. The authors
conclude a stronger inhibitory effect of miR-3649 for the A allele.
[EFNA1;rs12904;miR-200c]: The case is analyzed in [201]. The SNP rs12904
is defined by G↔A at 3’UTR position 154 of NM 182685. The 3’UTR length
is 843 nt. The authors investigated miRNA binding sites in SNPs and whether
they interfere with gastric cancer (GC) susceptibility. Luciferase assays indicated
EFNA1 as the target of hsa-miR-200c and rs12904 G→A change resulted in al-
tered regulation of luciferase expression.
[IL-23R;rs10889677;let-7e]: The case is analyzed in [202]. The SNP rs10889677
is defined by C↔A at 3’UTR position 309 of NM 144701.2. The 3’UTR length
is 851 nt. The authors study risk factors for inflammatory bowel diseases where
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they employ real-time PCR and luciferase assays for measuring expression levels,
and finally conclude a stronger inhibitory effect of let-7e for the C-allele. [IL-
23R;rs10889677] is also associated in [203] with breast cancer development.
[RYR3;rs1044129;miR-367]: The case is analyzed in [204]. The SNP rs1044129
is defined by A↔G at 3’UTR position 839 of NM 001036.3. The 3’UTR length is
880 nt. The authors study risk factors of breast cancer development. The authors
employ real-time PCR and luciferase assays for measuring expression levels. The
authors observe a stronger inhibitory effect of miR-367 for the A-allele.
[AGTR1;rs5186;miR-155-5p]: The case is analyzed in [180]. The SNP rs5186
is defined by A↔C at 3’UTR position 86 of NM 032049.3. The 3’UTR length is
888 nt. The authors analyze luciferase assays for measuring expression levels and
observe a stronger inhibitory effect of miR-155-5p for the A-allele, see ’long case’
in Figure 2C in [180].
[FGF20;rs12720208;miR-433-3p]: The case is analyzed in [158]. The SNP
rs12720208 is defined by C↔T at 3’UTR position 182 of NM 019851.2. The
3’UTR length is 903 nt. The authors analyze luciferase assays for measuring
expression levels and observe a stronger inhibitory effect of miR-433-3p for the
C-allele. We note that in this specific case we used the submission ss20399075 in-
stead of the default dbSNP entry ss28476621 for consistency with the NCBI entry of
NM 019851.2 and the corresponding 3’UTR transcript entry ENST00000180166
at Ensembl.
[DROSHA;rs10719;miR-27b]: The case is analyzed in [205]. The SNP rs10719
is defined by T↔C at 3’UTR position 92 of NM 013235. The 3’UTR length is
937 nt. Luciferase reported gene assay confirmed that rs10719 T to G substitu-
tion disrupted the binding site for hsa-miR-27b, resulting in increased levels of
DROSHA protein. The authors observe a stronger inhibitory effect of miR-27b
for the T-allele.
[HOXB5;rs9299;miR-7-5p]: The case is analyzed in [206]. The SNP rs9299
is defined by G↔A at 3’UTR position 141 of NM 002147.3. The 3’UTR length
is 952 nt. The miRNA-3’UTR binding is studied in the context of bladder can-
cer development. Both real-time PCR and luciferase reporter assays are applied
gene expression measurements. The authors observe a stronger inhibitory effect
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of miR-7-5p for the A-allele.
[RAD51;rs7180135;miR-197-3p]: The case is analyzed in [182]. The SNP
rs7180135 is defined by G↔A at 3’UTR position 718 of NM 002875.4. The 3’UTR
length is 978 nt. The methodology is the same as for [LIG3;rs4796030;miR-221]
and [PARP1;rs8679;miR-145-5p]. The authors conjecture a stronger inhibitory
effect of miR-197-3p for the G-allele.
[REV3L;rs465646;miR-25]: The case is analyzed in [207]. The SNP rs465646
is defined by C↔T at 3’UTR position 461 of NM 002912. The 3’UTR length
is 985 nt. The authors investigate association between REV3L polymorphisms
and lung cancer risk. One of the strongest associations observed was for the
3’UTR C↔T polymorphism (rs465646). Surface plasmon resonance analysis and
luciferase assays showed that the T allele demonstrated a stronger binding affinity
for miR-25, resulting in significantly weaker reporter expression levels.
[ORAI1;rs76753792;miR-519a-3p]: The case is analyzed in [208]. The SNP
rs76753792 is defined by C↔T at 3’UTR position 86 of NM 032790.3. The 3’UTR
length is 1034 nt. The authors study the susceptibility of atopic dermatitis in
Japanese and Taiwanese populations. Among other methods, real-time PCR is
applied to gene expression analysis. The authors mention the impact of miRNAs
as subject of future research, i.e. no specific miRNA is identified. Based upon
miRNA target predictions for ORAI1 and the SNP position we selected miR-
519a-3p for the present study. For miR-519a-3p, the binding prediction returned
by StarMir is stronger for the C-allele.
[RAP1A;rs6573;miR-196a]: The case is analyzed in [209]. The SNP rs6573 is
defined by A↔C at 3’UTR position 366 of NM 002884.2. The 3’UTR length is
1078 nt. The authors study how rs6573 affects the risk of esophageal squamous
cell carcinoma. The regulatory function of miR-196a is analyzed by luciferase
reporter assays. The authors conclude a stronger inhibitory effect of miR-196a
for the A-allele.
[APP;T171C;miR-147]: The case is analyzed in [210]. The SNP T171C is
defined by T↔C at 3’UTR position 171 of NM 000484. The 3’UTR length is
1120 nt. The authors provide proof-of-principle that APP 3’UTR polymorphisms
could affect Alzheimer’s disease risk through modulation of APP expression reg-
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ulation. Using luciferase-based assays, the authors could show that the T171C
variant inhibited miR-147 binding.
[IL1A;rs3783553;miR-122]: The case is analyzed in [211]. The SNP rs3783553
is defined by a TTCA insertion at 3’UTR position 928 of NM 000575. The 3’UTR
length is 1152 nt. It was shown in vitro and in vivo that the variant allele consist-
ing of a 4-bp (TTCA) insertion disrupts the binding sites for miR-122, thereby
increasing the expression of IL-1A. Therefore the authors conclude a stronger
inhibitory effect of the studied miRNA for the wild type allele.
[CD133;rs2240688;miR-135b]: The case is analyzed in [212]. The SNP
rs2240688 is defined by A↔C at 3’UTR position 667 of NM 0011458. The 3’UTR
length is 1167 nt. The authors investigated the associations between putative
functional SNPs in CD133 and both the risk and the survival of lung cancer in
southern Chinese. Functional assays including Real-time PCR and luciferase-
based assays revealed that the A to C transition gained a new binding of the
microRNA hsa-miR-135b and decreased the CD133 expression.
[PDCD1;rs10204525;miR-4717]: The case is analyzed in [213]. The SNP
rs10204525 is defined by G↔A at 3’UTR position 889 of NM 005018. The
3’UTR length is 1177 nt. In this study, three miRNAs were predicted to pu-
tatively interact with PD1 rs10204525 polymorphic site of allele G. One of them,
miRNA-4717, was demonstrated to allele-specifically affect luciferase activity in
a dose-dependent manner in cells transfected with vectors containing different
rs10204525 alleles. The authors conclude a stronger inhibitory effect of miR-4717
for the G allele.
A summary of the dataset is given in Table 2.1.
2.3 Dataset Analysis
2.3.1 Common Framework for miRSNPs-disease
Association Studies
We extracted the common working scheme followed in most of the comprehensive
studies of miRSNPs described in the previous section. A flowchart summarizing
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the common steps is given in Figure 2.1. The first step is the selection of can-
didate genes associated with a selected disease, its risk and prognosis. Usually,
selected genes are confirmed to be significantly associated with the selected dis-
ease and are retrieved from one or more previous association studies between
gene polymorphisms and disease risk. The selected genes are narrowed down
to retain only polymorphic 3’UTRs where SNPs were, in-silico, able to affect
the binding with specific miRNAs that are expressed in the relevant cell type.
To this end, miRNA target prediction software are essentially applied to search
for the putative SNPs within miRNA binding sites in the 3’UTR of candidate
genes. Moreover, databases integrating data on miRNA expression accross dif-
ferent tissues and cell types are used. The selected SNPs are usually assessed in
appropriate case-control studies, where allele and genotype frequencies are sta-
tistically analyzed. The next stage usually consists of experimentally verifying
whether the predicted 3’UTRs are truly target sites for the predicted miRNAs
and whether the SNPs affect the strength of the binding. Experiments are carried
out on cell lines transfected with the Renilla/Luciferase gene reporters, where the
3’UTRs of the Luciferase is replaced by the 3’UTRs of the two genes (either in
their common wild-type or variant forms). Synthetic miRNAs are also transfected
in order to measure the Luciferase/Renilla ratio under different miRNA binding,
to detect whether the polymorphism truly affect the binding to the 3’UTR. This
last step allows reaching the conclusion if the selected miRNA binds differentially
to the wild-type and the variant 3’UTRs and therefore should help to elucidate
functional consequences of the candidate miRSNPs in the selected disease.
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2.3.2 Commonly Used microRNA Target Prediction
Methods
A crucial step in the process of miRSNP-disease association is the selection of
candidate SNPs, giving their predicted impact on binding with a selected set of
miRNAs. To this end, an in-silico analysis involving one or more miRNA tar-
get prediction methods needs to be carried out. Excluding the case of ORAI1,
where no particular miRNAs were mentioned in the work, we had a look at this
particular stage in all other 33 publications and listed the most frequently used
miRNA target prediction tools. Apart from the FGF20 case, where no partic-
ular computational method was mentioned, 23 out of the other 32 articles used
TargetScan web server directly or via the PolymiRTS database. miRanda came
second with 19 publications mentioning the use of this algorithm directly or via
online databases using miRanda such as SNPinfo [214] and MirSNP [215]. It was
followed by MicroCosm-miRBase used in 13 instances, PicTar in 10 publications,
DIANA-microT in 6, MicroInspector in 5, RNAhybrid in 4 and finally PITA in
only 3 publications. Moreover, in 22 out of the 32 works, the authors selected
miRSNPs with the highest support from the available tools, using the predictions
of several algorithms. More importantly, for the cases where variant alleles are
expected to have a stronger inhibitory effect, tools which allow sequence entry
may be favored; 12 instances belong to this category and all these cases, with
the exceptions of NFKBIA and REV3L instances, used either miRanda, PITA or
RNAhybrid in their miRNA target predictions stage. As an example miRanda was
used in the case of LIG3 [182] to compute the difference in ∆G for the two alleles
(wild-type allele ∆G minus variant allele ∆G) calculated as ∆∆G. Looking closely
at the in-silico analysis in the case of NFKBIA, the predicted target site given
in [191] (see Figure 2) covers the positions 110-124 of the NFKBIA 3’UTR and
therefore does not include the SNP position 126, as given by the dbSNP database.
The authors searched for target microRNAs of NFKBIA using the prediction
tools TargetScan and MicroCosm. Thus, we had a look at the predictions given
by these two tools and could not find a relevant binding site with the SNP po-
sition inside. In the case of REV3L, target prediction tools Targetscan and
Pictar both predicted that the REV3L 3’UTR harbours two binding sites for
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miR-25/32/92/363/367 and the SNP is located within one of these binding sites.
Although the precise binding site was not given in the publication, we looked at
the TargetScan and Pictar predictions and failed to find any binding site with
the SNP position 460 inside.
2.4 Dataset Coverage by Online SNP
Effects Prediction Databases
Recently, several databases studying disease associated SNP effects on miRNA
bindings have been released. These databases follow similar algorithms as those
used in miRNA target prediction tools in order to detect the effects of the SNPs
on miRNA bindings. These algorithms are either run on the whole genome and
then results are stored in a database, or come as web-based applications where the
SNP effect is computed in real time. Usually, the user can query these databases
using SNP, gene or miRNA IDs. A number of these databases offer valuable
repositories for experimentally validated, disease associated, SNPs which have
been verified to affect a miRNA binding. In this section, we compare results of
some of the well known available databases for predicted SNP effects. Note that at
the time of writing, the database Patrocles is not working. The latest release of
the miRBase database is Release 21 and the Genome Reference Consortium most
recent release of the human genome assembly is GRCh38. The latest release
of NCBI dbSNP database is build 146. The case [APP;T171C;miR-147] has an
unknown SNP ID and therefore was removed from this analysis.
2.4.1 MicroSNiPer
MicroSNiPer is a web-based application which predicts the impact of a SNP on
putative miRNA targets. MicroSNiPer interrogates the 3’UTR and predicts if
a SNP within a target site will disrupt/eliminate or enhance/create a miRNA
binding site. This application computes these sites and examines the effects of
SNPs in real time. Although MicroSNiPer current update is using previous gene
annotation releases (human genome GRCh37/hg19 release and dbSNP build 137),
users can input their own 3’UTR sequence and SNPs, enabling them to analyse
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novel SNPs. However, there is less flexibility in the fact that users are unable
to enter specific miRNAs and can only rely on the output display showing the
miRNA-binding sites, using the old miRBase Release 19. Although MicroSNiPer
gives a straightforward graphical representation of the binding sites, a numerical
value, a score or an energy value is not provided to assess the binding. As an
example, in the case of [REV3L;rs465646;miR-25] and [KRT81;rs3660;miR-17],
both wild type and variant alleles have predicted binding sites with the same
seed length (8 bp) and although the binding sites differ, it is not clear which
allele is predicted to have a stronger binding with hsa-miR-25-3p and hsa-miR-
17-5p respectively and therefore no conclusion can be drawn from this result.
MicroSNiPer correctly predicted SNPs to affect the interactions between the
studied miRNAs and the 3’UTR in 15 instances.
2.4.2 miRdSNP
miRdSNP is a database of manually curated dSNPs on the 3’UTRs of human
genes from available publications in PubMed. miRdSNP annotates genes with ex-
perimentally confirmed targeting by miRNAs and indexes miRTSs predicted by
TargetScan and PicTar as well as potential miRTSs newly generated by disease
associated SNPs. The database was released in 2011 and no further updates were
released. Only 2 of the 33 instances from our dataset are marked as disease asso-
ciated SNPs. We also found 5 instances where the miRNA is listed as predicted
targeting the gene, but not marked as experimentally verified interactions. Only
one case ([HLA-G;rs1063320;miR-148a-3p]) is hosted as experimentally validated
SNP effect associated to a disease.
2.4.3 PolymiRTS Database 3.0
The Polymorphism in microRNA Target Site (PolymiRTS) database aims to iden-
tify SNPs that affect miRNA targeting in human and mouse. The PolymiRTS
database was created by scanning 3’UTRs of mRNAs in human and mouse for
SNPs and INDELs in miRTSs. Then, the potential downstream effects of these
polymorphisms on gene expression and higher-order phenotypes are identified.
The PolymiRTS database also includes polymorphisms in target sites that have
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been supported by a variety of experimental methods and polymorphisms in
miRNA seed regions. The last significant update to the PolymiRTS database
dates from 2013. Using the search interface of PolymiRTS, we found 11 instances
from our dataset listed as predicted target sites with no experimental support.
Only 2 cases are listed as disease associated SNPs. Five instances (SPI1, FGF20,
AGTR1, HTR3E, HLA-G) are listed as miRNA:gene interactions supported by
a low-throughput experiment (luciferase reporter assay or Western blot).
2.4.4 mrSNP
mrSNP [216] provides a web service for researchers working especially with RNA-
Seq Data, to predict the impact of a SNP in a 3’UTR on miRNA binding. The
software accepts input SNPs with the related information containing the organ-
ism, the assembly according to which the mapping is done, the chromosome on
which the SNP is located, the position of the SNP in the given chromosome, and
the SNP alleles. However, the available chromosomal locations in this database
are based on a previous human genome build (GRCh37/hg19). The prediction
method applied is adapted from the DIANA-microT prediction tool and the bind-
ing energy is calculated using RNAhybrid. mrSNP correctly identified 9 of the
SNPs disrupting the binding with the associated miRNA.
2.4.5 Mirsnpscore
Mirsnpscore [217] is a computational tool that can help identifying SNPs asso-
ciated with diseases, by focusing on SNPs affecting miRNA-regulation of genes.
The tool predicts the effects of miRSNPs and uses linkage disequilibrium to map
these miRNA-related variants to SNPs of interest in GWAS. The used sequences
are sourced from the human genome assembly hg18 and miRNA sequences are
sourced from miRBase release 13.0 and 16.0. Therefore, some of the SNP queries
were not found in the database or the SNP information were incorrect. Mirsnpscore
successfully identified 6 of the SNP-miRNA pairs from our dataset.
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2.4.6 miRNASNP 2.0
miRNASNP [218] aims to provide a resource of the miRNA-related SNPs, which
includes SNPs in pre-miRNAs of human and other species, and target gain and
loss by SNPs in miRNA seed regions or 3’UTR of target mRNAs. The last re-
lease 2.0 dates from 2014 and is based on miRBase 19 and dbSNP 137. In this
last release, validated miRNA-mRNA interactions supported by experimental
methods were also integrated from several databases including DIANA-TarBase,
miRecords, miRTarBase and miR2Disease. Using the module ’targets gain/loss
by SNP in gene’s 3’UTR’, we used the SNP IDs to search the available pre-
compiled data. miRNASNP correctly predicts the effect of 7 SNPs. Among these
cases, 3 instances were marked as experimentally verified human miRNA targets
(HTR3E, AGTR1 and EFNA1). In the case of KRT81, miRNASNP predictions
are in favor of the weaker allele. Four other cases were also included in the pre-
dictions: FGF20, CD133, AGT and SMUG1. However, the 3’UTR sequences, for
the wild-type and variant alleles from our dataset, do not seem to match the data
from the dbSNP database.
2.4.7 Discussion
The dataset analysis in the different databases is summarized in Table 2.2. The
MicroSNiPer and PolymiRTS databases successfully detect the SNPs to disturb
a binding site with the associated miRNA in respectively 15 and 16 instances
from the dataset, therefore performing better than the other platforms. Some
databases restrict the user to catalogued 3’UTRs and SNPs, limiting the possi-
bility for the user to enter a novel or unreported SNP. Only MicroSNiPer tool
provides a relatively high degree of flexibility at the input stage by allowing the
user to enter a user defined UTR sequence with an associated SNP. Furthermore,
some of these available online resources provide only precomputed predictions,
based on older version of human genome builds and/or previous releases of dbSNP
and miRBase. Therefore the available predictions may be outdated and not rel-
evant to the user. One limitation for most of these databases is the inability to
study SNPs where polymorphisms are small insertions and deletions (INDELs)
in miRTSs. These cases include NPM1, NCSTN and IL1A instances. Only
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PolymiRTS handles this category of polymorphisms and therefore this tool was
the only software to be able to successfully predict the SNP effect in the case of
NCSTN.
Table 2.2: Dataset Coverage by Online SNP effect Prediction Databases.





HTR3E X X X X
KRT81 X X X X
SPI1 X X










WFS1 X X X X X
MSX1 X X X X
EFNA1 X X X X X
IL-23R
RYR3











2.5 Dataset Coverage by Experimentally
Validated miRNA Target Interactions
Databases
Our dataset represents 34 ,disease associated experimentally validated SNPs ,re-
ported in the literature to affect miRNA binding and curated from low through-
put experiments. We discuss in this section how much of this validated work
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is recorded in the abundant number of databases, which host records of experi-
mentally verified miRNA-gene interactions. Note that this section does not cover
the actual effect of the SNPs on miRNA bindings. The SMUG1 and the ORAI1
cases were removed from the analysis, as the related publications do not mention
a particular miRNA.
2.5.1 miRTarBase
miRTarBase is a curated database of miRNA-target interactions. The listed inter-
actions are collected by manually surveying pertinent literature after data mining
of the text systematically filter research articles related to functional studies of
miRNAs. miRTarBase database was first released in 2010 and have been reg-
ularly updated. The latest release 6.0 dates from 2015. We searched for the
miRNAs:gene interactions from our dataset and we were able to find 11 instances
covered in this database.
2.5.2 DIANA-TarBase v7.0
DIANA-TarBase was initially released in 2006 and it was the first database aiming
to catalog published experimentally validated miRNA:gene interactions.
DIANA-TarBase v7.0 is the last update and was released in 2014. The user
interface provides detailed information about positive or negative experimental
results, the utilised experimental methodology, experimental conditions including
cell/tissue type and treatment etc. We found that 10 out the 32 interactions from
our dataset are covered in this database.
2.5.3 miRecords
miRecords is a resource for animal miRNA-target interactions. The Validated
Targets component of miRecords is a large, high-quality database of experimen-
tally validated miRNA targets resulting from meticulous literature curation. Al-
though miRecords was last updated in 2013, only 3 out of the 32 interactions
from our dataset are recorded.
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2.5.4 miRWalk 2.0
The web-interface of miRWalk2.0 [219] is classified into the Predicted Target
(PTM) and the Validated Target (VTM) modules. The VTM module documents
experimentally verified miRNA-target interaction information collected via an au-
tomated text-mining search and data from existing resources (miRTarBase 4.0,
PhenomiR 2.0, miR2Disease 2008 and HMDD 2.0). This module was last updated
in 2014. We used the validated gene-miRNA interaction information retrieval sys-
tem to check and we found that 8 out of 32 interactions are covered.
2.5.5 HMDD v2.0
HMDD (the Human microRNA Disease Database) is a database that curated experiment-
supported evidence for human miRNA and disease associations. The original
HMDD database was released in 2007. However, the last update was released in
2013 and integrated experimentally verified disease-related miRNAtarget interac-
tions. We were able to download the freely available text file containing a list of
miRNA-disease association data from miRNA-target interactions and we could
find 11 out of the 32 interactions from our dataset listed.
2.5.6 miR2Disease
miR2Disease is a manually curated database, which aims at providing a compre-
hensive resource of miRNA deregulation in various human diseases. Addition-
ally, the database integrates manually extracted disease-related miRNA-target
pairs, which were experimentally verified by luciferase reporter experiments. The
database was created in 2008. However, there is no direct information about the
last update release date. While looking at the experimentally verified miRNA-
target file, available freely to download, we were able to find 4 out of the 32
publications from our dataset listed in miR2Disease.
2.5.7 Discussion
The dataset analysis in the different databases is summarized in Table 2.3. The
HTR3E and the AGTR1 cases are covered by all databases. Fourteen of the 32 in-
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stances from our dataset are not included in any database (LIG3, MSLN, CBR1,
KRT81, MTHFD1L, NFKBIA, TYMS, NPM1,AGT, PARP1, WFS1, MSX1,
APP and IL1A). miRTarBase and HMDD include equally the same number of publi-
cations from our study. However, they only have 6 publications in common. Some
databases have a user submission form that allows users to notify the database cu-
rators of recent publications related to experimentally validated miRNA:gene in-
teractions. These include miR2Disease, HMDD and miRecords. This can benefit to
the database by having regular updates with new entries. While DIANA-TarBase
contains more data related to each interaction, miRTarBase seemed to be more
user friendly. As an example, while searching for the CD133 gene, the name was
not recognised by DIANA-TarBase 7.0. However, in miRTarBase, the name was
automatically converted to the commonly used Alias which is PROM1.
Table 2.3: Dataset Coverage by Experimentally Validated miRNA Target Inter-
actions Databases.





HTR3E X X X X X X
KRT81
SPI1 X X X














AGTR1 X X X X X X
FGF20 X X X X X
DROSHA X
HOXB5 X X X X
RAD51 X X X







2.6 Dataset Coverage by Online miRNA Target
Prediction Databases
In 22 out of the 32 works used in this study, the authors considered that the com-
bination of several miRNA-target prediction approaches would greatly reduce the
possibility of false positives. There is also a strong demand among researchers for
integrated miRNA target databases. In fact, several resources have been estab-
lished to systematically retrieve precompiled lists of predicted targets, generated
by multiple target prediction methods. In this section, we analyze some of the
commonly used databases and check whether they predict the miRNAs:3’UTR
interactions from our study. Of particular interest were the cases where the wild
types are experimentally proven to interact with the miRNAs. Attention was par-
ticularly given to the sequences used for predictions. For consistency, the same
NCBI Reference Sequence (RefSeq) accessions and miRNA IDs were used in the
queries. Similar to the previous section, this section does not cover the actual
effect of the SNPs on miRNA bindings.
2.6.1 miRecords
The Predicted Targets component of miRecords is an integration of predicted
miRNA targets produced by 11 established miRNA target prediction programs.
The targets predicted by the different tools were obtained by either submitting
queries to the relevant web servers(DIANA-microT, MicroInspector, miTarget,
NBmiRTar and RNA22), running a local implementation of the software (miRanda
and RNAhybrid) or downloading the precompiled sets (MirTarget2, PicTar, PITA
and TargetScan/TargetScanS Version 4.1). miRecords was last updated in 2013
and the sequences were based on older versions of miRBase and human genome
assembly. If the user specifies the RefSeq accession or a gene name of an indi-
vidual candidate target, the prediction is made in real time by submitting the
request to each of the original predicting servers. In our case, we used the RefSeq
IDs. However, some of the original servers were down (indicated by red sym-
bols in the predictions table) and therefore the predictions were not complete
for MicroInspector, miTarget, NBmiRTar and RNA22 tools. The predictions
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obtained for the 34 cases are summarized in Table 2.4. The miRNA was not
found in the case of [PDCD1;miR-4717] and [MSX1;miR-3649]. The used RNA
sequence could not be verified in the case of [WFS1;miR-668] and [HTR3E;miR-
510]. [AGT;miR-31] is not predicted by any tool. The remaining cases were
predicted by at least one tool.
Table 2.4: Dataset Coverage by miRecords database where predictions by 7 es-
tablished miRNA target prediction programs are shown.





HTR3E X X X
KRT81 X X X
SPI1 X X
HLA-G X X
MTHFD1L X X X
NFKBIA X X X
TYMS X X X
CCNE1 X X X
NPM1 X






EFNA1 X X X X
IL-23R X X X
RYR3 X X X
AGTR1 X X X
FGF20 X X X
DROSHA X X
HOXB5 X X X X
RAD51 X X X X
REV3L X X X X
ORAI1 X X X X
RAP1A X
APP X X X
IL1A X X
CD133 X X X
PDCD1
2.6.2 miRWalk2.0
The PTM module of miRWalk2.0 database documents miRNA binding sites
within the complete sequence of a gene and combines this information with a com-
parison of binding sites resulting from 13 existing miRNA-target prediction pro-
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grams (DIANA-microTv4.0, DIANA-microT-CDS, miRanda-rel2010, miRBridge,
miRDB4.0, miRmap, miRNAMap, doRiNA i.e.,PicTar2, PITA, RNA22v2, RNAhybrid2.1
and Targetscan6.2). All the possible targets are obtained from these established
miRNA-target prediction programs, predicted without any threshold or filter, and
stored in miRWalk database. PITA, miRanda, RNAhybrid and Targetscan were
locally executed to identify miRNA binding sites within the putative target se-
quences. The generated miRNA binding sites were merged with the remaining
8 prediction datasets, gathered from the existing resources. miRBase release 20
and RefSeq release 61 are utilised as sources for the genomic sequences. Using
the miRNA information retrieval system, we carried out miRNA-based searches
by providing the relevant identifiers of miRNAs. Putative target genes tables
containing precompiled predictions are then returned and used to search for the
relevant RefSeq ID of the target gene. The predictions obtained for the 34 cases
are summarized in Table 2.5. Apart from [NPM1;miR-337] and [MSLN;miR-611]
instances, all other cases were successfully predicted by at least one miRNA-target
prediction program.
2.6.3 starBase v2.0
starBase Pan-Cancer Analysis Platform is designed for deciphering Pan-Cancer
Networks of lncRNAs, miRNAs, ceRNAs and RNA-binding proteins (RBPs) by
mining clinical and expression profiles of 14 cancer types (> 6000 samples) from
The Cancer Genome Atlas (TCGA) Data Portal [138]. Additionally, starBase
provides predicted miRNA-target interactions processed from five miRNA target
prediction software programs (TargetScan, PicTar, PITA, miRanda and RNA22),
last generated in 2013. Predicted miRNA-target interactions listed in the database
are overlapped with CLIP-Seq data. The human genome sequences from UCSC
hg19, miRNA IDs from miRBase Release 20 and the TargetScan Release 6.2
were used. In the query page of miRNA-mRNA interactions, users can enter
a gene symbol and select one miRNA of interest to browse their relationships.
Eight interactions from our dataset were predicted by at least one miRNA target



























































































































































































































































































































































































































































































Our dataset is a collection from literature of pairs of positive examples of miRNA-
target genes. Thus, the lack of negative examples makes a direct comparison
of prediction performance among tools, involving sensitivity and precision, not
possible. However, a performance comparison in terms of the number of the
experimentally validated interaction that are predicted by at least one miRNA
target prediction tool can be done. Overall, starBase is the worst database in
terms of predictions. The main reason for this performance is that although the
5 prediction algorithms are also used in miRWalk, only the conserved miRTSs,
intersected with Ago CLIP clusters to gain CLIP-supported sites, are retrieved.
Only 2 interactions were not predicted by miRecords (MSX1 and PDCD1) and 3
interactions were not predicted by miRWalk (MSLN, NPM1 and RAP1A). How-
ever, looking more closely at the predictions results, although 6 miRNA target
prediction tools are used in both miRecords and miRWalk, the prediction results
are different.
In miRWalk platform, it is stated that all the possible predicted targets are
obtained from the established miRNA-target prediction programs with no thresh-
old or filter. This information was not available in the case of miRecords. The
default settings of some of miRNA target prediction tools, including miRanda and
RNAhybrid, are set to ensure the maximal detection of targets. As a consequence,
these tools are reported to have better sensitivity than other methods. However,
this makes them prone to high false positive rates [220] leading to a lower speci-
ficity. In [99], the authors strongly recommend using optimized parameters in-
stead of the default parameters. Therefore, the RNAhybrid tool is usually used to
find the minimum free energy hybridization after filtering steps. In this study, we
are focusing on measuring the sensitivity and not the specificity of the tools and
therefore as expected, RNAhybrid performed the best in both platforms. The tar-
gets predicted by RNAhybrid were obtained by running a local implementation of
the RNAhybrid algorithm provided by the authors (version 2.1 in miRWalk and ver-
sion 2.2 in miRecords). Only 4 cases are not predicted by RNAhybrid-miRWalk.
However, these cases are predicted by miRecords-RNAhybrid. Similarly, 3 cases
are not predicted by RNAhybrid-miRecords, but these are predicted by miRWalk-RNAhybrid.
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The targets predicted by miRanda were obtained by running a local implemen-
tation of the algorithm provided by the authors in both platforms. However,
in miRecords Version 1.9 (2004) is indicated while miRanda 2010 version (3.3)
is used in miRWalk. The miRanda tool from both databases predicts 9 cases in
common. Three additional instances are predicted by miRecords-miRanda and
11 more cases are predicted by miRWalk-miRanda. In miRecords, the targets
predicted by PITA version 6 from 2008 were downloaded from the PITA web site
as a pre-compiled dataset. In miRWalk, an earlier 2007 version of the software
was locally executed. PITA in miRWalk predicts 15 cases, all of them are also
predicted by PITA in miRecords. Eleven other cases are predicted by PITA in
miRecords only. The targets predicted by DIANA-microT were obtained by sub-
mitting queries to the DIANA-microT server in miRecords, where the 2004 version
was used. DIANA-microT in miRecords does not predict any case. The predic-
tion dataset of Diana-microT 4.0 and 5.0 from 2013 was downloaded and used
by miRWalk. Six instances were predicted by Diana-microT-miRWalk. The tar-
gets predicted by TargetScan/TargetScanS Version 4.1 were downloaded from
the tool web page as a pre-compiled dataset in miRecords. In miRwalk, it is in-
dicated that TargetScan 6.1 program was locally executed with gene sequences
RefSeq 61 and miRBase V20. Only 5 cases are predicted in common between
the two platforms. Two are only predicted by TargetScan-miRecords while a
further 17 cases are only predicted by TargetScan-miRWalk. PicTar in both
databases predicts 4 cases. However, only 3 cases are in common. PicTar in
miRecords predicts KRT81 while PicTar2 in miRWalk predicts RYR3. A 2007
version of PicTar precompiled set was used in miRecords while a precompiled
set of doRiNA (PICTAR2) is used in miRWalk.
The difference in prediction results for the same tools can be a result of ei-
ther using different genomic sequences, or using different threshold values of the
different parameters, or finally a result of using different versions of the same
miRNA-target prediction software. Although these databases are attractive for
their ease of use, they need to be actively maintained to keep up with the regular
updates of the annotation databases. Considering this limitation, we believe that
the use of tools which allow sequence entry are more relevant to miRSNP-disease
association studies.
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2.7 Site Accessibility compared with the
Conservation Feature in MicroRNA Target
Prediction
While introducing our 34, manually curated, disease associated miRSNPs, we
analyzed the relevant publications and we extracted the common framework fol-
lowed in most of these studies. We also listed the most frequently used miRNA
target prediction tools. While the conservation feature based tool TargetScan
is the most widely used, structure-based miRNA target prediction models are
hardly mentioned, even though, as discussed in Section 1.3.4, it has been shown
that the accessibility criterion strongly influences the RNA hybridization process.
We propose in this section to compare the performance of three individual miRNA
target prediction methods based on ranked list of target predictions: TargetScan
compared with the two structure-based methods PITA and STarMir.
TargetScan relies on the evolutionary conservation of target sites containing
seed regions. TargetScan ranked lists are grouped by families, based on their
identical seed sequence, with the idea that they should potentially have shared
targets. Predicted targets of each miRNA family are sorted by total context+
score and the default ranked list does not show genes with only poorly conserved
sites. The context+ score for a specific site is the sum of the contribution of
these six features, calculated as in [107]: site-type contribution, 3’ pairing contri-
bution, local AU contribution, position contribution, TA (target site abundance)
contribution and finally SPS (seed-pairing stability) contribution. For each pre-
dicted target of each miRNA, the sum of the context+ scores for the sites to that
miRNA was calculated as the total context+ score. The predictions generated by
STarMir, accessible from the the web searchable database STarMirDB, are based
on an old human genome Build 36 version 3 dating from 2008 and similarly, the
PITA catalog version 6 of predicted miRNA targets is based on miRBase version
11 and the human genome release hg18 from 2006. However, we have seen in
the previous section that using different genomic sequences may lead to differ-
ent prediction outcomes. Therefore, in order to use the same UTR and miRNA
sequences, we proceeded with the following steps:
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• Start with the miRBase database and search for the miRNA of interest. In
the corresponding miRBase page, links to experimentally validated targets
for the specified miRNA (miRTarBase and DIANA-TarBase) are given.
• Use DIANA-TarBase and miRTarbase databases to filter out validation meth-
ods with weaker evidence, to keep only experiments with Reporter assays,
qPCR and/or Western Blot.
• Retrieve the ranked list of predicted targets by TargetScan for the specified
miRNA.
• Locate the highest ranked in the list of predicted targets, that is an exper-
imentally validated target.
• If this target exists and is in the top 10 of predicted targets, apply PITA
and STarMir to the validated miRNA-target and then to the other ranked
predicted targets in the top 10 of the TargetScan list. To this end, we
used STarMir and PITA web servers, which allow users to provide mRNA
and miRNA sequences, to generate predictions for the given miRNA with
the same UTR and miRNA sequences used to generate the ranked list for
TargetScan.
• Compare the STarMir scores and rank the targets for each miRNA. The
same is applied to PITA scores.
After this process is finished, we obtain, for each miRNA, three ranked lists
generated by the three tools of the same UTRs. In this section, we use a dataset
comprising of more than 150 miRNAs. For each miRNA, we extract the top
10 target genes ranked by TargetScan. We only keep the miRNAs that have
at least one experimentally confirmed target in the top 10, supported by strong
experimental evidences (Reporter assay, Western blot or qPCR). This led to a
reduced number of 36 analyzed miRNAs. We then compare the performance
of the methods for each miRNA based on the rank of the first experimentally
confirmed target. With respect to each miRNA, we score each method using a
number called ranking score in the range of 1 to 3, with 1 indicating the best
method and 3 the worst method. Finally, we calculate the ranking score of each
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method by summing up its scores for all miRNAs. The lower the ranking score
of a method, the better the method is. A summary of the rankings is provided
in Supplementary Material in Section .2.
Using this scoring scheme, PITA has the best overall score while STarMir
comes second and finally TargetScan comes last. This study shows that miRNA
target prediction using structural information may outperform usual tools using
the conservation feature.
2.8 Conclusion
In this chapter, we introduced the main motivation of our work on analyzing
the disease associated SNP effect on miRNA bindings. We selected a dataset
of 34 [mRNA/3’UTR; SNP; miRNA] instances from recent literature, based on
strong expression level analyses and we analyzed the corresponding publications,
concluding that the use of miRNA-target prediction methods is a crucial step in
the process of miRSNP-disease association.
We subsequently wanted to investigate how online resources, made available
to researchers for miRNA research, can be used in these miRSNPs-disease asso-
ciation studies. We presented a brief overview of the most widely used databases
and repositories, mainly in three categories. The results obtained for the 34 cases
are summarized in Table 2.6, where the instances are ordered in decreasing order
of the total number of databases covering the case. Of particular interest were
online databases available for predicting SNP effects on putative miRNA targets.
These resources are of a great interest for researchers studying miRSNPs and we
found that 12 instances out the 34 from the dataset were not predicted by any of
the available repositories. We also found that very few resources allow a certain
degree of flexibility at the input stage and most of the databases restrict the users
to cataloged 3’UTRs, SNPs and miRNA sequences, which can be outdated and
not relevant to the user. This represents the main limitation for users looking to
predict the effects of novel or unreported SNPs.
Furthermore, we compared the results of two major computational approaches
to miRNA target ranking prediction: conservation feature using TargetScan tool
and target site accessibility feature using PITA and STarMir tools. We conclude
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that using the site accessibility feature may improve miRNA-target predictions.
In our work, we plan to investigate how to improve detecting the effects of
SNPs located in miRNA-3’UTR binding regions, on mRNA-miRNA bindings.
We are particularly interested in the impact of these SNPs on miRNA bindings
to metastable structures. Thus, as a first step, we will carry out an in-depth
analysis of features related to the accessibility of binding regions in secondary
structures representing relatively deep local minima, which applies to wild-type
as well as to mutated sequences. If the findings of such an analysis are promising,
we plan to devise a novel miRNA target prediction tool that can be used to
evaluate SNP-effect on miRNA regulation.
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Table 2.6: Summary of the dataset coverage indicating the number of online
databases and repositories covering each case. SNP dbs refers to the number
of SNP-effect prediction databases and Exp dbs indicates the number of the
databases which offer repositories for experimentally validated miRNA-target in-
teractions. The cases are ordered by decreasing number of Total which indicates
the sum over the three studied categories of databases. Used Tools refers to the
number of miRNA target prediction tools used in the in-silico analysis in the
corresponding publication.
L(3’UTR) nt SNP dbs Exp dbs miRecords miRWalk starBase Total Used Tools
REV3L 985 1 3 4 9 5 22 2
EFNA1 843 5 2 4 7 2 20 2
HOXB5 952 1 4 4 8 3 20 4
HTR3E 302 4 6 3 5 0 18 1
AGTR1 888 4 6 3 4 0 17 1
RAD51 978 4 3 4 6 0 17 6
CCNE1 531 3 4 3 5 0 15 4
FGF20 903 2 5 3 5 0 15 NA
KRT81 342 4 0 3 8 0 15 2
HLA-G 386 6 4 2 1 1 14 5
SPI1 369 2 3 2 6 0 13 1
NFKBIA 502 0 0 3 8 1 12 2
TYMS 502 2 0 3 7 0 12 1
WFS1 779 5 0 2 5 0 12 2
NCSTN 623 1 1 2 6 1 11 1
DROSHA 937 1 1 2 6 1 11 4
MTHFD1L 393 2 0 3 5 0 10 2
AGT 618 2 0 3 5 0 10 2
MSX1 790 4 0 0 6 0 10 1
RYR3 880 0 1 3 6 0 10 3
ORAI1 1034 0 NA 4 6 0 10 NA
IL-23R 851 0 1 3 4 0 9 1
CD133 1167 2 1 3 1 0 7 1
PDCD1 1177 2 0 0 4 0 6 3
CGA 258 0 1 2 2 0 5 4
APP 1120 NA 0 3 2 0 5 3
IL1A 1152 0 0 2 2 0 4 1
CBR1 284 0 0 2 2 0 4 5
SMUG1 628 1 NA 1 2 0 4 1
PARP1 769 0 0 1 2 0 3 6
RAP1A 1078 1 1 1 0 0 3 4
LIG3 124 0 0 1 1 1 3 6
MSLN 132 0 0 2 0 0 2 5




binding sites in metastable RNA
secondary structures in the
presence of SNPs
In Chapter 2, we introduced the context of our work on how to improve de-
tecting the effects of disease-associated SNPs on mRNA-miRNA bindings. We
researched the recent literature for studies on the impact of some of these SNPs
on miRNA bindings and we analyzed the corresponding publications. More-
over, we investigated the limitations of some of the available online resources for
miRNA research. In this chapter, we study miRNA bindings to metastable RNA
secondary structures close to minimum free energy (MFE) conformations in the
context of SNPs and mRNA concentration levels, i.e. whether features of miRNA
bindings to metastable conformations could provide additional information sup-
porting the differences in expression levels of the two sequences defined by a SNP.
In our study, the instances [mRNA/3’UTR; SNP; miRNA] were selected based
on strong expression level analyses, SNP locations within binding regions and the
73
computationally feasible identification of metastable conformations. We identi-
fied 14 basic cases [mRNA; SNP; miRNA] of 3’UTR-lengths ranging from 124
up to 1078 nt reported in recent literature, and we analyzed the number, struc-
ture and miRNA binding to metastable conformations within an energy offset
δE above MFE conformations. For each of the 14 instances, the miRNA binding
characteristics are determined by the corresponding STarMir output. Among the
different parameters we introduced and analyzed, we found that three of them,
related to the average depth and average opening energy of metastable confor-
mations, may provide supporting information for a stronger separation between
miRNA bindings to the two alleles defined by a given SNP.
The work carried out in this chapter is a joint work between Ouala Abdelhadi
Ep Souki, Luke Day, Andreas A. Albrecht and Kathleen Steinho¨fel. All authors
participated in the design of the methodology, the analysis of the results and the
writing of the manuscript. Luke Day implemented the application MSBind and
generated the data in Section .4 and Ouala Abdelhadi Ep Souki carried out the
miRNA binding site and energy predictions from Section .3 and the analysis of
the predictions. We note that this work has been published in [221].
3.1 Background
Within the past few years, analyzing concentration levels of microRNAs (miR-
NAs) and their putative messenger RNA (mRNA) targets has become a major
topic in miRNA research.
Subkhankulova et al. [104] experimentally evaluated a parameterized analyt-
ical expression that estimates the number of genes g having t transcripts present
in a single cell. The parameters are adjusted based on microarray data for a
large number of genes extracted from single embryonic mouse neural stem cells,
where the actual aim is the comparison of transcript numbers in phenotypically
identical cells. The authors conclude from observed data for about 13,000 genes
that the typical number of gene copies lies between 5 and 20, with 85% of genes
having less than 100 copies in a single cell. Although the analysis is carried
out for a specific cell type, the authors expect similar distribution results for a
wide range of cell types. Arvey et al. [222] provide experimental evidence that
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short RNAs (miRNAs and siRNAs) having a higher number of target transcripts
within a single cell will downregulate each individual target gene to a lesser extent
than those with a lower number of targets, which implies that the competition
between target genes for a limited number of small RNAs may determine the de-
gree of downregulation; see also Salmena et al. [223] for the concept of competing
mRNAs associated with the number and distribution of multiple binding sites.
Saito and Sætrom [224] provide data supporting the assumption that endoge-
nous miRNAs preferentially target mRNAs with long 3’UTRs. The authors also
discuss - among other features - the interaction between exogenous and endoge-
nous miRNAs and critically assess the value of microarray data in the context
of miRNA target prediction. The sequencing method developed by Mullokandov
et al. [225] supports the assertion that only the most abundant miRNAs medi-
ate target suppression. For example, deep sequencing of monocyte cells revealed
the presence of about 310 miRNAs, with only about 40% of the miRNAs show-
ing suppressing activity. For more than 80% of the targets, the corresponding
miRNA was expressed above 100 reads per million. For the miRNA target pre-
diction tool TargetScan, Garcia et al. [107] demonstrate how predictions may
improve if target abundance is accounted for in binding scores. The impact of
the life cycle of mRNAs on siRNA and microRNA efficacy is studied in [226].
The authors draw the conclusion that microRNA target prediction could be im-
proved if data about mRNA turnover rates are incorporated into prediction tools.
While [222; 226] focus on mRNA concentration levels, Cuccato et al. [227] pro-
pose different parameterised models of RNA interference that describe the effects
of varying quantities of siRNAs. The models are derived from the basic equa-
tion dXm/dt = km − dmXm − δ(Xm, Xs), where Xm and Xs are the mRNA and
siRNA concentrations, km is the mRNA transcription rate, dm the basal mRNA
degradation rate, and δ(Xm, Xs) is the siRNA induced mRNA degradation rate.
The models differ in the assumption about δ(Xm, Xs) and are fitted to experi-
mental data obtained for a single siRNA targeting the coding region of the EGFP




h∼ 4.5, p ∼ 0.008/min, and q∼ 0.1pmol. Within a similar framework, Osella et
al. [228] study the so-called miRNA-mediated feedforward loop in which a mas-
ter transcription factor regulates a miRNA together with a set of target genes,
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and the mathematical models studied by Loinger et al. [229] additionally account
for the concentration level of the argonaute protein complex. Baker et al. [230]
study analytically the impact of multiple small non-coding RNAs on the regula-
tion of a single target mRNA and subsequently the dynamics of protein produc-
tion. Ragan et al. [106] combine the concept of miRNA binding site accessibility
with miRNA and mRNA concentration levels. For [S], [T ] and [ST ] denoting
the equilibrium (final) concentrations of the miRNA, target mRNA and of the
hybridized structure, respectively, the authors utilize the equilibrium condition
[ST ]/([S][T ]) = exp(−∆∆G/c), where ∆∆G is the energy score that accounts for
making the binding site accessible and the free energy of the hybridized structure
(the constant c stands for the product of the gas constant and the temperature).
Combining the equilibrium condition with conservation of mass equations (for
initial concentrations [S0] and [T0]) eventually leads to an analytical expression
for [S] in terms of [S0], [T0] and ∆∆G, where the latter is calculated for a partic-
ular binding site. Marin and Vanio˘ek [231] introduce a new accessibility-based
algorithm that uses a statistical analysis of all putative binding sites for a given
miRNA-3’UTR pair. Among the top 100 target predictions for 153 fruit fly miR-
NAs, the algorithm finds more than twice as many validated targets compared to
other accessibility-based target prediction methods. Reviews of existing miRNA
target prediction tools and information about latest developments can be found
in [232] and [233]. The target prediction tool CoMeTa designed by Gennarino et al.
[234] operates on the assumption that targets of a given miRNA are co-expressed
with each other. The target prediction score is based upon the evaluation of
thousands of publicly available microarray data. For the 675 human miRNAs
analyzed in the study, more than 90% of the validated targets fall within the first
50% of predicted targets (which, however, could be a large number). In a similar
way, the tool miRror designed by Balaga et al. [235] combines scores produced by
an ensemble of established miRNA target prediction tools with rankings obtained
from gene expression and HITS-CLIP data.
Johnson and Srivastava [96] consider the problem of selecting an antisense
sequence that is able to effectively bind to a target mRNA and block protein
synthesis. One of the key features of the authors’ method is the presupposi-
tions that mRNA secondary structures are in a constant state of flux and are
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assuming different suboptimal states, which also determines the approach taken
in the present work. Johnson and Srivastava [96] designed a tool that generates
and compares suboptimal secondary structures of a given mRNA sequence. The
comparison aims at identifying regions that are least similar among the set of
folded structures, which indicates volatility in intramolecular hydrogen bonding.
Such regions are seen as candidates for antisense binding. The method is evalu-
ated on six mRNA sequences and compared to results produced by the Soligo
application of Sfold [236].
In the present work, we study miRNA bindings to sets of metastable secondary
structures induced by 3’UTRs and their mutated counterparts, where the SNPs
are located within the miRNA binding site. Long et al. [97] briefly mention the
analysis of miRNA bindings to metastable conformations. The authors compare
the prediction performance over samples of 1,000 secondary structures without
constraints to samples of 100 metastable conformations. They report the sample
of 1,000 conformations is more favorable. In our approach, we discriminate be-
tween metastable conformations with regard to the depth and average opening
energies.
3.2 Approach
As mentioned in the preceding section, the present study assumes the existence
of multiple active RNA conformations instead of a unique minimum free energy
conformation as the single biologically active state, see [96], [36], and the literature
therein. The second basic feature of our approach relates to the presence of
multiple copies of each individual mRNA. In more detail, we proceed as follows for
a given [mRNA; SNP; miRNA] instance (a flowchart of the approach is provided
in Figure 3.1):
(A) For both alleles (3’UTR and SNP), the sets MS(3’UTR, δE) and MS(SNP, δE)
of metastable states within an energy offset δE above the MFE conforma-
tion are identified by using RNAsubopt and Barriers; cf. [37; 237; 238].
Alternative tools are, for example, (modified) version of RNAlocopt [40]
and Regliss [44].
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Figure 3.1: Approach of data analysis.
(B) STarMir [239] is applied to both alleles for the given miRNA. Although the
14 basic cases [mRNA; SNP; miRNA] selected from recent literature were
analyzed in the corresponding publications by prediction tools different from
STarMir, we obtained for each of the cases at least for one allele a binding
site predicted by STarMir with the SNP position inside.
(C) For the predicted binding site BS(miRNA), the elements of the sets MS(3’UTR, δE)
and MS(SNP, δE) are examined with respect to a number of basic features,
such as the number of base pair bindings within BS(miRNA) and the ap-
proximate free energy ∆GBS of bindings within BS(miRNA) according to
standard data of the Nearest Neighbour Model [26; 240].
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(D) Subsets of MS(· · ·, δE) are analyzed in the context of the number of mRNA
copies, as analyzed in Subkhankulova et al. [104], in the same way as in
(C), i.e. for k = 20, 60, 100 the sets MS(· · ·, k)⊂MS(· · ·, δE) are examined,
where k indicates the assumption about the number of mRNA copies. We
note that the number of copies is different from concentration levels, which
are measured, e.g. per mol, see [227].
The analysis in this work has been carried out on the first retrieved [mRNA; SNP;
miRNA] instances described in detail in Chapter 2- Section 2.2. These fourteen















In these 14 cases, the miRNA bindings are predicted by the latest version of
STarMir [239] at least for the allele with the stronger inhibitory effect with the
SNP position being inside the binding region.
3.3 Results
When executing step (A), we applied the standard settings of RNAsubopt and
Barriers, where isolated base pairings are not permitted and free energy values
are discriminated with an accuracy of 0.1 kcal/mol. The setting of δE depends
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on the length of the 3’UTR and was selected in such a way that a sufficiently
large number of metastable conformations is available for analysing MS(· · ·, k)
with k ≤ 100. Along with the energy offset δE, we tried to restrict metastable
states to ‘deep’ local minima. The parameter D indicates the ‘depth’ of a local
minimum or ‘escape height’ from a local minimum, which is taken from the barrier
tree as the distance to the nearest saddle point. By |SecStrucw/s| (short for both
cases of |SecStrucweak| and |SecStrucstrong|) we denote the number of secondary
structures returned by RNAsubopt for an offset δE above the MFE conformation,
where the index w indicates the allele with the weaker and s with the stronger
miRNA inhibitory effect (binding prediction - for [ORAI1;rs76753792;miR-519a-
3p]). Analogously, |MSw/s| is the number of local minima within the δE range
with an ‘escape height’ larger or equal to D.
3.3.1 Number of Metastable Conformations
The results of step (A) with respect to δE,D , |MSw/s| and |SecStrucw/s| are
summarized in Table 3.1. For 9 of the 14 instances, the values of |MSw| and
|MSs| are relatively close or (much) larger for |MSs|, see Table 3.1 and Figure 3.2.
For the remaining instances, the ratio |MSw|/|MSs| ranges from 1.31 (FGF20)
up until 6.47 (AGTR1). Thus, the number of secondary structures classified as
metastable conformations per se does not discriminate between the two cases of
weaker and stronger binding to the associated miRNA. The correlation between
|MSw| and |MSs| does not necessarily extend to |SecStrucw/s| (see Figure 3.3).
For example, for LIG3 we have |MSw|/|MSs|>1, whereas
|SecStrucw|/|SecStrucs|<1.
3.3.2 MicroRNA Binding Sites and Energy Predictions
The results obtained in step (B) are summarized in Table 3.2. For a given input
[3’UTR/SNP;miRNA], STarMir returns a large number of data items and graph-
ical representations of miRNA binding patterns. We focus on the binding regions
and four energy values, all generated by the STarMir method:
(a) ∆Gnucl relates to the assumption that the initial stage of base-pairing (nu-
cleation) requires a gain in free energy that is greater than the energy
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cost for the translational and rotational entropy loss when both miRNA
and mRNA are fixed in a conformation by intermolecular base-pairing.
The value of ∆Gnucl is calculated by using a sample of 1,000 structures
computed by Sfold, where the calculation is restricted to short base-pair
blocks within a 4 nt single-stranded segment of a putative binding site.
The energy cost for the translational and rotational entropy loss is called
initiation energy ∆Ginit, and the standard setting in the STarMir tool is
∆Ginit = 4.09 kcal/mol, i.e. ∆Gnucl + ∆Ginitiation<0 kcal/mol can be seen as
a basic requirement for miRNA–mRNA interaction.
(b) ∆Gdisrupt is the energy needed for the disruption of base pairs that are
present within a putative binding site in a given mRNA secondary structure.





(c) ∆Ghybrid is the energy gained by the hybridisation of the miRNA with the
particular binding site.
(d) ∆Gtotal is the basic STarMir score defined by ∆Gtotal = ∆Ghybrid - ∆Gdisrupt.





The binding regions and energy values shown in Table 3.2 are determined by the
STarMir prediction with the strongest seed match among all predictions having
the SNP position inside, leading in some cases to weaker ∆Gtotal values. In case
of a missing strong seed match the target predictions provided by the PITA tool
[24] are taken into account.
By |BPw| and |BPs| we denote the number of base pairs in the corresponding
MFE conformations, which are part of the output obtained in step (A), within the
miRNA binding region predicted by STarMir for an individual allele ( w = weak
and s = strong allele with respect to miRNA binding). Detailed information about
the STarMir output is provided in Supplementary Material in Section .3, which
also includes PITA predictions and, where available, data provided by FindTar
[241]. The PITA tool returns miRNA binding predictions for the binding sites
covering the SNP position as predicted by STarMir for nine out of the fourteen
instances: HTR3E, HLA-G, WFS1, IL-23R, RYR3, AGTR1, FGF20, RAD51,
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RAP1A. TargetScan, Release 6.2 from June 2012, returns miRNA binding pre-
dictions for the 3’UTR of HTR3E, RYR3, AGTR1, FGF20 and ORAI1, however,
with the SNP position located at some distance from the actual binding region
predicted by TargetScan. For the miRanda tool, version v3.3a, we lowered the
cut-off score from standard 140 to 90 and obtained for thirteen instances bind-
ing predictions for at least one allele with the SNP position inside. For CBR1,
miRanda returns a binding prediction for the A-allele (s-case) with a score of 138,
and no prediction is made for the G-allele (w-case). For the remaining twelve
instances, the binding predictions for the four instances PARP1, RYR3, HOXB5
and ORAI1 are inconclusive (identical or very close scores for both alleles). For
the eight instances HTR3E, HLA-G, WFS1, IL-23R, AGTR1, FGF20, RAD51
and RAP1A, the miRNA binding prediction is stronger for the allele with the
stronger binding claimed in the underlying literature source (minimum score dif-
ference equal to 16, maximum 32), i.e., overall, 64% of the experimental data are
supported by the miRanda tool.
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Figure 3.2: |MSweak|/|MSstrong| ratios. We obtained a larger or equal number
of metastable conformations for the allele with the stronger miRNA binding in
the case of CBR1, HTR3E, PARP1, WFS1, RYR3 and RAP1A (green colour).
The ratio is larger but close to one in the case of LIG3, HLA-G and IL-23R
(blue colour). In the case of AGTR1, FGF20, HOXB5, RAD51 and ORAI1, we
obtained a much larger number of metastable conformations for the allele with
the weaker miRNA binding (red colour).
83
Figure 3.3: |SecStrucweak|/|SecStrucstrong| ratios. In the case of LIG3,
CBR1,HTR3E, PARP1, WFS1, RYR3 and RAP1A, we obtained a larger or equal
number of secondary structures calculated by RNAsubopt for the allele with the
stronger miRNA binding (green colour). For HLA-G and RAD51 (blue colour),
the ratio is larger but close to one, and we obtained a much larger number of
secondary structures for the allele with the weaker miRNA binding in the case of
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Except for IL-23R (L=851), the ∆Gtotal predictions by STarMir are stronger
for the allele identified for stronger miRNA bindings in the corresponding publi-
cation (cf. the row for ∆∆Gtot and description of instances in Chapter 2; we recall
that for ORAI1 no particular miRNA is mentioned). Except for LIG3 (L=124),
HTR3E (L=302), HLA-G (L=386) , IL-23R (L=851) and AGTR1 (L=888), the
absolute value of ∆Gdisrupt is smaller for the allele with the stronger miRNA bind-
ing stated in the corresponding publication (s-allele indicated in Table 3.2, see
also the row for ∆∆Gdis). For IL-23R and AGTR1, the total STarMir score is
positive for both alleles, for IL-23R even with ∆Gstotal > ∆G
w
total.
The instance [IL-23R;rs10889677;let-7e] has been analyzed in [202], with strong
experimental evidence for an inhibitory effect of let-7e on the C-allele. The bind-
ing patterns for the C allele provided by STarMir (see Supplementary Material in
Section .3) and in Figure 3A of [202] differ only slightly towards the 5’ end of the
C allele. We note that for the A allele we have the only case in Table 3.2 where
the SNP position is not within the ‘binding site’ predicted by STarMir. The
PITA tool returns (the equivalent of) ∆Gtotal = −14.12 kcal/mol for the C allele,
and ∆Gtotal = −10.02 kcal/mol for the A allele (see Supplementary Material in
Section .3), which is in line with the experimental data from [202]. The absolute
value of ∆Gdisrupt is also slightly smaller for the C allele.
For [LIG3;rs4796030;miR-221], the absolute value of ∆Gdisrupt is larger for the
C allele by 4.19 kcal/mol, and there is no PITA prediction with the SNP position
inside the reported binding region. The PITA predictions close to the SNP position
favor the C allele with respect to the total score and ∆Ghybrid, which complies with
[182]. The selection of positions 77–98 for the A allele and 80–98 for the C allele
is motivated by the seed-like bindings predicted by STarMir, see Supplementary
Material in Section .3.
For ORAI1, the positions 69–88 were selected due to ∆Gsnucl =−4.32 kcal/mol.
For [HTR3E;rs56109847;miR-510-5p], the ∆Ghybrid value is stronger for the G
allele (s-case) by 6.2 kcal/mol, and the stronger binding prediction is supported
by PITA and FindTar (no binding prediction for A allele-w-case). For [HLA-
G;rs1063320;miR-148a-3p], PITA returns a stronger total score for the G allele,
which is in line with the STarMir total score and experimental data from [189].
However, as for STarMir, the absolute value of ∆Gdisrupt is larger for the G allele
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(by 1.12 kcal/mol for PITA and 1.73 kcal/mol for STarMir). FindTar also strongly
supports the miRNA binding to the G allele.
For [AGTR1;rs5186;miR-155-5p], the ∆Ghybrid value is stronger for the A allele
(s-case) by 4.3 kcal/mol. The stronger binding prediction for the A allele is
supported by PITA and FindTar (no binding prediction for C allele-w-case).
For the 14 instances under consideration, the PITA predictions either support
(or improve for IL-23R) the STarMir predictions displayed in Table 3.2, or no
predictions with the SNP position inside the reported binding region are returned.
In summary, if STarMir and PITA (for IL-23R) are taken together, the ∆Gtotal
predictions are stronger for the corresponding allele (s-case) identified in the
description of the 14 instances in Chapter 2.
3.3.3 Analysis of Metastable Conformations
STarMir and PITA operate on sequences as input, not on representations of sec-
ondary structures. Therefore, we utilize RNAeval [237] for the energy evaluation
of metastable conformations within binding regions predicted by STarMir, which
also complies with the data generated by RNAsubopt and Barriers, see Table 3.1.
To facilitate a coherent analysis of energy values, we use energy values calculated
for binding regions within the corresponding MFE structure as templates for com-





















































































































































































































































































































































































































































































































































































































































































































































































































































































































Let S denote a secondary structure (either MFE conformation or metastable
conformation) for a 3’UTR (wild-type or SNP-type) listed in Table 3.1. By Sopen
we denote the associated secondary structure where all base pair bindings within
the miRNA binding region reported in Table 3.2 are removed. For example, if
S is the MFE conformation of the 3’UTR of the C allele of LIG3, then S has
seven base pair bindings in positions 80–98 (see Table 3.2), and the seven base-
pair bindings are removed in Sopen. For S being a metastable conformation, the
number of base-pair bindings within the miRNA binding region can be larger, the
same or smaller in comparison to the corresponding value reported in Table 3.2
for the MFE conformation. We then define




The index ‘ind’ specifies the different cases we consider, and the different val-
ues in (3.1) and (3.2) relate either to individual structures or to average values
(according to the value assigned to ‘ind’) over sets of metastable conformations:
(i) ind = mfe indicates the single MFE conformation.
(ii) ind = tot indicates the average value over all metastable conformations as
counted in Table 3.1. For example, ∆Gtot:sopen stands for the average value over
317 metastable conformations in case of the C allele of LIG3, see Table 3.1.
(iii) ind = N+ indicates for N = 20, 60 and 100 the N+ metastable conformations
S with the N+ lowest free energy values calculated by RNAeval(S) that are
above the MFE conformation.
The output obtained in step (A) consists of a list of metastable secondary
structures within the energy offset δE above MFE conformations, ordered
with respect to increasing free energy. Each energy level usually adds more
than a single conformation. As an example, three conformations are accu-
mulated at energy level −35.0 kcal/mol, in the case of the C allele of LIG3
(see Figure 3.4). Therefore, the notion ’N+’ indicates that the highest en-
ergy level involved covers N conformations above the MFE structure, plus
in most cases some more structures, i.e. the actual number N+ of confor-
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mations can be slightly larger than N. For example, for LIG3 C allele, 100+
means 108 metastable conformations as shown in Figure 3.5. Note that for
each case, N+ may be different for wild type and variant alleles.
There are a few exceptions for 60+, where the number is between 50 and
60, because the next energy level results already in a conformation num-
ber above 100. For example, for PARP1, 60+ means 55, because 55 con-
formations are accumulated at energy level −186.4 kcal/mol, while level
−186.3 kcal/mol adds 48 conformations, which leads to 100+ = 103.
Figure 3.4: Example of the output obtained in step (A) for the case of the LIG3, C
allele, where only ten conformations are displayed. The first secondary structure
corresponds to the MFE conformation. The three highlighted conformations are
accumulated at energy level −35.0 kcal/mol.
Figure 3.5: Part of the output obtained in step (A) for the case of the LIG3,
C allele. Level −32.4 kcal/mol adds the nine highlighted conformations, which
leads to 100+ = 108.
Furthermore, we order the metastable conformations Sms with respect to the
absolute value of |∆Gopen| and the depth D(Sms) (deepest first), respectively (see
Figure 3.6 for an example). As in (3.2), we define
∆∆Gasc:N+ = ∆G
asc:N+:s







Figure 3.6: Part of the output obtained in step (A) for the case of the LIG3, C
allele. The conformations are ordered with respect to the depth D(Sms), where
the ten deepest metastable conformations are displayed.
where D
w/s
N+ denotes the average depth of the N+ deepest metastable conforma-
tions. The index ‘asc’ in (3.3) indicates that, unlike in (3.2), the N+ metastable
conformations are ranked in ascending order with respect to |∆Gopen|, and the
average value is taken over N+ conformations.
Finally, we combine opening energies, as defined in (3.2) and (3.3), with the
depth D(Sms) of metastable conformations, as defined by D
w/s
N+ and used in (3.4):
We look at the average depth of structures Sms with the N+ smallest values of
|∆Gopen|. Let DN+:w/sopen denote the average depth of metastable conformations Sms
counted in the calculation of ∆G
asc:N+:w/s




Comprehensive information about the distribution of metastable conforma-
tions and their respective energy values is provided in Supplementary Material
in Section .4. In Table 3.3 we report representative data that are useful for dis-
criminating between the two alleles involved for each instance. Positive values of
∆∆Gmfe, ∆∆Gtot, ∆∆GN+, ∆∆Gasc:N+ and ∆D
N+
open are interpreted as being in favor
of the allele with the stronger miRNA binding stated in the underlying literature
source, which is also the case for RN+ < 1. For LIG3 (L=124), HTR3E (L=302),
HLA-G (L=386), IL-23R (L=851) and RAD51 (L=978), the data for ∆∆Gmfe,
∆∆Gtot, ∆∆GN+ and ∆∆Gasc:N+ shown in Table 3.3 are not in favor of the allele
with the stronger miRNA binding stated in the underlying literature (HOXB5
with L=952 not included here, please see later in the text). For LIG3, IL-23R and
RAD51 the values of RN+ are either close to or smaller than 1.00, and the values
92
of ∆DN+open are all positive, suggesting more stable local minima for structures with
the smallest absolute value of opening energies for the allele with the stronger
miRNA binding.
For HLA-G (L=386), the values of RN+ are equal or close to 1.00, and the
values of ∆D60+open and ∆D
100+
open are positive. Moreover, the ∆∆Gasc:N+-values shown
in Table 3.3 are close to zero, and the values of ∆∆GN+ are in the range of
∆Gsdisrupt−∆Gwdisrupt =−1.73 kcal/mol from Table 3.2. Thus, for HLA-G the values
of ∆G
s/w
hybrid shown in Table 3.2 seem to be decisive for an assessment of a putative
miR-148a-3p↔HLA-G/rs1063320 binding (based on prediction tools).
For HTR3E, only the values of ∆DN+open are in favor of the allele with the
stronger miRNA binding stated in the underlying literature. Unlike the case of
HLA-G, the negative values of∆∆GN+ and ∆∆Gasc:N+ are more substantial, i.e. in
terms of absolute values above the range of corresponding values from Table 3.2.
Thus, only the values of ∆Gshybrid, ∆G
s
nucl (both Table 3.2) and ∆D
N+
open (Table 3.3)
support the binding to the G allele (s-case).
For HOXB5, the ∆∆GN+ values are negative yet close to zero, and the ∆∆Gasc:N+
values support the stronger miRNA binding of the A-allele (s-case), which makes
the HOXB5 instance different from the five instances discussed earlier in the text.
The RN+-values are close to 1.00, and ∆D
100+
open is positive.
For RAP1A (L=1078), the STarMir predictions for ∆Gdisrupt and ∆Ghybrid,
respectively, are very close for both alleles. The SNP at position 366 is located in
the middle of a loop (positions 363–369) in both MFE secondary structures, which
leads to identical values of ∆G
ind:s/w
open and related features. Therefore, similar to
HTR3E, ∆Gshybrid and ∆G
s
nucl from Table 3.2 appear to determine the evaluation of
miR-196a↔RAP1A/rs6573 bindings. For CBR1 (L=284), WFS1 (L=779), RYR3
(L=880), AGTR1 (L=888), FGF20 (L=903) and ORAI1 (L=1034), the data for
∆∆Gmfe, ∆∆Gtot, ∆∆GN+ and ∆∆Gasc:N+ (Table 3.3) are all in favor of the allele
with the stronger miRNA binding stated in the underlying literature.However,
for each of the five instances at least one of the two parameters RN+ and ∆D
N+
open
does not fully support the predicted binding.
For RYR3 (L=880), only ∆D20+open =−0.26 kcal/mol is clearly not in favor of the
predicted binding. Similarly, the values of ∆DN+open do not support the predicted
stronger binding for CBR1. For ORAI1, this is the case for the RN+ values
93
and ∆D100+open = −0.05 kcal/mol, but with a relatively strong value of ∆D20+open =
0.75 kcal/mol. For AGTR1, all three values of ∆DN+open are clearly in favor of the
predicted binding pattern. The instances WFS1 and FGF20 are the only two cases
where for all N+ values both parameters do not support the predicted stronger
binding. Finally, for PARP1 (L=769) all energy values shown in Table 3.3 support
the stronger miRNA binding to the T-allele (s-case). We recall that for the
instance ORAI1 from Chang et al. [208] no individual miRNA is identified in
the literature source. For ORAI1 and miRNA-519a-3p, the two binding sites
predicted by STarMir intersect only by 8 nt, with a positive value ∆Gtotal =
5.62 kcal/mol for the T-allele (w-case), which suggests that no binding occurs.
Although RN+ > 1.00 for all cases of N+ considered, we obtain strong positive
values for ∆∆Gmfe, ∆∆Gtot, ∆∆GN+ and ∆∆Gasc:N+, along with the STarMir predic-
tions ∆Gtotal = −7.21 kcal/mol and ∆Gnucl = −4.32 kcal/mol for the C-allele
(s-case). Moreover, the data for ∆DN+open are ∆D
10+
open = 0.89 kcal/mol, ∆D
20+
open =
0.75 kcal/mol and ∆D60+open = 0.08 kcal/mol, which support a binding of miR-519a
to the 3’UTR of ORAI1.
3.4 Conclusion
Out of the 14 instances we analyzed, 13 instances are sensitive to the param-
eters ∆∆Gind, ∆∆Gasc:N+, RN+ and ∆D
N+
open we introduced in Equation(3.1) until
Equation (3.5). For RAP1A (L=1078), slightly larger values of δE did not create
differences between basic parameters for both alleles and eventually led to an
unmanageable size of data for standard desktop computer configurations.
The absence of experimental data about copy numbers of mRNA transcripts
considered in the present study prevents the selection of a particular value of
∆DN+open (or of the other two highlighted parameters), which is why we considered
four representative values of N+ simultaneously, without calculating p-values.
The upper bound of N=100+ is motivated by the work provided in [104] where
the authors conclude from observed data for about 13,000 genes that the typical
number of gene copies lies between 5 and 20, with 85% of genes having less than







































































































































































































































































































































The data provided in Table 3.3 indicate that ∆∆Gmfe, ∆∆Gtot, ∆∆GN+ does
not necessarily contribute to a deeper insight into miRNA binding patterns to
different alleles, see also the discussion of instances in Section 3.3.3. In particular,
∆∆Gtot and ∆∆GN+ are related only to free energy values of metastable structures,
which is why a further discrimination by the depth of metastable conformations
and the opening energy of binding regions was introduced. Consequently, we
focus in the summary of findings presented in Table 3.4 on the values calculated
for ∆∆Gasc:N+, RN+ and ∆D
N+
open.
In Table 3.4, the row ’STarMir(total)’ indicates by ’+’ that the ∆Gtotal score
(see Table 3.2) supports the allele with the stronger miRNA binding stated in
the underlying literature; ± indicates 0< |∆Gstotal|< |∆Gwtotal|. As aforementioned,
data about estimations of copy numbers are not available for the mRNA tran-
scripts we consider in the present study. To avoid the inclusion of irrelevant data
(by averaging or thresholding), we consider a ’best case scenario’ for each instance:
We select a value of N+ in such a way that the support of the miRNA binding
to the allele identified in the underlying literature source (s-case) is maximized.
In case of multiple N+ values (for 11 instances same pattern as in Table 3.4 for
at least two N+), the smallest N+ is selected and named in Table 3.4 in the row
’N+ selection’.
For the selected N+, the Table 3.4 entry is labeled as positive ’+’, if ∆∆Gasc:N+
and ∆DN+open are positive, respectively, or RN+<1.00. If the data are inconclusive
(equal or close to 0.00 or 1.00), we use ±. For example, for HLA-G we select
N+=60+ and obtain from Table 3.3 the entries for Table 3.4 as follows: ∆∆Gasc:N+
= ±, RN+ = ±, and ∆DN+open = +.
Table 3.4 demonstrates that the combined measure ∆DN+open defined in (3.5)
is the best match to the binding predictions, with two inconclusive and two
negative values. The inconclusive value of ∆D20+open for CBR1 is accompanied by
two positive values of the other two parameters, and RAP1A is a special instance
due to the SNP location, as discussed in Section 3.3.3. The negative values of
∆D20+open for WFS1 and FGF20 are accompanied by relatively strong positive values
of ∆∆Gasc:20+. Future research will focus on how to establish a suitable total score
that takes into account weighted partial scores provided by ∆∆Gasc:N+, RN+ and
∆DN+open. For example, the simple weight selection −1 ≡ −, 0 ≡ ± and 1 ≡ +
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applied to Table 3.4 results in a total score of -1 for HTR3E and FGF20, and
a total score of 0 for WFS1, RAD51 and RAP1A. However, WFS1 has a strong
∆∆Gasc:20+ score, RAD51 has a strong ∆D
N+
open score and RAP1A is a special case
due to the location of the SNP. The relatively strong score of ∆∆Gasc:20+ could
outweigh the other two scores. HTR3E remains an ambiguous case, see also the
discussion of the HTR3E-miR-510-5p instance in [174].
We hypothesize that an in-depth analysis of metastable conformations based
upon parameters such as ∆∆Gasc:N+, RN+ and ∆D
N+
open can provide useful infor-
mation for the assessment of putative miRNA-mRNA bindings in the context of
SNPs. In the literature sources we researched for the current study, the number of
genes and miRNAs exposed to experimental analysis is relatively small, yet each
analysis is time-consuming and costly. Examining features of metastable confor-
mations in a preprocessing step of wet lab experiments may improve the confi-
dence about expected miRNA-mRNA bindings. We emphasize that for ORAI1
no specific microRNA is identified by Chang et al. [208]. The data we presented
support the binding of miR-519a-3p to the 3’UTR of ORAI1 in the region of
position 86.
In the present study, the energy values associated with the accessibility of
binding sites are approximated by using RNAeval, and the range of the binding
sites is directly adapted from the miRNA target prediction tool STarMir.
Subsequently, we aim at an automated, individual miRNA-mRNA binding
prediction algorithm, which continues our work presented in this chapter. We plan
to incorporate the approach into a procedure designed for the analysis of miRNA
bindings to 3’UTR conformations, using samples of metastable conformations





Based upon Metastable RNA
Secondary Structures
In Chapter 3, we studied the problem of miRNA bindings to metastable secondary
structures in the context of SNPs and mRNA concentration levels. Our analysis
showed that the number of metastable structures and features of miRNA bindings
to metastable conformations could provide additional information supporting the
differences in expression levels of mRNAs and their corresponding SNP variants.
As a consequence, we concluded that miRNA target predictions using metastable
conformations in a pre-processing step of wet lab experiments may improve the
confidence about expected miRNA-mRNA bindings.
In this chapter, we present RNAStrucTar, a new miRNA target prediction tool
that analyses putative mRNA binding sites within 3’UTR secondary structures
representing metastable conformations. The first stage consists of generating
conformations that can be classified as deep local minima. The second stage in-
corporates duplex structure prediction through sequence alignment and energy
computation. Target site accessibility related to different sets of metastable con-
formations is also taken into account. An overall interaction score computed from
multiple binding sites is returned. The approach is discussed in the context of
single nucleotide polymorphisms (SNPs). In Chapter 2, we selected 34 instances
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of type [mRNA;SNP;miRNA] reported in recent literature where methods such
as PCR and/or luciferase reporter assays are utilised. If the two main scores
returned by RNAStrucTar are combined, 25 instances are correctly classified ac-
cording to experimental findings from the literature, with two false classifications
and seven indifferent outcomes. We finally prove that predictions improve when
additionally combined with STarMir and PITA results. We note that a part of
this work has been published in [242].
4.1 Background
Computational methods perform the predictions based upon features extracted
from experimental data. Early target prediction algorithms primarily focus on
sequential features, such as PicTar [91], TargetScan [85], and miRanda [115].
Most methods require the target sequence to have a near perfect complementarity
to a region in the miRNA sequence, which is named seed and defined by the
first 2–8 nucleotides, starting at the 5’ end. The prediction accuracy can be
improved by taking into account evolutionary conservation of binding sites in both
sequences [93]. Thermodynamic stability of miRNA–mRNA duplex structures is
also one of the most frequently used features, where the overall change in Gibbs
free energy is employed as an indicator of how strongly bound the sequence pair
is. More detailed reviews of features used in existing miRNA target prediction
tools can be found in [88; 232; 233; 243; 244].
Advanced methods take into account the secondary structure of mRNAs. One
of the key concepts underlying such tools is the accessibility of potential bind-
ing sites. In reality, there is an energy cost to be considered for freeing base
pairing interactions within the mRNA. This feature was first used in the work
of Zhao et al. [245], where they provide evidence that RNA accessibility is a
principal feature of miRNA target recognition. However, they only integrate the
MFE structure, generated by mfold [12], into their predictions. Subsequent works
consider the complete Boltzmann ensemble of all possible structures rather than
relying on a single predicted MFE structure. A statistical sample of the ensem-
ble allows sampling estimates of the structural accessibilities around target sites.
Our work in Chapter 3 assumes the existence of multiple active RNA conforma-
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tions different instead of a unique MFE structure as the single biologically active
state. The second basic feature of our work relates to the presence of multiple
copies of each individual mRNA. We studied the problem of miRNA bindings to
metastable secondary structures in the context of SNPs and mRNA concentration
levels. Our analysis showed that the number of metastable structures and fea-
tures of miRNA bindings to metastable conformations could provide additional
information supporting the differences in expression levels of mRNAs and their
corresponding SNP variants. As a consequence, miRNA target predictions using
metastable conformations in a pre-processing step of wet lab experiments may
improve the confidence about expected miRNA-mRNA bindings. RNAStrucTar,
the method described in the present work, is a new miRNA target prediction
tool that analyses putative mRNA binding sites - in contrast to Chapter 3 - by a
specific energy evaluation of duplex structures based upon secondary structures
representing metastable conformations.
4.2 Approach
There are two main stages in RNAStrucTar. The first stage is the generation
of metastable conformations, and the second stage comprises of miRNA target
prediction based upon an energy assessment that incorporates target accessibility
related to an input set of secondary structures.
While the first stage is similar to our analysis discussed in Chapter 3, the
remaining steps are different. In Chapter 3, we looked manually at the range of
one single binding site for each case, predicted by STarMir with the SNP positions
inside. Moreover, the energy values associated with the accessibility of the binding
sites were approximated manually by using RNAeval. Conversely, RNAStrucTar
is a self contained tool which analyses automatically the input mRNA sequence
for putative binding sites, uses structural accessibility feature related to different
sets of metastable conformations and finally takes the number of target sites into
account to generate a final score. A flowchart showing the particular steps of
RNAStrucTar is given in Figure 4.1.
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Figure 4.1: RNAStrucTar flowchart. Figure 4.2: RNAStrucTar ex-
ample.
4.2.1 Metastable Secondary Structures
Metastable secondary structures are generated by using standard tools provided
by the Vienna RNA server [237]. The RNAsubopt tool by Wuchty et al. [37]
generates all suboptimal foldings of a sequence in a partial energy landscape
defined by an energy range δE above the MFE structure. A method to elucidate
the basin structure of landscapes by means of tree-structures representing local
minima and their connecting saddle points is provided by the Barriers program
[39]. The input to Barriers is a list of conformations sorted by energy values.
The RNAsubopt tool together with the Barriers program allows the user to
identify the set of metastable conformations MS within an energy range δE above
the MFE conformation. We denote the number of local minima by ms = |MS|.
4.2.2 Identification of Putative Nucleation Sites
RNAStrucTar first scans the mRNA sequence in search for putative nucleation
sites, considering complementarity with the seed region of the miRNA. This seed
match step is commonly used and considered as a speed-up factor that accelerates
the algorithm while it differs from tool to tool in terms of number of of matches.
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A flexible miRNA seed window - nucleotides 2 to 8, counting from the 5’ end of
the miRNA - is used to scan the mRNA sequence for potential target sites. We
first predefine the different complementary sequences of the seed region of the
miRNA. The number of these sequences depends on the required user defined
seed match n-mer (n varies between 3 for shorter seed matches and 7 for longer
ones). There must be n consecutive Waston Crick basepairs with no G-U wobble
allowed to appear. Each complementary sequence will slide through the input
UTR sequence to find all matching positions. All results shown in this work were
obtained by using 3-mers or 4-mers complementarity to miRNA positions 2–5 in
the seed match step; see Figure 4.2.
4.2.3 [binding region, miRNA]-duplex Structure Predic-
tion
After the seed regions are identified, the upstream flanking region of the seed
region is extracted for the next step. Among common features of prediction pro-
grams are dynamic programming and the alignment of the miRNA seed region
to the target mRNA. We propose a dynamic programming approach for finding
minimum energy alignments between the full length of the miRNA and the target
sequence for each putative binding site. For this purpose, a modified version of
RNAduplex [125] is adapted to compute the optimum duplex structure for each
putative binding site. For each such site j, the binding pattern and its free energy
∆Gjbinding are computed according to the seed alignment from the previous step;
see Figure 4.2. At the end of this step, weak binding sites are filtered out by ap-
plying an energy threshold ϑ with the default setting -10kcal/mol. We considered
the performance of various threshold values in filtering out the weak sites that
will not go through the next step and we found a cut-off value between -8kcal/mol
and -10kcal/mol most suitable to distinguish between confident binding sites and
weaker ones. However, users may wish to lower the number of putative binding
sites at the end of this step by choosing a more stringent cut-off threshold. This
way we obtain k binding sites that satisfy the condition ∆Gjbinding ≤ ϑ, j = 1, ..., k.
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4.2.4 Integration of Target Site Accessibility
Similar to [24] and [97], we adopted the simplifying assumption that the binding
of a miRNA to a longer target mRNA should cause a local structural alteration
at the target site, but has no long-range effects on the overall target secondary
structure. This leads to a breakage of intramolecular bonds within the target
region. For each input secondary structure Fi ∈ MS, i = 1, ...,ms, the energy
contribution ∆Gjopen,i of the deleted bindings is computed for each site j by using
RNAeval [237] and according to standard data of the Nearest Neighbour Model
[26; 240]. Given Fi, we denote by Fopen,i the associated secondary structure where
all base pair bindings within j are removed. We then define
∆Gjopen,i = RNAeval(Fi)−RNAeval(Fopen,i). (4.1)
4.2.5 miRNA-target Score Derived from a Single Binding
Site
At this stage, we estimate the free energy of the miRNA:mRNA duplex struc-
ture by using RNAeval. For each putative binding site j and for each input
secondary structure Fi, we generate an artificial RNA sequence that consists
of the original mRNA (3’UTR) sequence, a linker sequence XXXX, and the
miRNA sequence. The corresponding folding is denoted by Fjconcat,i. The score




We integrate the scores of multiple conformations Fi for the hj ≤ ms negative
values of Si,j < 0 by setting a logarithmic sum of Boltzmann-weighted energies
for these different conformations
Sj = − log
hj∑
s=1
e−Sis,j , j = 1, ...., k; (4.3)
see Figure 4.3. In Figure 4.3 we assume for simplicity hj = ms for all j ≤ k.
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 S1,1 . . . S1,k... ... ...
Sms,1 . . . Sms,k






Sms,1 . . . Sms,k
S1 . . . Sk






Sms,1 . . . Sms,k
S1 . . . Sk Stot

Figure 4.3: Integration of multiple binding sites and conformation into a single
score.
The setting according to Eqn. 4.3 is inspired by the PITA score [24], where
the sum corresponds to the partition function of the conformations, and the
logarithmic is therefore linearly related to the probability of that ensemble of
conformations.
4.2.6 MicroRNA Target Prediction Scores
Some existing target prediction methods check the presence of multiple target
sites and take the number of target sites into account for a final score.
We explored different ways to account for the occurrence of multiple binding
sites and we ended up with a scoring function where the emphasis is on combin-
ing strong duplex conformations with a user-defined target region. To integrate
multiple sites with Sj-scores for a given miRNA and a fixed 3’UTR into an overall
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miRNA:target interaction score, we define




We note that by definition Sj < 0 (assuming hj ≥ 1) for all j ≤ k, see Eqn. 4.3.
We recall that each Sj ≤ 0 represents information about hj ≤ ms bindings to
metastable conformations Fi, i = 1, ..., hj, which justifies the notation Stot as
total score.
Additionally, other alternative scoring functions were also analyzed: For each
conformation Fi, the linear sum Si of ki ≤ k values of Si,j < 0 is computed, and











In addition to Stot and Ssum, RNAStrucTar allows the user to calculate a score
Su derived from a binding site u that contains a user defined position (usually,















We emphasise that based upon Eqns. 4.3–4.8 the values of Sj, Stot, Si, Ssum, Su,
and SP are either negative or not defined (e.g., if hj = 0 for some j or ki = 0 for
some i).
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4.2.7 Metastable Conformations Sets
In our analysis in Chapter 3, along with the energy offset δE above the MFE
conformation, we tried to restrict metastable states to deep local minima. The
parameter D indicates the depth of a local minimum or - in other terms - the
escape height from a local minimum, which is taken in barrier trees as the dis-
tance to the nearest saddle point. We found that out of the three different
parameters we introduced, the average depth and the average opening energy
of metastable conformations may provide supporting information for a stronger
separation between miRNA bindings to the two alleles defined by a given SNP.
Here, we aim at individual miRNA–mRNA binding predictions over samples of
metastable conformations defined by these parameters. Therefore, we order the
metastable conformations with respect to:
(a) The depth D(Fi) in descending order (deepest first).
(b) The absolute value of the opening energy ∆Guopen,i of the user defined target
region, ranked in ascending order.
We obtain the following two sets, where N is a user defined parameter:
(a) Set A: the N deepest metastable conformations among MS.
(b) Set B: the N most easily accessible conformations in the user defined target
region among the deepest metastable conformations.
4.3 Results
4.3.1 Test Dataset
The tools RNAsubopt and Barriers generate a huge amount of secondary struc-
tures, even for a small offset δE above the MFE value. The number of structures
returned by RNAsubopt grows exponentially with both sequence length and en-
ergy range [42]. Consequently, a large scale test or a genome wide prediction
analysis is not possible at this stage. In order to test our approach, we use the
same data acquisition method as in Chapter 3, i.e., we use miRNA–mRNA pairs
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from published experimental work where SNPs are linked to specific diseases.
SNPs can be located in miRNA binding regions, and consequently they could
affect gene expression. RNAStrucTar can be used to evaluate how SNPs affect
miRNA regulation by using as input the wild type and the SNP variant. Our aim
is to determine the ability of RNAStrucTar to provide supportive information for
a stronger discrimination between miRNA bindings to the two alleles defined by
a given SNP (also denoted as wild type and SNP sequences). We analyzed the
34 instances of [mRNA/3’UTR;SNP;miRNA] interactions described in Chapter
2-Section 2.2.
All results shown in this work were obtained using 3-mers or 4-mers comple-
mentarity to the miRNA positions 2–5 in the seed match step. The setting of
δE depends on the length of the 3’UTR and was selected in such a way that a
sufficiently large number of metastable conformations is available. Experimen-
tal findings suggest that the typical number of gene copies lies between 5–20.
Therefore, tests were carried out with N=10 and N=20. For each case, the SNP
position was used as the user defined position in order to obtain the score Su.
4.3.2 Energy Scores
We note that the publications of experimental work where the test data are
taken from differentiate for each allele pair between weaker bindings (expres-
sion levels) and stronger bindings for the miRNA under consideration. Conse-
quently, we calculate energy scores for the weaker and stronger allele, respec-
tively, where it depends on the particular instance which one of the wild type
or SNP sequence produces the stronger or weaker interaction. Thus, for a given
input [mRNA/3’UTR;SNP;miRNA], RNAStrucTar returns the scores Stot from
Eqn. 4.4, Ssum from Eqn. 4.6, SP from Eqn. 4.8, and Su from Eqn. 4.7 (binding




tot −Sweakertot ; (4.9)
∆Ssum = S
stronger
sum −Sweakersum ; (4.10)
∆SP = S
stronger




u −Sweakeru . (4.12)
Negative values of ∆S are expected for a target prediction to be classified as
correct. Here, we focus on Case A (applied to Set A as described in Section
4.2.7), although Case B (applied to Set B as described in Section 4.2.7) is briefly
discussed. The results obtained for the 34 instances and Case A by using 3-
mers complementarity regarding the seed match and with setting N = 10 are
summarized in Table 4.1.
Table 4.1: Summary of miRNA binding prediction by RNAStrucTar. A‘+’ (‘-’)
indicates that the score supports the allele with the stronger (weaker) miRNA
binding, with ∆S threshold -1kcal/mol for ‘+’. A ‘0’ means −1kcal/mol<∆S≤
0kcal/mol.
L(3’UTR) nt W-allele S-allele miRNA SNP pos ∆Ssum ∆Su PITA STarMir
LIG3 124 A(w) C(v) 221 83 + + + +
MSLN 132 A(v) G(w) 611 69 + + 0 -
CGA 258 T(w) A(v) 1302 215 + + + +
CBR1 284 G(w) A(v) 574 133 + + + +
HTR3E 302 A(v) G(w) 510 76 - - + +
KRT81 342 C(v) G(w) 17 102 + + + -
SPI1 369 T(v) C(w) 569 330 0 0 + +
HLA-G 386 C(w) G(v) 148a 233 + + + +
MTHFD1L 393 A(w) G(v) 197 120 + + + -
NFKBIA 502 G(w) A(v) 449a 126 + 0 0 +
TYMS 502 A(w) G(v) 1248 89 0 + 0 -
CCNE1 531 T(v) C(w) 151a 332 0 0 0 0
NPM1 572 T(w) delT(v) 337 165 + + + +
AGT 618 A(v) C(w) 584 556 0 + + 0
NCSTN 623 delCA(v) CA(w) 455 515 0 0 + +
SMUG1 628 G(w) T(v) 770 80 + + 0 +
PARP1 769 C(v) T(w) 145 607 + + 0 +
WFS1 779 A(v) G(w) 668 253 + + + +
MSX1 790 G(v) A(w) 3649 276 + + + -
EFNA1 843 A(v) G(w) 200c 154 + + + -
IL-23R 851 A(v) C(w) let-7e 309 0 0 + -
RYR3 880 G(v) A(w) 367 839 + 0 0 +
AGTR1 888 C(v) A(w) 155 86 + + 0 +
FGF20 903 T(v) C(w) 433 182 - 0 0 -
DROSHA 937 C(v) T(w) 27b 92 0 0 0 -
HOXB5 952 G(w) A(v) 7 141 + 0 + -
RAD51 978 A(v) G(w) 197 718 + + 0 -
REV3L 985 C(w) T(v) 25 460 0 + 0 +
ORAI1 1034 T(v) C(w) 519a 86 0 0 0 +
RAP1A 1078 C(v) A(w) 196a 366 + + + +
APP 1120 C(v) T(w) 147 171 + 0 + +
IL1A 1152 TTCA(v) -(w) 122 928 0 0 0 +
CD133 1167 A(w) C(v) 135b 667 + + + +
PDCD1 1177 A(v) G(w) 4717 889 + 0 + 0
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We note that this work is an extension of the work published in [242] where a
part of the dataset was included (20 instances). In [242], we found that overall,
the score Ssum differentiates between the two alleles on 14 instances, giving better
predictions than the other scores. The score Su gives positive predictions for 12
instances and if Ssum and Su are taken together for Case A, the predictions are
in favor of the correct S-allele by at least one of the scores on 16 instances. We
concluded that the two other scores Stot and SP are less sensitive to binding
patterns when compared to Ssum and Su. Therefore, we will only include these
two scores in this analysis. A more detailed version of the predictions are given
in Supplementary Material in Section .5
The score Ssum differentiates particularly well between the two alleles on 22
instances, while the Ssum scores are indifferent (−1kcal/mol<∆Ssum≤0kcal/mol)
in 10 instances(SPI1, NCSTN, AGT, IL-23R, REV3L, ORAI1, IL1A, TYMS,
CCNE1 and DROSHA). For the two other cases (HTR3E and FGF20), Ssum is in
favor of the weaker allele (W-allele). If differences in scores in Case B are taken
into account for N = 10, Ssum returns a strong and correct prediction for REV3L
(Case A is also in favor of the S-allele, but above -1kcal/mol) and DROSHA where
Case A is indifferent. These results are in line with our analysis carried out in
Chapter 3 where the simple weight selection described in Section 3.4 results in a
non favorable total score for HTR3E and FGF20.
The score Su gives positive predictions for 20 instances and 13 indifferent pre-
dictions. However, if Ssum and Su are taken together for Case A, the predictions
are in favor of the correct S-allele by at least one of the scores on 25 instances
with 2 false predictions for HTR3E and FGF20 and 7 indifferent scores.
Single allelic variations in the gene 3’UTR can affect miRNA bindings by de-
stroying an existing miRNA-mRNA site or creating a new interaction. RNAStrucTar
has the ability to check this SNP effect using the score Su and the Case B. If Su
is predicted for Case A in the case of an allele and is not available with the other
allele, one can conclude that the SNP created or destroyed a valid binding site.
In our dataset, this was the case for the following instances: KRT81, TYMS,
NPM1, AGT, WFS1, EFNA1 and AGTR1. Additionally, SNPs have the poten-
tial to interfere and change the local structures within a close proximity to the
SNP position, affecting the accessibility of a binding site encapsulating the allelic
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change. However, other cases showed that a SNP may change the structure in a
location different from the binding region. As an example, in the case of NFK-
BIA and PDCD1, the difference in score Ssum is -4.7 and -2.3 respectively, while
no sites with SNP position inside are predicted. In the case of RYR3, HOXB5
and APP, the score Su coming from the SNP binding region does not contribute
to the total score Ssum, concluding the difference in Ssum between the two alleles
originates from the difference in accessibility within other regions of the UTR.
4.3.3 Comparison to Other Computational Methods
We compare our predictions to those produced by other accessibility-based target
prediction methods, PITA [24] and STarMir [97]. For the 34 instances we consider,
the PITA tool returns predictions in favor of the S-allele on 20 instances, with 14
indifferent scores. Thus, predictions for HTR3E, SPI1, NCSTN, AGT and IL-
23R are correct by PITA, but not by RNAStrucTar (Ssum only). Predictions for
MSLN, RAD51, NFKBIA, SMUG1, PARP1, RYR3 and AGTR1 are correct by
RNAStrucTar, but not by PITA. Both tools fail on REV3L, ORAI1, IL1A, TYMS,
CCNE1, FGF20 and DROSHA.
The equivalent of Ssum for STarMir predictions returns score differences in
favor of the S-allele on 20 instances, with 2 indifferent outcomes (AGT and
CCNE1) but 12 false predictions in favor of the W-allele on MSLN, RAD51,
KRT81, MTHFD1L, MSX1, EFNA1, HOXB5, PDCD1, IL-23R, TYMS, FGF20
and DROSHA. Thus, predictions for HTR3E, SPI1, NCSTN, REV3L, ORAI1
and IL1A are correct by STarMir, but not by RNAStrucTar. Predictions for
KRT81, MTHFD1L, MSX1, EFNA1, HOXB5, PDCD1, MSLN and RAD51 are
correct by RNAStrucTar, but not by STarMir. Both tools fail on AGT, IL-23R,
TYMS, CCNE1, FGF20 and DROSHA.
In Figure 4.4 we combine the results of the three methods. If we classify an
instance as positively predicted if at least two of the methods return a prediction
in favor of the S-allele, then 23 correct predictions are made. If only one positive
return by a single method is required, then 30 correct predictions are produced
by the three methods (only TYMS, CCNE1, FGF20 and DROSHA are rejected).
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Figure 4.4: Comparison of predictions between RNAStrucTar and two existing
methods.
4.4 RNAStrucTar: A Standalone microRNA Tar-
get Prediction Tool
The requirement to run RNAStrucTar using the command line may be a technical
barrier for a biologist. Therefore, a user friendly version of RNAStrucTar with
an appropriate interface has been implemented. The RNAStrucTar user interface
is implemented using Perl tk. The user needs to input the sequences for both
miRNA and the potential target and other mandatory parameters which will be
needed to generate the metastable conformations: the desired energy range above
the MFE and the desired energy barrier, as described in Section 4.2.1. The output
results are presented to the user through a text summarizing the predictions for
the different sets as described in Section 4.2.7. For each metastable conformations’
set, an output file is given, detailing all predicted binding sites by RNAStrucTar
with the corresponding energy scores, as described in Section 4.2.5. Figure 4.5 is
a screenshot of the implemented user interface.
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Figure 4.5: RNAStrucTar graphical user interface.
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4.5 Conclusion
We presented in this chapter RNAStrucTar, a miRNA target prediction tool which
incorporates target site accessibility related to metastable secondary structures
close to the MFE conformation. We tested our method on 34 miRNA:mRNA
interaction pairs that have been experimentally evaluated in the literature. We
found that a combination of the two main scores returned by RNAStrucTar sup-
ports the experimental findings on 25 instances, with seven indifferent outcomes
and two false classifications. If STarMir results (20 correct, but partly on differ-
ent instances) are taken into account, then experimental findings are supported
on 28 instances.
In contrast, in Chapter 2 Section 2.4 where six databases studying disease
associated SNP effects on miRNA bindings have been compared, the MicroSNiPer
and PolymiRTS databases successfully detected the SNPs to disturb a binding site
with the associated miRNA in respectively 15 and 16 instances from the dataset.
Thus, we think that RNAStrucTar may provide additional, useful information for
miRNA target predictions, specifically in SNP related studies, where the user is
studying the effects miRNA target site variations may have on the development
of various human diseases.
In Table 4.2, we combine the predictions of RNAStrucTar, STarMir and PITA
with the predictions from Chapter 2 Section 2.4. All instances are successfully
predicted by at least one prediction program. Nine out of the 12 instances that
are not predicted by the available databases in Chapter 2 Section 2.4 are correctly
predicted by RNAStrucTar. Among these instances, the case [APP;T171C;miR-
147] has an unknown SNP ID and therefore we were unable to include it in our
analysis in Chapter 2. However, RNAStrucTar tool provides flexibility at the input
stage by allowing the user to enter a user defined UTR and miRNA sequences
with an associated SNP position and therefore we were able to correctly predict
the effect of the SNP in this case.
Consequently, we believe that the proposed tool may be useful in the predic-
tion step of the common working scheme followed in most of the comprehensive
studies of miRSNPs, as described in Section 2.3.1 from Chapter 2.
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Table 4.2: Summary of the predictions for the 34 instances from the dataset. SNP
dbs refers to the number of databases, studying disease-associated SNP effects
on miRNA bindings, correctly predicting the effect of the SNP.
SNP dbs RNAStrucTar STarMir PITA
HLA-G 6 X X X
WFS1 5 X X X
CD133 2 X X X
RAP1A 1 X X X
CGA 0 X X X
CBR1 0 X X X
LIG3 0 X X X
NPM1 0 X X X
APP NA X X X
EFNA1 5 X X
AGTR1 4 X X
KRT81 4 X X
MSX1 4 X X
SPI1 2 X X
MTHFD1L 2 X X
PDCD1 2 X X
NCSTN 1 X X
HOXB5 1 X X
SMUG1 1 X X
NFKBIA 0 X X
RYR3 0 X X
PARP1 0 X X















In this chapter, we evaluate the contributions of the work presented in this thesis
and discuss its possible extensions.
5.1 Evaluation of Contribution
In this thesis, we have addressed the problem of miRNA bindings to metastable
RNA secondary structures in the context of SNPs. With the aim to improve
detecting the effects of the SNPs on miRNA bindings, we first looked for exper-
imentally validated, disease associated, SNPs which have been verified to affect
a miRNA binding and selected a dataset of 34 [mRNA/3’UTR; SNP; miRNA]
instances from recent literature, based on strong expression level analyses. After
analysis of the common working scheme followed in most of the literature sources
we researched for the current work, we highlighted that the use of miRNA-target
prediction methods is a crucial step in the process of miRSNP-disease associa-
tion, predicting the effect of SNPs on miRNA bindings. We subsequently carried
out a review of three categories of miRNA-target gene related research databases:
the databases which offer repositories for experimentally validated miRNA-target
interactions, the databases which provide direct access to miRNA-target pre-
dictions from several well established tools and finally databases offering SNP-
effect predictions. Furthermore, we compared the results of two major computa-
tional approaches to miRNA target ranking prediction: conservation feature us-
ing TargetScan tool and target site accessibility feature using PITA and STarMir
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tools. We conclude that using the site accessibility feature may improve miRNA-
target predictions. Consequently, we studied the problem of miRNA bindings to
metastable secondary structures in the context of SNPs and mRNA concentration
levels i.e. whether features of miRNA bindings to metastable conformations could
provide additional information supporting the differences in expression levels of
the two sequences defined by a SNP. Among the different parameters we intro-
duced and analyzed, we found that three of them, related to the average depth
and average opening energy of metastable conformations, may help improve the
confidence about expected miRNA-mRNA bindings in a preprocessing step of
wet lab experiments. Finally, we implemented RNAStrucTar, a miRNA target
prediction tool which incorporates target site accessibility related to metastable
secondary structures close to the MFE conformation. The proposed tool outper-
forms similar methods when testing on the manually curated [mRNA/3’UTR;
SNP; miRNA] dataset and therefore may improve miRNA-target predictions,
specifically in SNP-disease association studies.
5.2 Limitations
In the literature sources we researched for the current work, the number of genes
and miRNAs exposed to experimental analysis is relatively small, yet each analy-
sis is time-consuming and costly. Additionally, the approach presented in the cur-
rent work is clearly limited by the vast amount of secondary structures returned
by RNAsubopt for longer sequences, within even a small energy range above the
MFE conformation. Due to this computational limitation, only mRNA/3’UTR
sequences below approximately 1100nt could be included. Because we are aim-
ing at the applicability of MSbind and RNAStrucTar by using standard hardware
facilities, we are seeking for alternative ways of identifying metastable confor-
mations, with preference given to approximation methods, where at the cost of
completeness (within an acceptable error range) metastable conformations are
calculated within a feasible time. Moreover, the proposed RNAStrucTar program
is currently accessible by a command-line interface, that needs to be installed
in Linux and therefore non specialist users may find it difficult to perform runs
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using this implemented user interface.
5.3 Future Research
In view of extending our work on miRNA-target prediction using metastable
secondary structures, we intend to make RNAStrucTar a web service for remote
calls, thus eliminating the need for a local installation. An interesting extension of
our current work may include a similar study on target prediction in the context
of RNA-binding proteins (RBPs). In fact, the 3’UTR is also a favoured target for
RBPs that regulate maturation, stability, transfer, localization and translation of
mRNAs [246]. It has been also shown that the mRNA accessibility of a potential
RBP target site plays an important role in finding whether the RBP actually binds
to the site [247; 248]. Therefore, we intend to incorporate target site accessibility
related to metastable secondary structures, representing local minima and close
to the MFE conformation, into predictions of target selection by RBPs. For
future research, we would like to investigate haplotypes and miRNA bindings,
as discussed in Martin et al. [179], and the analysis of SNPs in miRNAs, see
[178]. Furthermore, we plan to examine data provided by eQTL studies as an
additional source of experimental data bearing information about the effect of
SNPs on miRNA bindings to putative targets. For example, Westra et al. [249]
report that trans-eQTL SNPs are enriched within miRNA binding sites in blood
cell lines studied in the article, see Figure 1 in Westra et al. [249]. Although in
the present study we focus on miRNA binding within 3’UTRs, we also plan to
look into the case where miRNA binding sites near the terminal coding region




For a given set of metastable secondary structures, the application MSBind used
in Chapter 3 is available at http://kks.inf.kcl.ac.uk/MSbind.html for calculating
features of metastable conformations determined by putative miRNA binding
sites.
The RNAStrucTar program described in Chapter 4 is written in C++/Perl. The
sourcecode and the disease-associated SNPs within miRNA target sites dataset
are currently available on request. The current version can be downloaded in a
compressed form tar.gz format. In Linux, it can be decompressed using tar -zxvf
rnastructar.tar.gz. RNAStrucTar is using the Vienna RNA package [237] that
needs to be compiled ( cd ViennaRNA.
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Supplementary Tables
.1 Reference numbers and sequences from the
NCBI, the dbSNP and the Ensembl databases
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This document completes the information about the 34 cases included in our dataset (Chapter 2).  
For each case, we provide the information related to the UTR sequence used for testing in the 
related publication (‘In publication’ section). ‘In dbSNP’ section includes the information retrieved 
related to the SNP ID, NCBI's dbSNP official SNP identifiers ("rs-numbers"). ‘In Ensembl BioMart’ 
section lists the UTR sequences retrieved from the BioMart from the Ensembl database, using both 
the  RefSeq IDs from the previous sections and the associated gene name for other UTR sequences. 
The SNP position is indicated in each sequence for each case. 
 
LIG3   
 
L(3'UTR) nt   124     
mRNA RefSeq No NM 002311.4  
Ensembl Gene ID  ENSG00000005156 
Ensembl Transcript ID ENST00000262327  
SNP ID    rs4796030 
In publication  













>ENSG00000005156|ENST00000378526|LIG3 Sequence of length 5237 
SNP not found in the sequence 
 
Other available LIG3 3’UTR transcripts in Biomart:  
 
> ENSG00000005156|ENST00000588109|LIG3  Sequence of length 477 
 
Average Sequence length:  1946 
 
Unavailable Sequences: ENST00000588713, ENST00000592244, ENST00000586119, 





L(3'UTR) nt   132     
mRNA RefSeq No NM_005823   
Ensembl Gene ID  ENST00000566549   
Ensembl Transcript ID ENSG00000102854  
SNP ID    rs1057147   
In publication 
The RefSeq of the used 3′UTR of MSLN is given (NM_005823.5). The SNP rs1057147 G > A falls within 






In Ensembl Biomart  
NM_005823 









>ENSG00000102854|ENST00000382862 Sequence of length 128 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000102854|ENST00000566549  Sequence of length 132 
>ENSG00000102854|ENST00000566269 Sequence of length 65 
 
Average Sequence length:  116 
 




L(3'UTR) nt   258     
mRNA RefSeq No NM_000735  
Ensembl Gene ID  ENSG00000135346 
Ensembl Transcript ID ENST00000627148  
SNP ID    rs6631  
In publication 
The SNP position falls within the given predicted binding site (Substitution of T by A at rs6631, the 













>ENSG00000135346|ENST00000610310 Sequence of length 72  
SNP not found in the sequence. 
 
Other available 3’UTR transcripts in Biomart:  
>ENSG00000135346|ENST00000369582 Sequence of length 253 
>ENSG00000135346|ENST00000630630 Sequence of length 427 
 
Average Sequence length:  252 
 
Unavailable Sequences: ENST00000627552, ENST00000625577. 
 
CBR1 
L(3'UTR) nt   284     
mRNA RefSeq No NM 001757.2    
Ensembl Gene ID  ENSG00000159228   
Ensembl Transcript ID ENST00000290349   
SNP ID    rs9024  
In publication  
The GenBank sequence NM_001757.2 is used. The binding site is in direct proximity to the SNP 





In Ensembl Biomart  
NM_001286789 
>ENSG00000159228|ENST00000530908|CBR1  Sequence of length 1227 
 







Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000159228|ENST00000439427|CBR1 Sequence of length 386 
>ENSG00000159228|ENST00000399191|CBR1 Sequence of length 88 
 
Average Sequence length:  496 
 
Unavailable Sequences: ENST00000466328.  
HTR3E 
L(3'UTR) nt   302     
mRNA RefSeq No NM_182589.2  
Ensembl Gene ID  ENSG00000186038    
Ensembl Transcript ID ENST00000335304    
SNP ID    rs56109847       
In publication 
The SNP position falls within the given miRNA binding site (HTR3E binding region is showed in a 
figure, where the variant c.*76G>A (rs62625044) disrupts the perfect seed match). 
In dbSNP 
















>ENSG00000186038|ENST00000440596 Sequence unavailable 
 
NM_001256613 








>ENSG00000186038|ENST00000425359|HTR3E Sequence unavailable 
 
NM_198314 
>ENSG00000186038|ENST00000436361|HTR3E Sequence unavailable 
 
No other available 3’UTR transcripts in Biomart. 
 
Average Sequence length:  302 
 
Unavailable Sequences: ENST00000431041 
  
KRT81 
L(3'UTR) nt   342      
mRNA RefSeq No NM_002281   
Ensembl Gene ID  ENSG00000205426 
Ensembl Transcript ID ENST00000327741  
SNP ID    rs3660   
In publication  
rs3660G>C: the SNP position falls within a binding site for the studied miRNAs (The rs3660 G-to-C 





In Ensembl Biomart  
 
NM_001320198  (Gene KRT86 and not KRT81) 










Average Sequence length:  342 
 
Unavailable Sequences: ENST00000615839. 
 
SPI1 
L(3'UTR) nt   369      
mRNA RefSeq No NM_003120  
Ensembl Gene ID  ENSG00000066336 
Ensembl Transcript ID ENST00000378538  
SNP ID    rs1057233  
In publication  
The SNP rs1057233 C/T alters the target sequence of the miRNA (The binding site is showed in a 





In Ensembl Biomart  
 
NM_001080547 
>ENSG00000066336|ENST00000227163|SPI1 Sequence of length 314 









Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000066336|ENST00000533030|SPI1  Sequence of length 383 
>ENSG00000066336|ENST00000533968|SPI1  Sequence of length 418 
 
Average Sequence length:  370 
 
HLA-G 
L(3'UTR) nt   386    
mRNA RefSeq No NM 002127.5  
Ensembl Gene ID  ENSG00000204632 
Ensembl Transcript ID ENST00000360323  
SNP ID    rs1063320  
In publication 













Several available sequences are available in the Ensembl Biomart database. The length of the 
sequences range between 383  and 389 nucleotides. 
 
MTHFD1L 
L(3'UTR) nt   393     
mRNA RefSeq No NM_001242767  
Ensembl Gene ID  ENSG00000120254 
Ensembl Transcript ID ENST00000611279  
SNP ID    rs7646   
In publication 
The NCBI Reference of the used sequence is given ( NM_001242767 of length 393). A detailed effect 
on the binding region is given: the SNP rs7646 is present in position 120, the seed sequence of miR-




















>ENSG00000120254|ENST00000618312|MTHFD1L  Sequence of length 391 
 
NM_015440 
>ENSG00000120254|ENST00000367321|MTHFD1L  Sequence of length 393 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000120254|ENST00000453602|MTHFD1L Sequence of length 224 
>ENSG00000120254|ENST00000367307|MTHFD1L Sequence of length 114 
>ENSG00000120254|ENST00000441122|MTHFD1L Sequence of length 574 
>ENSG00000120254|ENST00000420192|MTHFD1L Sequence of length 315 
>ENSG00000120254|ENST00000450635|MTHFD1L Sequence of length 253 
 
 
Average Sequence length:  261 
 
Unavailable Sequences: 




L(3'UTR) nt   502      
mRNA RefSeq No NM_020529  
Ensembl Gene ID  ENSG00000100906 
Ensembl Transcript ID ENST00000216797  
SNP ID    rs696   
In publication 
The SNP (2758A>G (rs696) in NFκBIA) falls within the given binding site (the binding site is showed in 














Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000100906|ENST00000554001|NFKBIA Sequence of length 1075 
>ENSG00000100906|ENST00000557389|NFKBIA Sequence of length 468 
>ENSG00000100906|ENST00000557140|NFKBIA Sequence of length 473 
 
Average Sequence length:  629 
 
Unavailable Sequences: ENST00000553342, ENST00000557100, ENST00000555629, 
ENST00000555371, ENST00000556664, ENST00000557459. 
 
TYMS 
L(3'UTR) nt   502    
mRNA RefSeq No NM_001071   
Ensembl Gene ID  ENSG00000176890  
Ensembl Transcript ID ENST00000323274  
SNP ID    rs2790   
In publication 
The rs2790 A>G falls within the seed region of the given target site (showed in a figure). The length 


















NM_001126123 (Gene ENOSF1) 
>ENSG00000132199|ENST00000383578|ENOSF1 
NM_001318759 (Gene ENOSF1) 
>ENSG00000132199|ENST00000383578|ENOSF1 
NM_017512 (Gene ENOSF1) 
>ENSG00000132199|ENST00000251101|ENOSF1 
NM_202758        (Gene ENOSF1) 
>ENSG00000132199|ENST00000340116|ENOSF1 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000176890|ENST00000323224|TYMS Sequence of length 487 
>ENSG00000176890|ENST00000323274|TYMS Sequence of length 581 
 
Average Sequence length:  523 
 




L(3'UTR) nt   531      
mRNA RefSeq No NM_001238  
Ensembl Gene ID  ENSG00000105173 
Ensembl Transcript ID ENST00000262643  
SNP ID    rs3218073   
In publication  















Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000105173|ENST00000576532|CCNE1   Sequence of length 233 
>ENSG00000105173|ENST00000444983|CCNE1   Sequence of length 435 
>ENSG00000105173|ENST00000357943|CCNE1   Sequence of length 531 
 
Average Sequence length:   432 
 
Unavailable Sequences: ENST00000586912, ENST00000574121, ENST00000575243 
 
NPM1 
L(3'UTR) nt   572     
mRNA RefSeq No NM_002520  
Ensembl Gene ID  ENSG00000181163 
Ensembl Transcript ID ENST00000296930  
SNP ID    rs34351976  
In publication 



















>ENSG00000181163|ENST00000351986|NPM1  Sequence of length 319 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000181163|ENST00000517671|NPM1 Sequence of length 318 
>ENSG00000181163|ENST00000393820|NPM1 Sequence of length 720 
 
 
Average Sequence length:  482 
 
Unavailable Sequences: ENST00000521260, ENST00000524204, ENST00000523622, 
ENST00000518587, ENST00000521672, ENST00000523339, ENST00000521710, ENST00000519955. 
 
AGT 
L(3'UTR) nt   618     
mRNA RefSeq No NM_000029  
Ensembl Gene ID  ENSG00000135744 
Ensembl Transcript ID ENST00000366667  
SNP ID    rs7079   
In publication 
The hAGT +11525 C/A polymorphism (rs7079) occurs in the seed binding sequence of miR-584 and 



















L(3'UTR) nt   681     
mRNA RefSeq No NM_001290184  
Ensembl Gene ID  ENSG00000162736 
Ensembl Transcript ID ENST00000368063  
SNP ID    rs141849450    
In publication 
The delCA515–516 (rs141849450) variant falls within the seed region of the given target site (a 
figure shows the delCA515–516 disrupts a perfect seed match) .  The full length (∼700 bp) of the 



















>ENSG00000162736|ENST00000294785|NCSTN   Same sequence of length  681 
 
NM_015331 
>ENSG00000162736|ENST00000294785|NCSTN   Same sequence of length  681 
 
Average Sequence length:  681 
 
Unavailable Sequences: ENST00000469159, ENST00000491332, ENST00000424754, 
ENST00000421914, ENST00000424645, ENST00000435149, ENST00000438008, ENST00000491390, 
ENST00000467837, ENST00000459963, ENST00000437169, ENST00000465223 
SMUG1 
L(3'UTR) nt   628        
mRNA RefSeq No NM_001243787   
Ensembl Gene ID  ENSG00000123415 
Ensembl Transcript ID ENST00000337581  
SNP ID    rs2233921    
In publication 
The SMUG1 rs2233921 (G/T) is in position 80 and is within target-binding sites. The authors mention 






















>ENSG00000123415|ENST00000508394|SMUG1  Sequence of length 821 
 
NM_001243789 
>ENSG00000123415|ENST00000513838|SMUG1  Sequence of length 1161 
 
NM_001243790 
>ENSG00000123415|ENST00000514685|SMUG1  Sequence of length  66 
 
NM_001243791 
>ENSG00000123415|ENST00000243112|SMUG1  Sequence of length  48 
 
NM_014311 
>ENSG00000123415|ENST00000337581|SMUG1  Same sequence of length  628 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000123415|ENST00000401977|SMUG1  Sequence of length  142 
>ENSG00000123415|ENST00000505128|SMUG1  Sequence of length 2103 
>ENSG00000123415|ENST00000506595|SMUG1  Sequence of length 66 
>ENSG00000123415|ENST00000514196|SMUG1  Sequence of length 24 
>ENSG00000123415|ENST00000509864|SMUG1  Sequence of length 190 
>ENSG00000123415|ENST00000514685|SMUG1  Sequence of length 66 
>ENSG00000123415|ENST00000635546|SMUG1  Sequence of length 465 
 
 
Average Sequence length:   478 
 
Unavailable Sequences: ENST00000503306,  ENST00000511522, ENST00000504797, 
ENST00000506169, ENST00000505662, ENST00000507904, ENST00000634429, ENST00000635234, 




L(3'UTR) nt   769     
mRNA RefSeq No NM 001618.3   
Ensembl Gene ID  ENSG00000143799  
Ensembl Transcript ID ENST00000366794   
SNP ID    rs8679    
In publication 


















Other available PARP1 3’UTR transcripts in Biomart:  
 
>ENSG00000143799|ENST00000366792  Sequence of length 80 
>ENSG00000143799|ENST00000366790|PARP1 Sequence of length 44 
 
 
Average Sequence length:  302 
 
Unavailable Sequences: ENST00000463968, ENST00000469663, ENST00000491816, 
ENST00000629232, ENST00000498787, ENST00000490921, ENST00000468608. 
 
WFS1 
L(3'UTR) nt   797    
mRNA RefSeq No NM_001145853   
Ensembl Gene ID  ENSG00000109501 
Ensembl Transcript ID ENST00000226760  
SNP ID    rs1046322    
In publication 




















>ENSG00000109501|ENST00000226760|WFS1 same sequence 
  
Other available 3’UTR transcripts in Biomart:  
>ENSG00000109501|ENST00000503569|WFS1     Sequence of length 414 
 
 
Average Sequence length:  605 
 




L(3'UTR) nt   790      
mRNA RefSeq No NM_002448  
Ensembl Gene ID  ENSG00000163132 
Ensembl Transcript ID ENST00000382723  
SNP ID    rs12532  
In publication 
















No other available 3’UTR transcripts in Biomart. 
 
Unavailable Sequences: ENST00000468421 
EFNA1 
L(3'UTR) nt   843    
mRNA RefSeq No NM_182685   
Ensembl Gene ID  ENSG00000169242 
Ensembl Transcript ID ENST00000368406  
SNP ID    rs12904    
In publication 
The rs12904 G > A disrupts the perfect match between the seed region of miR-200c and the binding 
site in EFNA1 3′UTR (the SNP position is 154 in the publication).  
























































No other available 3’UTR transcripts in Biomart.  
 
Average Sequence length:   816 
 
Unavailable Sequences: ENST00000474413,  ENST00000469878,  ENST00000497282 
IL-23R 
L(3'UTR) nt   851     
mRNA RefSeq No NM_144701.2  
Ensembl Gene ID  ENSG00000162594 
Ensembl Transcript ID ENST00000347310  
SNP ID    rs10889677   
In publication 
The IL-23R 3′UTR (RefSeq NM_144701.2) is given. The SNP falls within the seed region of the target 


















Other available 3’UTR transcripts in Biomart:  
>ENSG00000162594|ENST00000425614|IL23R  Sequence of length 120 
>ENSG00000162594|ENST00000395227|IL23   Sequence of length 543 
>ENSG00000162594|ENST00000473881|IL23R  Sequence of length 1263 
>ENSG00000162594|ENST00000637002|IL23R  Sequence of length 39 
 
Average Sequence length:  563 
 
RYR3 
L(3'UTR) nt   880     
mRNA RefSeq No NM_001036.3  
Ensembl Gene ID  ENSG00000198838 
Ensembl Transcript ID ENST00000634891  
SNP ID    rs1044129   
In publication 
The SNP (rs1044129 A→G) is located near the miRNA-367 binding site (the binding region is showed 



























Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000198838|ENST00000389232|RYR3 Sequence of length 872 
>ENSG00000198838|ENST00000622037|RYR3 Sequence of length 872 
>ENSG00000198838|ENST00000637948|RYR3 Sequence of length 2173 
>ENSG00000198838|ENST00000634418|RYR3 Sequence of length 498 
>ENSG00000198838|ENST00000634730|RYR3 Sequence of length 895 
>ENSG00000198838|ENST00000635790|RYR3 Sequence of length 5224 
>ENSG00000198838|ENST00000636845|RYR3 Sequence of length 1610 
>ENSG00000198838|ENST00000636568|RYR3 Sequence of length 851 
 
 
Average Sequence length:  1475 
 
Unavailable Sequences: ENST00000560791, ENST00000557931, ENST00000638052, 
ENST00000636656, ENST00000635749, ENST00000638038, ENST00000637522, ENST00000638145, 
ENST00000638032, ENST00000636497, ENST00000637072, ENST00000559333, ENST00000559917, 
ENST00000558060, ENST00000635875, ENST00000637201, ENST00000638085, ENST00000636753, 
ENST00000634750, ENST00000635842, ENST00000636878, ENST00000636417, ENST00000637615, 
ENST00000636583, ENST00000637984. 
AGTR1 
L(3'UTR) nt   888    
mRNA RefSeq No NM_009585  
Ensembl Gene ID  ENSG00000144891 
Ensembl Transcript ID ENST00000497524  
SNP ID    rs5186   
In publication  
The rs5186 (1166A/C), is located in the region that interacts with the miR-155 seed (the binding 








In Ensembl Biomart  
 
NM_009585 














>ENSG00000144891|ENST00000349243|AGTR1 Same sequence of length 888 
 
NM_004835 
>ENSG00000144891|ENST00000418473|AGTR1 Same sequence of length 886 
 
NM_031850 
>ENSG00000144891|ENST00000418473|AGTR1 Same sequence of length 886 
 
NM_032049 
>ENSG00000144891|ENST00000402260|AGTR1 Same sequence of length 886 
 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000144891|ENST00000404754|AGTR1 sequence of length 893 
>ENSG00000144891|ENST00000461609|AGTR1 sequence of length 132 
>ENSG00000144891|ENST00000474935|AGTR1 sequence of length 132 
>ENSG00000144891|ENST00000475347|AGTR1 sequence of length 132 
 
Average Sequence length:  636 
 
Unavailable Sequences: ENST00000475166 
FGF20 
L(3'UTR) nt   903    
mRNA RefSeq No NM_019851.2   
Ensembl Gene ID  ENSG00000078579 
Ensembl Transcript ID ENST00000180166  
SNP ID    rs12720208  
In publication  
The SNP rs12720208  lies within a predicted binding site for miR-433. The binding region is showed 
in a figure where  the allele C base paired with G in Watson-Crick mode whereas allele T wobble 
base paired with G. 
In dbSNP 
We selected for rs12720208 the dbSNP submission ss20399075 instead of ss28476621, which results in a 
complete match to the 3'UTR NM_019851.2:c.*182C>T (ENST00000180166). 
AAAAAAATCTTGACTAGAAATAGAT[C/T]ATGATCACTCTTTATATGTGGATTA 
NM_019851.2:c.*182C>T 














Other available 3’UTR transcripts in Biomart:  
>ENSG00000078579|ENST00000519941|FGF20 sequence of length 94 
 
Average Sequence length:  498 
 
DROSHA 
L(3'UTR) nt   935    
mRNA RefSeq No NM_013235  
Ensembl Gene ID  ENSG00000113360 
Ensembl Transcript ID ENST00000511367  
SNP ID    rs10719   
In publication  
The RefSeq ID of the used transcript for DROSHA is given (NM_013235). The SNP rs10719TC was 





In Ensembl Biomart  
NM_001100412 















Other available 3’UTR transcripts in Biomart:  
>ENSG00000113360|ENST00000442743|DROSHA sequence of length 930 
>ENSG00000113360|ENST00000344624|DROSHA sequence of length 930 
 
Average Sequence length:  773 
 
Unavailable Sequences: ENST00000509608, ENST00000507438, ENST00000510178, 
ENST00000504133, ENST00000509067, ENST00000512885, ENST00000504361, ENST00000510375, 
ENST00000512124, ENST00000512166, ENST00000514927, ENST00000507174, ENST00000512076, 
ENST00000511778, ENST00000505601, ENST00000512302, ENST00000511803. 
HOXB5 
L(3'UTR) nt   952    
mRNA RefSeq No NM_002147.3  
Ensembl Gene ID  ENSG00000120075 
Ensembl Transcript ID ENST00000239151  
SNP ID    rs9299  
In publication 
The used RefSeq ID of the HOXB5 3’UTR is given (NM_002147.3) . The binding region is given in a 























L(3'UTR) nt   978     
mRNA RefSeq No NM 002875.4   
Ensembl Gene ID  ENSG00000051180 
Ensembl Transcript ID ENST00000267868  
SNP ID    rs7180135    
In publication 







In Ensembl Biomart  
NM_001164269 
 
























>ENSG00000051180|ENST00000532743|RAD51|1515 Sequence of length 238 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000051180|ENST00000531277|RAD51 353 




Average Sequence length:  493 
 
Unavailable Sequences: ENST00000526763 , ENST00000527860 
REV3L 
L(3'UTR) nt   985     
mRNA RefSeq No NM_002912  
Ensembl Gene ID  ENSG00000009413 
Ensembl Transcript ID ENST00000358835  
SNP ID    rs465646  
In publication  





















>ENSG00000009413|ENST00000435970|REV3L Similar sequence of length 964 
 
NM_001286432 
>ENSG00000009413|ENST00000435970|REV3L Similar sequence of length 964 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000009413|ENST00000413831|REV3L Sequence of length 336 
>ENSG00000009413|ENST00000434009|REV3L Sequence of length 10469 
>ENSG00000009413|ENST00000422377|REV3L Sequence of length 10362 
>ENSG00000009413|ENST00000368802|REV3L Sequence of length 985 
>ENSG00000009413|ENST00000368805|REV3L Sequence of length 985 
 
Average Sequence length:  3256 
 
Unavailable Sequences: ENST00000494858,  ENST00000492520, ENST00000470871, 
ENST00000467500, ENST00000462119, ENST00000460981, ENST00000619481 
ORAI1 
L(3'UTR) nt   1034    
mRNA RefSeq No NM_032790.3  
Ensembl Gene ID  ENSG00000276045 
Ensembl Transcript ID ENST00000617316  
SNP ID    rs76753792  
In publication 




















Other available 3’UTR transcripts in Biomart:  
>ENSG00000276045|ENST00000611718|ORAI1 Sequence of length 461 
 
 
Average Sequence length:  747 
 
RAP1A 
L(3'UTR) nt   1078    
mRNA RefSeq No NM_002884.2  
Ensembl Gene ID  ENSG00000116473 
Ensembl Transcript ID ENST00000369709  
SNP ID    rs6573  
In publication 
SNP rs6573 lays within a given binding site of RAP1A for miR-196a (binding region 
TGATCTTTTTATCATGATCCTMCCTA). the A allele matches the predicted seed region of miR196a, 






In Ensembl Biomart  
NM_001010935 
>ENSG00000116473|ENST00000369709|RAP1A Sequence of length 4290 
 
NM_001291896 





>ENSG00000116473|ENST00000436150      Sequence of length 712 
 
 
Other available 3’UTR transcripts in Biomart:  
>ENSG00000116473|ENST00000356415|RAP1A   Sequence of length 712 
 
Average Sequence length:  2216 
 
Unavailable Sequences: ENST00000494982, ENST00000433097 
APP 
L(3'UTR) nt   1120    
mRNA RefSeq No NM_000484  
Ensembl Gene ID  ENSG00000142192 
Ensembl Transcript ID ENST00000346798  
SNP ID    T171C  
In publication 
The SNP region is given in the article (GAATTAATCCACACA) with the binding site. The T171C SNP 
disrupts the perfect match between the seed region of miR-147and the given binding site (showed in 
a figure). 
Length hAPP 3’UTR ~ 1100 bp in figure 1 
In dbSNP 
Rs ID unknown. 















Other available 3’UTR transcripts in Biomart:  
>ENSG00000142192|ENST00000440126|APP  Sequence of length 339 
>ENSG00000142192|ENST00000359726|APP  Sequence of length 1119 
>ENSG00000142192|ENST00000358918|APP  Sequence of length 60 
>ENSG00000142192|ENST00000448850|APP  Sequence of length 390 
>ENSG00000142192|ENST00000439274|APP  Sequence of length 338 
>ENSG00000142192|ENST00000357903|APP  Sequence of length 1120 
>ENSG00000142192|ENST00000354192|APP  Sequence of length 1120 
>ENSG00000142192|ENST00000348990|APP  Sequence of length 1120 
 
 
Average Sequence length:  747 
 
Unavailable Sequences: ENST00000466453, ENST00000548570, ENST00000463070, 
ENST00000491395, ENST00000462267, ENST00000474136, ENST00000464867, ENST00000415997 
 
IL1A 
L(3'UTR) nt   1152    
mRNA RefSeq No NM_000575  
Ensembl Gene ID  ENSG00000115008 
Ensembl Transcript ID ENST00000263339  
SNP ID    rs3783553  
In publication  
The rs3783553 SNP lies within a given binding site for human miR-122. rs3783553 occurs in the 7 bp 
























L(3'UTR) nt   1167    
mRNA RefSeq No NM_0011458  
Ensembl Gene ID  ENSG00000007062 
Ensembl Transcript ID ENST00000540805  
SNP ID    rs2240688  
In publication  










In Ensembl Biomart  
 
NM_001145847 
>ENSG00000007062|ENST00000508167|PROM1 Sequence of length 1168 
 NM_001145848 



















>ENSG00000007062|ENST00000539194|PROM1 Same sequence of length 1167 
 
NM_001145851 
>ENSG00000007062|ENST00000540805|PROM1 Same sequence of length 1167 
 
NM_001145852 
>ENSG00000007062|ENST00000539194|PROM1 Same sequence of length 1167 
 
NM_006017 
>ENSG00000007062|ENST00000447510|PROM1 Same sequence of length 1167 
 
Other available 3’UTR transcripts in Biomart:  
 
>ENSG00000007062|ENST00000503884|PROM1 Sequence of length 425 
>ENSG00000007062|ENST00000513946|PROM1 Sequence of length 301 
>ENSG00000007062|ENST00000511153|PROM1 Sequence of length 1432 
>ENSG00000007062|ENST00000510224|PROM1 Sequence of length 1159 
 
Average Sequence length:  1044 
 
Unavailable Sequences: ENST00000514693, ENST00000513108, ENST00000511270, 
ENST00000513448,  ENST00000508940, ENST00000504842, ENST00000508322, ENST00000514967, 
ENST00000502943, ENST00000502501, ENST00000512304 
 
PDCD1 
L(3'UTR) nt   1177    
mRNA RefSeq No NM_005018  
Ensembl Gene ID  ENSG00000276977 
Ensembl Transcript ID ENST00000618185  
SNP ID    rs10204525  
In publication 






















Other available 3’UTR transcripts in Biomart:  
>ENSG00000188389|ENST00000418831|PDCD1 Sequence of length 791 
>ENSG00000276977|ENST00000630560|PDCD1 Sequence of length 791 
 
 
Average Sequence length:  984 
 
Unavailable Sequences: ENST00000343705, ENST00000630230 
 
.2 Site Accessibility compared with the Conser-
vation Feature in MicroRNA Target predic-
tion
149
This analysis was carried out in early 2015. The STarMir and PITA web servers were used to generate 
predictions and the TargetScan ranked lists were sourced from release was 6.2. In the following 
tables of ranked lists, the highlighted genes are experimentally verified targets. The interaction 
scores computed by STarMir and PITA are given in parentheses. The last table gives the ranking 
score of each method by summing up its scores for all miRNAs. 
MicroRNAs from our dataset 
hsa-miR-221-3p 
 Targetscan 6.2 STarMir PITA 
SNX4(1135) 1 4(-188.291) 5(-7.59) 
RGS6(4063) 2 1(-920.254) 1(-19.00) 
CDKN1B (1344) 3 5(-145.344) 4(-8.71) 
CXCL12(3163) 4 3(-585.671) 3(-12.67) 
TCF12(2371) 5 2(-589.71) 2(-15.96) 
 
hsa-let-7e-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 4(-410.039) 3(-15.78) 
FIGNL2(2560) 2 3 (-489.319) 2(-16.07) 
HMGA2(2999) 3 1 (-1011.974) 1(-17.31) 
LIN28B(4548) 4 2(-835.916) 5(-12.97) 
TRIM71(468) 5 5(-111.959) 4(-13.54) 
 
hsa-miR-7-5p 
 Targetscan 6.2 STarMir PITA 
UBXN2B(3950) 1 1(-480.296) 1(-12.16) 
SPATA2(2228) 2 4(-137.187) 5(-11.27) 
C5orf22(2156) 3 2(-299.734) 3(-11.36) 
ZNF828(1047) 4 6(-128.544) 2(-11.53) 
POLE4(706) 5 8(-72.345) 8(-9.57) 
CNO(797) 6 10(-47.391) 9(-9.03) 
RAF1(913) 7 9(-55.174) 7(-10.43) 
IDE(2760) 8 3(-295.805) 4(-11.34) 
EGFR(1721) 9 5(-131.624) 6(-10.58) 
RELA(782) 10 7(-73.938) 10(-6.21) 
 
hsa-miR-155-5p 
 Targetscan 6.2 STarMir PITA 
QKI(5435) 1 2(-443.291) 3(-8.26) 
ZBTB38(3814) 2 3(-383.593) 2(-9.77) 
JARID2(1791) 3 4(-166.433) 4(-7.69) 
RAB11FIP2(4082) 4 1(-484.856) 1(-10.7) 
C2orf80(460) 5 5(-34.778) 5(-5.49) 
 
hsa-miR-122-5p 
 Targetscan 6.2 STarMir PITA 
CLIC4(3387) 1 1(-669.789) 7(-10.80) 
CTDNEP1(598) 2 10(-82.92) 6(-12.41) 
MASP1(1602) 3 3(-384.86) 3(-14.57) 
LMNB2(2745) 4 2(-445.015) 1(-16.33) 
SPOCK2(3726) 5 4(-338.386) 4(-12.48) 
PRKRA(683) 6 8(-93.784) 5(-12.44) 
RFXAP(1850) 7 5(-246.67) 9(-8.58) 
P4HA1(1000) 8 9(-85.602) 10(-8.20) 
MAP3K12(690) 9 6(-174.154) 8(-10.79) 
NICN1(2500) 10 7(-150.57) 2(-14.72) 
 
hsa-miR-17-5p 
 Targetscan 6.2 STarMir PITA 
FGD4(5518) 1 2(-792.261) 2(-12.62) 
PKD2(2085) 2 3(-318.783) 5(-11.82) 
MAP3K2(8910) 3 1(-1359.315) 4(-12.24) 
ZNFX1(1365) 4 4(-315.556) 1(-21.77) 
PDCD1LG2(1323) 5 5(-305.503) 3(-12.44) 
 
hsa-miR-151a-5p 
 Targetscan 6.2 STarMir PITA 
WNT1(973) 1 5(-256.451) 3(-11.61) 
SEZ6L(3302) 2 3(-596.447) 2(-11.65) 
NTRK2(6081) 3 1(-891.66) 4(-11.33) 
N4BP1(4178) 4 4(-569.642) 1(-27.63) 




 Targetscan 6.2 STarMir PITA 
C1orf144(3002) 1 2(-323.552) 1(-16.12) 
ONECUT2(14575) 2 1(-883.886) 3(-11.57) 
SEMA6A(3058) 3 5(-225.827) 2(-12.13) 
MED12L(3873) 4 3(-306.534) 4(-10.53) 
DCUN1D4(3253) 5 4(-280.19) 5(-8.62) 
Let7e family 
hsa-miR-98-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 3(-235.682) 3(-13.80) 
FIGNL2(2560) 2 4(-143.786) 4(-9.83) 
HMGA2(2999) 3 2(-501.509) 1(-16.43) 
LIN28B(4548) 4 1(-512.255) 2(-14.04) 
TRIM71(468) 5 5(-50.402) 5(-9.81) 
 
hsa-let-7a-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 3(-358.25) 4(-13.02) 
FIGNL2(2560) 2 4(-288.242) 3(-14.74) 
HMGA2(2999) 3 1(-767.099) 1(-18.92) 
LIN28B(4548) 4 2(-642.169) 2(-14.98) 
TRIM71(468) 5 5(-100.548) 5(-10.6) 
 
hsa-let-7b-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 4(-383.811) 4(-13.47) 
FIGNL2(2560) 2 3(-402.358) 2(-16.26) 
HMGA2(2999) 3 1(-1042.27) 1(-19.98) 
LIN28B(4548) 4 2(-1060.15) 3(-15.31) 
TRIM71(468) 5 5(-100.829) 5(-11.27) 
 
hsa-let-7c-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 3(-324.371) 4(-13.12) 
FIGNL2(2560) 2 4(-266.478) 2(-16.43) 
HMGA2(2999) 3 2(-824.512) 1(-18.85) 
LIN28B(4548) 4 1(-840.032) 3(-15.44) 
TRIM71(468) 5 5(-85.116) 5(-11.33) 
 
hsa-let-7d-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 4(-389.889) 5(-11.7) 
FIGNL2(2560) 2 3(-414.082) 2(-17) 
HMGA2(2999) 3 2(-796.627) 1(-18.3) 
LIN28B(4548) 4 1(-867.816) 3(-15.67) 
TRIM71(468) 5 5(-114.416) 4(-12.1) 
 
hsa-let-7g-5p 
 Targetscan 6.2 STarMir PITA 
C14orf28(1707) 1 3(-325.43) 4(-12.26) 
FIGNL2(2560) 2 4(-238.759) 3(-14.71) 
HMGA2(2999) 3 2(-550.577) 1(-21.07) 
LIN28B(4548) 4 1(-572.898) 2(-16.18) 
TRIM71(468) 5 5(-91.508) 5(-11.09) 
 
Mir 10a/b family 
hsa-mir-10b 
 Targetscan 6.2 STarMir PITA 
ARSJ(1990) 1 7(-66.58) 8(-5.66) 
CADM2(7646) 2 1(-202.453) 2(-14.28) 
SOBP(3106) 3 4(-121.375) 1(-15.70) 
BDNF(2926) 4 5(-110.456) 5(-9.08) 
FIGN(1944) 5 10(-30.673) 10(-4.26) 
KLHL29(1949) 6 3(-137.514) 9(-5.43) 
TFAP2C(1269) 7 6(-71.959) 3(-13.51) 
CRLF3(1503) 8 9(-44.147) 6(-8.71) 
KLHDC10(4974) 9 2(-173.597) 7(-8.01) 
NCOR2(991) 10 8(-61.828) 4(-13.38) 
 
Mir 24 family 
hsa-mir-24 
 Targetscan 6.2 STarMir PITA 
IFFO2(4281) 1 4(-623.7) 1(-16.43) 
BCL2L11(4214) 2 3(-672.746) 3(-13.36) 
DNAJB12(2980) 3 5(-547.801) 4(-13.06) 
TAOK1(8881) 4 1(-1075.51) 5(-12.88) 
NDST1(4879) 5 2(-781.85) 2(-15.19) 
 
Mir 25 family 
hsa-mir-92a 
 Targetscan 6.2 STarMir PITA 
CD69(995) 1 4(-90.509) 2(-11.57) 
FNIP1(2971) 2 3(-194.713) 3(-11.19) 
SLC12A5(2545) 3 1(-346.633) 5(-8.18) 
MAN2A1(730) 4 5(-50.252) 1(-12.40) 
ACTC1(2316) 5 2(-308.603) 4(-10.26) 
 
Mir 26 family 
hsa-mir-26a 
 Targetscan 6.2 STarMir PITA 
KLHDC5(4874) 1 1(-338.692) 1(-12.75) 
TET2(3284) 2 2(-218.908) 5(-6.92) 
STRADB(818) 3 5(-68.6) 2(-12.25) 
CHORDC1(1976) 4 4(-96.853) 3(-8.74) 
FAM98A(1114) 5 3(-113.707) 4(-7.42) 
 
Mir 27 family 
hsa-mir-27a 
 Targetscan 6.2 STarMir PITA 
GXYLT1(5940) 1 1(-684.089) 1(-12.25) 
PLK2(600) 2 10(-86.624) 4(-11.6) 
AKIRIN1(2010) 3 2(-208.847) 3(-11.90) 
GCC2(1768) 4 9(-99.906) 9(-7.91) 
SBF2(1751) 5 6(-128.655) 2(-12.17) 
RGPD4(1813) 6 8(-101.78) 8(-8.14) 
RGPD8(1809) 7 7(-103.995) 7(-8.29) 
PDS5B(2968) 8 3(-205.428) 10(-6.93) 
CDS1(2654) 9 4(-139.597) 6(-9.22) 
FBXW7(1623) 10 5(-134.736) 5(-9.88) 
 
 Mir 29abc family 
hsa-mir-29a 
 Targetscan 6.2 STarMir PITA 
ATAD2B(3382) 1 2(-176.597) 5(-6.77) 
COL3A1(972) 2 5(-42.857) 3(-9.71) 
ELN(1206) 3 3(-60.436) 2(-9.95) 
HBP1(1098) 4 4(-50.966) 1(-10.03) 




 Targetscan 6.2 STarMir PITA 
ATAD2B(3382) 1 3(-95.391) 5(-6.74) 
COL3A1(972) 2 5(-49.498) 2(-10.05) 
ELN(1206) 3 4(-64.484) 4(-8.93) 
HBP1(1098) 4 2(-106.69) 1(-10.49) 
COL4A4(4614) 5 1(-188.83) 3(-9.72) 
 
 hsa-mir-29c 
 Targetscan 6.2 STarMir PITA 
ATAD2B(3382) 1 2(-101.918) 5(-6.89) 
COL3A1(972) 2 4(-46.083) 1(-11.70) 
ELN(1206) 3 5(-40.283) 2(-11.13) 
HBP1(1098) 4 3(-53.723) 3(-10.03) 
COL4A4(4614) 5 1(-210.915) 4(-8.99) 
Mir 93/105 family 
hsa-mir-302b 
 Targetscan 6.2 STarMir PITA 
CROT(1152) 1 5(-74.518) 5(-5.97) 
FGD4(5517) 2 1(-503.496) 2(-9.02) 
LATS2(1833) 3 4(-117.18) 3(-7.21) 
TGFBR2(2542) 4 3(-195.661) 4(-6.1) 
ZKSCAN1(3583) 5 2(-269.55) 1(-10.54) 
 
hsa-mir-372 
 Targetscan 6.2 STarMir PITA 
CROT(1152) 1 5(-188.766) 5(-6.45) 
FGD4(5517) 2 1(-522.948) 2(-13.33) 
LATS2(1833) 3 4(-209.713) 4(-8.24) 
TGFBR2(2542) 4 2(-365.351) 3(-11.24) 




 Targetscan 6.2 STarMir PITA 
CROT(1152) 1 5(-168.31) 5(-8.94) 
FGD4(5517) 2 1(-1215.109) 2(-15.21) 
LATS2(1833) 3 4(-269.555) 4(-9.37) 
TGFBR2(2542) 4 3(-766.765) 3(-11.48) 
ZKSCAN1(3583) 5 2(-1011.351) 1(-15.71) 
 
Mir 96 family 
hsa-mir-96 
 Targetscan 6.2 STarMir PITA 
KIAA2022(6549) 1 2(-446.166) 5(-9.56) 
PRTG(8471) 2 1(-609.319) 2(-11.53) 
ADCY6(2399) 3 4(-164.654) 4(-9.59) 
FRS2(4827) 4 3(-322.267) 3(-10.76) 
NLGN2(2061) 5 5(-97.449) 1(-13.56) 
 
Mir 125b family 
hsa-mir-125b 
 Targetscan 6.2 STarMir PITA 
FAM169B(2469) 1 1(-160.629) 3(-11.30) 
STARD13(2458) 2 3(-111.257) 4(-7.14) 
ZNF792(1602) 3 2(-120.197) 5(-7.10) 
CCR2(808) 4 4(-71.349) 2(-11.93) 
ACHE(964) 5 5(-15.322) 1(-12.67) 
 
hsa-mir-125a-5p  
 Targetscan 6.2 STarMir PITA 
RORA(9171) 1 3(-525.238) 2(-15.09) 
ARID3B(2357) 2 5(-134.965) 5(-12.03) 
PRTG(8471) 3 1(-635.548) 4(-12.6) 
ZNF704(12915) 4 2(-616.997) 1(-26.1) 
ANKRD33B(7703) 5 4(-468.16) 2(-15.09) 
Mir 126 family 
hsa-mir-126 
 Targetscan 6.2 STarMir PITA 
PTPN9(1648) 1 2(-73.181) 2(-9.38) 
PLXNB2(725) 2 4(-23.993) 5(-0.96) 
RGS3(785) 3 5(-14.33) 4(-1.03) 
KANK2(2291) 4 1(-104.024) 1(-13.75) 
EFHD2(1619) 5 3(-50.695) 3(-8.14) 
Mir 135ab family 
hsa-mir-135a 
 Targetscan 6.2 STarMir PITA 
ANGPT2(3447) 1 4(-179.755) 3(-10.89) 
GK5(8095) 2 1(-437.486) 2(-11.14) 
NR3C2(2580) 3 3(-193.814) 1(-11.83) 
GULP1(1914) 4 5(-98.218) 4(-9.86) 
LOC221710(4134) 5 2(-236.434) 5(-8.37) 
 
Mir 137 family 
hsa-mir-137 
 Targetscan 6.2 STarMir PITA 
PDLIM3(1633) 1 5(-56.714) 4(-5.86) 
APPL2(1017) 2 2(-77.14) 5(-5.26) 
MITF(3089) 3 3(-73.581) 3(-6.74) 
CEP128(1001) 4 4(-71.649) 1(-9.06) 
RAVER2(2246) 5 1(-77.128) 2(-7.77) 
 
Mir 139-5p family 
hsa-mir-139-5p 
 Targetscan 6.2 STarMir PITA 
HNRNPU(4150) 1 4(-527.276) 1(-13.05) 
MNT(2841) 2 5(-425.775) 4(-11.46) 
PPARGC1B(7464) 3 2(-806.886) 5(-9.97) 
IGF1R(7088) 4 1(-888.289) 3(-11.54) 
KPNA4(7109) 5 3(-614.984) 2(-12.69) 
 
Mir 140-5p family 
hsa-mir-140-5p 
 Targetscan 6.2 STarMir PITA 
ZNF800(1514) 1 4(-136.034) 3(-9.83) 
YOD1(5171) 2 1(-434.662) 1(-11.33) 
FGF9(3066) 3 2(-235.338) 5(-8.17) 
SEPT2(2089) 4 3(-176.067) 2(-10.19) 
MMD(1721) 5 5(-129.946) 4(-8.48) 
Mir 141family 
hsa-mir-141 
 Targetscan 6.2 STarMir PITA 
ZFR(1410) 1 5(-81.363) 5(-6.43) 
RANBP6(1271) 2 4(-84.99) 1(-15.51) 
ZEB2(5076) 3 2(-375.203) 3(-9.4) 
ABL2(8391) 4 1(-469.476) 2(-9.8) 
ARPC5(1339) 5 3(-90.005) 4(-9.04) 
 
hsa-mir-200a 
 Targetscan 6.2 STarMir PITA 
ZFR(1410) 1 5(-79.015) 5(-5.75) 
RANBP6(1271) 2 3(-109.951) 1(-12.31) 
ZEB2(5076) 3 2(-254.345) 3(-8.19) 
ABL2(8391) 4 1(-405.716) 2(-8.33) 
ARPC5(1339) 5 4(-84.156) 4(-7.71) 
Mir 143family 
hsa-mir-143 
 Targetscan 6.2 STarMir PITA 
GYGYF2(3719) 1 3(-295.717) 4(-10.95) 
SH3PXD2A(7789) 2 1(-833.424) 5(-10.27) 
KRAS(4549) 3 2(-456.871) 1(-14.3) 
TPM3(1275) 4 5(-139.301) 2(-12.83) 
ETV6(4345) 5 4(-273.459) 3(-11.3) 
 
Results after computing the ranking score of each method by summing up its 
scores for all miRNAs 
 






hsa-miR-221-3p 1 3 2 
hsa-let-7e-5p 2 1 1 
hsa-miR-7-5p 3 1 2 
hsa-miR-155-5p 2 1 1 
hsa-miR-122-5p 2 3 1 
hsa-miR-17-5p 2 3 1 
hsa-miR-151a-5p 2 2 1 
hsa-miR-27b-3p 2 3 1 
hsa-miR-98-5p 3 2 1 
hsa-let-7a-5p 3 1 1 
hsa-let-7b-5p 3 1 1 
hsa-let-7c-5p 3 1 1 
hsa-let-7d-5p 3 2 1 
hsa-let-7g-5p 3 2 1 
hsa-mir-10b 3 2 1 
hsa-mir-24 1 2 2 
hsa-mir-92a 1 2 2 
hsa-mir-26a 2 3 1 
hsa-mir-27a 3 1 2 
hsa-mir-29a 2 2 1 
hsa-mir-29b 1 3 1 
 hsa-mir-29c 2 3 1 
hsa-mir-302b 2 1 2 
hsa-mir-372 1 2 2 
hsa-mir-373 1 2 2 
hsa-mir-96 1 2 2 
hsa-mir-125b 1 2 3 
hsa-mir-125a-5p 1 2 2 
hsa-mir-126 1 3 2 
hsa-mir-135a 2 2 1 
hsa-mir-137 1 1 1 
hsa-mir-139-5p 3 1 2 
hsa-mir-140-5p 2 1 3 
hsa-mir-141 2 1 2 
hsa-mir-200a 2 1 2 
hsa-mir-143 3 2 1 
    
    
Total 72 67 54 
 
.3 Accessibility of microRNA binding sites in
metastable RNA secondary structures in the
presence of SNPs - PITA and STarMir
predictions
159
LIG3; rs4796030; mir-221  
 
A-Allele C-Allele 
STarMir predicts 13 seedless binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
9 77-93 No -15 -3.297 -5.236 -9.764 0.669 
10 77-96 No -15.500 -3.383 -6.527 -8.973 0.628 
11 77-98 No -20.300 -3.388 -11.769 -8.531 0.577 
12 81-107 No -21.400 -0.513 -19.753 -1.647 0.460 
 
STarMir predicts 14 binding sites.  





Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
9 80-93 No -19.300 -0.131 -8.888 -10.412 0.492 
10 80-96 No -19.800 -0.176 -9.749 -10.051 0.490 
11 80-88 No -18 -0.131 -8.513 -9.487 0.549 
12 80-98 No -24.600 -0.197 -15.961 -8.639 0.441 





    5'->3'        G    AGA     CU   U          
    Target    77   GAAA   CCAGU  GGG            93 
                   ||||   |||||  |||           
    miRNA     23   CUUU   GGUCG  UCU            1 





    5'->3'        G    AGA     CU        N    
    Target    77   GAAA   CCAGU  GG  GUGU      96 
                   ||||   |||||  ||  ||||     
    miRNA     23   CUUU   GGUCG  CU  UACA      1 





    5'->3'        G    AGA     CUG        G  
    Target    77   GAAA   CCAGU    GGUGUGG    98 
                   ||||   |||||    |||||||   
    miRNA     23   CUUU   GGUCG    UUACAUC    1 
    3'->5'             G       UCUG       GA 
  





    5'->3'        A     AGUCU  GU UG GA   C   A 
    Target    81   AGACC     GG  G  G  AUG AGC   107 
                   |||||     ||  |  |  ||| |||  
    miRNA     23   UUUGG     UC  C  U  UAC UCG   1 




 Site 9 
 
    5'->3'        A         CU   U          
    Target    80   AAGCCCAGU  GGG            93 
                   |||||||||  |||           
    miRNA     23   UUUGGGUCG  UCU            1 





    5'->3'        A         CU        N    
    Target    80   AAGCCCAGU  GG  GUGU      96 
                   |||||||||  ||  ||||     
    miRNA     23   UUUGGGUCG  CU  UACA      1 





    5'->3'        A         C             
    Target    80   AAGCCCAGU               88 
                   |||||||||              
    miRNA     23   UUUGGGUCG               1 





    5'->3'        A         CUG        G  
    Target    80   AAGCCCAGU    GGUGUGG    98 
                   |||||||||    |||||||   
    miRNA     23   UUUGGGUCG    UUACAUC    1 
    3'->5'        C         UCUG       GA 
  
 




PITA predicts 2 sites with an overall score -5.98.  
There is no binding site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
A-Allele hsa-miR-221 94-99  6:1:1 -15.6 -9.61 -5.98 
 
PITA predicts 2 sites with an overall score -7.45.  
There is no binding site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
C-Allele hsa-miR-221 94-99  6:1:1 -19.8 -12.34 -7.45 
 
CBR1; rs9024; mir-574-5p  
 
G-Allele A-Allele 
STarMir predicts 15 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
10 121-162 No -27.800 -5.364 -8.085 -19.715 0.527 
11 121-137 No -21.300 -3.355 -3.283 -18.017 0.528 
12 121-140 No -21.600 -3.538 -4.309 -17.291 0.565 
STarMir predicts 16 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
10 121-137 No -25.300 -4.513 -2.874 -22.426 0.584 
11 121-140 No -25.500 -4.599 -3.514 -21.986 0.631 
12 121-162 No -27.800 -5.224 -5.958 -21.842 0.563 





    5'->3'         A        UAAUGUAC   UAAUUGAGCAACCU         G 
    Target   121    GCACUCAC        UAC              ACGCACUCA   162 
                    ||||||||        |||              |||||||||  
    miRNA     23    UGUGAGUG        GUG              UGUGUGAGU   1 
    3'->5'        UG        U                                   
  
The bindings in green highlight positions predicted by PITA 





    5'->3'         A        UA         A  
    Target   121    GCACUCAC    AUGUACU    137 
                    ||||||||    |||||||   
    miRNA     23    UGUGAGUG    UGUGUGA    1 





    5'->3'         A        UAAUG        A  
    Target   121    GCACUCAC     UAC UACU    140 
                    ||||||||     ||| ||||   
    miRNA     23    UGUGAGUG     GUG GUGA    1 







    5'->3'         A        UA         A  
    Target   121    GCACUCAC    AUAUACU    137 
                    ||||||||    |||||||   
    miRNA     23    UGUGAGUG    UGUGUGA    1 





    5'->3'         A        UA           A  
    Target   121    GCACUCAC  AUAUAC UACU    140 
                    ||||||||  |||||| ||||   
    miRNA     23    UGUGAGUG  UGUGUG GUGA    1 





    5'->3'         A        UAAUAUAC   UAAUUGAGCAACCU         G 
    Target   121    GCACUCAC        UAC              ACGCACUCA   162 
                    ||||||||        |||              |||||||||  
    miRNA     23    UGUGAGUG        GUG              UGUGUGAGU   1 
    3'->5'        UG        U                                   
  
The bindings in green highlight positions predicted by PITA 





    5'->3'         A        UA       N    
    Target   121    GCACUCAC    AUAUA      135 
                    ||||||||    |||||     
    miRNA     23    UGUGAGUG    UGUGU      1 
    3'->5'        UG        UGUG     GAGU 
   
PITA predicts 3 sites with an overall score -17.94.  
There is no binding site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 




154-161 8:0:1 -24.49 -6.54 -17.94 
 
 
PITA predicts 4 sites with an overall score -19.21.  
There is one binding site covering the SNP position.  
 




133-138 6:1:1 -19.8 -2.56 -17.23 
 
The following site may cause the opening of the SNP position: 
 














3' UGUG-UGA-----GUGU-GUGUGUGUGAGU 5' 
   |:||*|||******:||***:||:|||||*    




HTR3E; rs56109847; miR-510-5p 
 
G-Allele A-Allele 
STarMir predicts 16 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
6 50-80 73-79 -28.700 -5.505 -12.645 -16.055 0.544 
7 50-76 No -20.300 -6.324 -11.509 -8.791 0.580 
STarMir predicts 16 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 





    5'->3'         G  CUG    GGUCUCCCCC            C 
    Target    50    GA   GCCA          CUUUCCUGAGUA   80 
                    ||   ||||          ||||||||||||  
    miRNA     22    CU   CGGU          GAGAGGACUCAU   1 
    3'->5'        CA  AA                             
  
The bindings in green highlight positions predicted by PITA 




    5'->3'         G  CUG    GGUCUCCCCC        N    
    Target    50    GA   GCCA          CUUUCCUG      76 
                    ||   ||||          ||||||||     
    miRNA     22    CU   CGGU          GAGAGGAC      1 








    5'->3'         G  CUG    GGUCUCCCCC       A    C 
    Target    50    GA   GCCA          CUUUCCU AGUA   80 
                    ||   ||||          ||||||| ||||  
    miRNA     22    CU   CGGU          GAGAGGA UCAU   1 
    3'->5'        CA  AA                      C      
  
The bindings in green highlight positions predicted by PITA 
72-79 with a 8 mer with one mismatch 
 
 
PITA predicts 6 sites with an overall score -16.41.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 
G-Allele miR-510-5p 72-79 8:0:0 -22.5 -6.08 -16.41 
 
PITA predicts 6 sites with an overall score -12.28.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 






Position Structure Loop Score ΔG 
60-80 
3' CACUAACGGUGAGAGGACUCAU 5' 
   *******||*||:|||||||||    








HLA_G; rs1063320; mir-148a-3p  
 
C-Allele G-Allele 
STarMir predicts 6 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
4 221-239 No -23.900 -4.554 -9.282 -14.618 0.492 
5 221-237 No -18.900 -4.182 -9.628 -9.272 0.475 
6 230-260 No -9.800 -3.556 -9.067 -0.733 0.528 
STarMir predicts 7 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
4 221-239 232-238 -30.500 -3.238 -11.006 -19.494 0.395 
5 221-235 No -21.100 -1.928 -9.059 -12.041 0.338 
6 221-233 No -15.600 -1.501 -11.349 -4.251 0.339 
 
 
STarMir Site 4 
 
    5'->3'        U              C      G 
    Target   221   CAAA  UUUGUGGU CACUGA   239 
                   ||||  |||||||| ||||||  
    miRNA     22   GUUU  AGACAUCA GUGACU   1 
    3'->5'        U    CA        C        
  
The bindings in green highlight positions predicted by PITA 
(231-238 with one mismatch) 
 
STarMir Site 5 
 
    5'->3'        U              C    N  
    Target   221   CAAA  UUUGUGGU CACU    237 
                   ||||  |||||||| ||||   
    miRNA     22   GUUU  AGACAUCA GUGA    1 
    3'->5'        U    CA        C    CU 
  
 
STarMir Site 6 
 
    5'->3'           U   CCA      CUAUAACUUACUUC      A  
    Target   230      GGU   CUG AG              UGUAUU    260 
                      |||   ||| ||              ||||||   
    miRNA     22      UCA   GAC UC              ACGUGA    1 




STarMir Site 4 (seed site) 
 
    5'->3'        U                     G 
    Target   221   CAAA  UUUGUGGUGCACUGA   239 
                   ||||  |||||||||||||||  
    miRNA     22   GUUU  AGACAUCACGUGACU   1 
    3'->5'        U    CA                 
 
The bindings in green highlight positions predicted by PITA.( 
231-238 with perfect seed match) 
 
STarMir Site 5 
 
    5'->3'        U                 N    
    Target   221   CAAA  UUUGUGGUGCA      235 
                   ||||  |||||||||||     
    miRNA     22   GUUU  AGACAUCACGU      1 
    3'->5'        U    CA           GACU 
  
 
STarMir Site 6 
 
    5'->3'        U               N      
    Target   221   CAAA  UUUGUGGUG        233 
                   ||||  |||||||||       
    miRNA     22   GUUU  AGACAUCAC        1 
    3'->5'        U    CA         GUGACU 
 
PITA predicts 7 sites with an overall score -1.16.  
There is only one site covering the SNP position: 
 




231-238 8:1:0 -16.8 -15.78 -1.01 
 
PITA predicts 7 sites with an overall score -6.49.  
There is only one site covering the SNP position: 
 










3' UGUUUCAAGACAUCACGUGACU 5' 
   *||||**|:|||:||*||||||    





3' UGUUUCAAGACAUCACGUGACU 5' 
   *||||**|:|||:|||||||||    
5' TCAAA--TTTGTGGTGCACTGA 3' 
-28.20 
 





STarMir predicts 25 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
22 592-611 No -18.300 -0.927 -10.683 -7.617 0.476 
23 592-614 No -19.700 -0.927 -12.191 -7.509 0.517 
STarMir predicts 25 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
22 592-611 No -17.800 -0.652 -17.666 -0.134 0.330 




    5'->3'            U     UCUCCA    U    A   
    Target   592       UUCCU      GGAA ACUG     611 
                       |||||      |||| ||||    
    miRNA     23       AAGGA      CCUU UGAC     1 





    5'->3'            U     UCUCCA    U    A  A 
    Target   592       UUCCU      GGAA ACUG AC   614 
                       |||||      |||| |||| ||  
    miRNA     23       AAGGA      CCUU UGAC UG   1 
    3'->5'        UCCCU     C         U    C   
 
The bindings in green highlight positions predicted by PITA 





    5'->3'            U     UCUCCA    C    A   
    Target   592       UUCCU      GGAA ACUG     611 
                       |||||      |||| ||||    
    miRNA     23       AAGGA      CCUU UGAC     1 





    5'->3'            U     UCUCCA    C    A  A 
    Target   592       UUCCU      GGAA ACUG AC   614 
                       |||||      |||| |||| ||  
    miRNA     23       AAGGA      CCUU UGAC UG   1 
    3'->5'        UCCCU     C         U    C    
  
 
The bindings in green highlight positions predicted by PITA 




PITA predicts 7 sites with an overall score -2.53.  
There is no binding site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 








615-621 6:1:1 -8.64 -12.82 4.18 
 
 
PITA predicts 7 sites with an overall score -2.51.  
There is no binding site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 












WFS1; rs1046322; hsa-miR-668-3p 
 
G-Allele A-Allele 
STarMir predicts 75 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
25 234-258 251-257 -26.600 -4.421 -10.641 -15.959 0.498 
STarMir predicts 75 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 





    5'->3'               C       UGACCUUUCU        U 
    Target   234          CUGAGCC          GAGUGACA   258 
                          |||||||          ||||||||  
    miRNA     23          GGCUCGG          CUCACUGU   1 
    3'->5'        CAUCACCC                           
 
The bindings in green highlight positions predicted by PITA 





    5'->3'               C       UGACCUUUCU  A     U 
    Target   234          CUGAGCC          GA UGACA   258 
                          |||||||          || |||||  
    miRNA     23          GGCUCGG          CU ACUGU   1 
    3'->5'        CAUCACCC                   C       
   
The bindings in green highlight positions predicted by PITA 
251-257 with a 7 mer with one mismatch 
 
PITA predicts 15 sites with an overall score -16.47.  
There is one binding site covering the SNP position.  
 









PITA predicts 15 sites with an overall score -11.13.  
There is one binding site covering the SNP position.  
 






























STarMir predicts 39 seedless binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
13 291-310 No -24.700 0 -25.819 1.119 0.201 
 
STarMir predicts 38 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 





    5'->3'         U   GC  U            U 
    Target   291    UUA  CA UCUUCUGCCUCA   310 
                    |||  || ||||||||||||  
    miRNA     22    GAU  GU GGAGGAUGGAGU   1 
    3'->5'        UU   AU  U              
  
 
The bindings in green highlight positions predicted by PITA 






    5'->3'         U   GC  U          A  
    Target   291    UUA  CA UCUUCUGCCU    308 
                    |||  || ||||||||||   
    miRNA     22    GAU  GU GGAGGAUGGA    1 
    3'->5'        UU   AU  U          GU 
 
  
The bindings in green highlight positions predicted by PITA 303 
-309 (7 mer with one G-U wobble and one mismatch) 
 
PITA predicts 14 sites with an overall score -14.23.  
There is one binding site covering the SNP position:  
 
Gene microRNA Position Seed dGduplex dGopen ddG 
C-Allele hsa-let-7e 303 -309 7:0:1 -19.4 -5.27 -14.12 
 
PITA predicts 14 sites with an overall score -12.11.  
There is one binding site covering the SNP position:  
 
Gene microRNA Position Seed dGduplex dGopen ddG 






Position Structure Loop Score ΔG 
287-310 
3' UUGAUAUGUUGGAGGAUGGAGU 5' 
   **:||**||**||:||:||||*    







Position Structure Loop Score ΔG 
287-310 
3' UUGAUAUGUUGGAGGAUGGAGU 5' 
   **:||**||**||:||:|||**    












STarMir predicts 12 seedless binding sites and one seed site. 








Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
11 830-847 No -16.300 -0.335 -7.633 -8.667 0.582 
12 835-857 852-857 -14.800 -1.222 -11.419 -3.381 0.532 
STarMir predicts 12 seedless binding sites and one seed site.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
11 830-847 No -16.300 -0.840 -11.825 -4.475 0.463 
12 830-857 852-857 -15.300 -0.194 -19.650 4.350 0.397 
 
 
STarMir Site 11 
 
    5'->3'        C   AAUACAA        C    
    Target   830   UCA       UGAAGUGC      847 
                   |||       ||||||||     
    miRNA     22   AGU       AUUUCACG      1 




Site 12 (seed site) 
The bindings in green highlight positions predicted by PITA 
but with A-U binding at the beginning (850-857) 
 
 
    5'->3'        A   AAUGAAG    CCAC      A 
    Target   835   UAC       UGC     UGCAAU   857 
                   |||       |||     ||||||  
    miRNA     22   GUG       ACG     ACGUUA   1 
    3'->5'        A   GUA       AUUUC      A 
 




    5'->3'        C   AAUA  G           C    
    Target   830   UCA    CA    UGAAGUGC      847 
                   |||    ||    ||||||||     
    miRNA     22   AGU    GU    AUUUCACG      1 




Site 12 (seed site) 
The bindings in green highlight positions predicted by PITA but 
with A-U binding at the beginning (850-857) 
 
 
    5'->3'        C   AAUA  GUGAAG    CCAC      A 
    Target   830   UCA    CA      UGC     UGCAAU   857 
                   |||    ||      |||     ||||||  
    miRNA     22   AGU    GU      ACG     ACGUUA   1 
    3'->5'            G     A        AUUUC      A 
 
  
PITA predicts 29 binding sites with an overall score -6.97.  
There is only  one  binding site covering the SNP position: 
 




835-840 6:1:0 -1.77 -6.76 4.99 
 
The following sites may cause the opening of the SNP position: 
 








840-845 6:1:1 -1.95 -9.23 7.28 
 
PITA predicts 29 binding sites with an overall score -6.97.  
There are two binding sites covering the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
G-Allele hsa-miR-367 838-845 8:1:1 -7.7 -11.38 3.68 
G-Allele hsa-miR-367 835-840 6:1:1 -1.77 -8.92 7.15 
 
The following site may cause the opening of the SNP position: 
 




850-857 8:1:0 -8.73 -14.31 5.58 
 
 
AGTR1; rs5186   ; miR-155-5p 
A-Allele C-Allele 
STarMir predicts 21 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
2 57-90 83-89 -20.900 -0.577 -28.561 7.661 0.283 
3 57-86 No -15.700 -0.085 -27.289 11.589 0.248 
STarMir predicts 20 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 









    5'->3'        U      CAGCACU    UACCAAAUG        C 
    Target    57   CCUCUG       UCAC         AGCAUUAG   90 
                   ||||||       ||||         ||||||||  
    miRNA     23   GGGGAU       AGUG         UCGUAAUU   1 
    3'->5'        U                 CUAA               
 
The bindings in green highlight positions predicted by PITA 




    5'->3'        U      CAGCACU    UACCAA  G    N    
    Target    57   CCUCUG       UCAC      AU AGCA      86 
                   ||||||       ||||      || ||||     
    miRNA     23   GGGGAU       AGUG      UA UCGU      1 




    5'->3'        U      CAGCACU    UACCAAAUG   C    C 
    Target    57   CCUCUG       UCAC         AGC UUAG   90 
                   ||||||       ||||         ||| ||||  
    miRNA     23   GGGGAU       AGUG         UCG AAUU   1 
    3'->5'        U                 CUAA        U      
  
The bindings in green highlight positions predicted by PITA 





    5'->3'        A    UAG   CUUU   GA    AAGGAGAAAAU      U 
    Target    84   GCCU   CUA    UCA  AUUG           GCAUUA   
123 
                   ||||   |||    |||  ||||           ||||||  
    miRNA     23   UGGG   GAU    AGU  UAAU           CGUAAU   1 
    3'->5'                          GC                     U 
        
   
PITA predicts 15 sites with an overall score -5.40.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 
A-Allele miR-155-5p 83-89 7:0:0 -14.27 -9.97 -4.29 
 
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
A-Allele miR-155-5p 100 7:1:1 -2.12 -10.04 7.92 
 
 
PITA predicts 15 sites with an overall score -5.19.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 
C-Allele miR-155-5p 83-89 7:1:0 -9.97 -6.84 -3.12 
 
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 









3' UGGGGAUAGUGCUAAUCGUAAUU 5' 
   ****|||*||*****|||||||*    





FGF20; rs12720208; miR-433-3p 
 
C-Allele T-Allele 
STarMir predicts 45 binding sites.  







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
9 166-187 180-186 -14.500 -2.356 -9.274 -5.226 0.426 
STarMir predicts 46 binding sites.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
9 166-187 No -12.300 -4.655 -10.123 -2.177 0.547 





    5'->3'          U    CU  AAAUAG        C 
    Target   166     UUGA  AG      AUCAUGAU   187 
                     ||||  ||      ||||||||  
    miRNA     22     GGCU  UC      UAGUACUA   1 
    3'->5'        UGU    CC  GGG             
  
 
The bindings in green highlight positions predicted by PITA 







    5'->3'          U    CU  AAAUAG        C 
    Target   166     UUGA  AG      AUUAUGAU   187 
                     ||||  ||      ||||||||  
    miRNA     22     GGCU  UC      UAGUACUA   1 
    3'->5'        UGU    CC  GGG             
 
The bindings in green highlight positions predicted by PITA 
180-186 with a 7 mer with one G-U wobble 
 
 
PITA predicts 22 sites with an overall score -11.08.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 
C-Allele miR-433-3p 180-186 7:0:0 -10.55 -7.11 -3.43 
 
 
PITA predicts 22 sites with an overall score -11.08.  
There is one binding site covering the SNP position.  
 
Gene microRNA Position Seed dGduplex dGopen ddG 










3' UGUGGCUCCUC--GG-GUAGUACUA 5' 
   ***::||**||***:**||||||||    






Position Structure Loop Score ΔG 
163-187 
3' UGUGGCUCCUC--GG-GUAGUACUA 5' 
   ***::||**||***:**||:|||||    





HOXB5 ; rs9299 ; miR-7-5p 
 
G-Allele      A-Allele 
 
STarMir predicts 26 seedless binding sites and one seed site. 







Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
1 126-145 No -17.200 -0.428 -6.624 -10.576 0.363 
2 126-154 148-154 -21.900 -0.493 -13.609 -8.291 0.389 
 
STarMir predicts 26 seedless binding sites and one seed site.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
1 126-154 148-154 -22.400 -1.391 -11.198 -11.202 0.466 





STarMir Site 1 
 
    5'->3'        U      UUUCGU        A   
    Target   126   ACGAUA      UUGGUCUU     145 
                   ||||||      ||||||||    
    miRNA     23   UGUUGU      GAUCAGAA     1 
    3'->5'               UUUAGU        GGU 
  
 
STarMir Site 2 seed site 
 
    5'->3'        U      UUUCGUUU    UUA        U 
    Target   126   ACGAUA        GGUC   GGUCUUCC   154 
                   ||||||        ||||   ||||||||  
    miRNA     23   UGUUGU        UUAG   UCAGAAGG   1 
    3'->5'               U           UGA        U 
  




STarMir Site 1 seed site 
 
    5'->3'        U      UUUCGUUU    UUA        U 
    Target   126   ACGAUA        GAUC   GGUCUUCC   154 
                   ||||||        ||||   ||||||||  
    miRNA     23   UGUUGU        UUAG   UCAGAAGG   1 
    3'->5'               U           UGA        U 
  
The bindings in green highlight positions predicted by PITA 
(147-154) 
 
STarMir Site 2  
 
    5'->3'        U      UUUCGUUU    U A      N   
    Target   126   ACGAUA        GAUC U GGUCUU     152 
                   ||||||        |||| | ||||||    
    miRNA     23   UGUUGU        UUAG G UCAGAA     1 
    3'->5'               U           U A      GGU 
  
 
PITA predicts 41 binding sites with an overall score -8.39.  
There is no binding site covering the SNP position. 
The following site may cause the opening of the SNP position: 
 
Gene miRNA Position Seed dGduplex dGopen ddG 
G-Allele hsa-miR-7 148-154  7:0:0 -16.4 -9.5 -6.89 
 
PITA predicts 41 binding sites with an overall score -10.25.  
There is no binding site covering the SNP position. 
The following site may cause the opening of the SNP position: 
 
Gene miRNA Position Seed dGduplex dGopen ddG 





Position Structure Loop Score ΔG 
126-155 
3' UGUUGUUUUAGUGAUCAGAAGGU 5' 
   *******::||***:|||||||*    






Position Structure Loop Score ΔG 
126-155 
3' UGUUGUUUUAGUGAUCAGAAGGU 5' 
   *******:|||***:|||||||*    








STarMir predicts 22 binding sites and 2 seed sites.  
















15 707-721 No -20.700 -0.076 -14.934 -5.766 0.298 
16 707-719 No -15.100 -0.076 -15.177 0.077 0.338 
 
STarMir predicts 21 binding sites and 2 seed site.  






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
14 707-725 719-724 -22 -1.201 -15.003 -6.997 0.348 






    5'->3'        A         CC           A 
    Target   707   GCU   UGG  AAGGUGGUGAA   725 
                   |||   |||  |||||||||||  
    miRNA     22   CGA   ACC  UUCCACCACUU   1 
    3'->5'            CCC   UC             
The bindings in green here highlight positions predicted by 





    5'->3'        A         CC       N    
    Target   707   GCU   UGG  AAGGUGG      721 
                   |||   |||  |||||||     
    miRNA     22   CGA   ACC  UUCCACC      1 





    5'->3'        A         CC     N      
    Target   707   GCU   UGG  AAGGU        719 
                   |||   |||  |||||       
    miRNA     22   CGA   ACC  UUCCA        1 







    5'->3'        A         CC   A       A 
    Target   707   GCU   UGG  AAG UGGUGAA   725 
                   |||   |||  ||| |||||||  
    miRNA     22   CGA   ACC  UUC ACCACUU   1 
    3'->5'            CCC   UC   C         
  
The bindings in green here highlight positions predicted by 




    5'->3'        A         CC   A     N  
    Target   707   GCU   UGG  AAG UGGUG    723 
                   |||   |||  ||| |||||   
    miRNA     22   CGA   ACC  UUC ACCAC    1 





PITA predicts 15 sites with an overall score -12.50.  
The following are those covering the SNP position: 
 








717-724 8:0:0 -22 -13.61 -8.38 
 
PITA predicts 14 sites with an overall score -12.48.  
There is one binding site covering the SNP position:  
 
Gene microRNA Position Seed dGduplex dGopen ddG 




Position Structure Loop Score ΔG 
707-725 
3' CGACCCACCUCUUCCACCACUU 5' 
   |||***|||**||||||||||*    





Position Structure Loop Score ΔG 
707-725 
3' CGACCCACCUCUUCCACCACUU 5' 
   |||***|||**|||*||||||*    
5' GCT---TGGCCAAGATGGTGAA 3' 
20.00 -19.30 
 
ORAI1 ; rs76753792 ; mir-519a-3p 
 
C-Allele       T-Allele 
 
STarMir predicts 4 seed sites and 32 seedless binding sites.  









Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
2 69-88 No -16.700 -4.322 -9.493 -7.207 0.562 
3 85-102 No -18.300 -0.019 -21.657 3.357 0.359 
 
STarMir predicts 4 seed sites and 32 seedless binding sites. 






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
2 81-95 No -15.200 0 -17.396 2.196 0.363 





    5'->3'        A      AC      CAGCC     A   
    Target    69   GC CUC     GGA     UGCGC     88 
                   || |||     |||     |||||    
    miRNA     22   UG GAG     CCU     ACGUG     1 





    5'->3'        U             C  G    C 
    Target    85   GCGC   AGGGGG UG GCUU   102 
                   ||||   |||||| || ||||  
    miRNA     22   UGUG   UUUUCC AC UGAA   1 




The bindings in green highlight positions predicted by PITA 







    5'->3'         A      UGC   GG  U     
    Target    81    GC CUG   AGG  GC       95 
                    || |||   |||  ||      
    miRNA     22    UG GAU   UCC  CG       1 





    5'->3'        A     G  C      C  G    C 
    Target    81   GC CU UG AGGGGG UG GCUU   102 
                   || || || |||||| || ||||  
    miRNA     22   UG GA AU UUUCCU AC UGAA   1 
    3'->5'           U  G            G    A 
  
 
The bindings in green highlight positions predicted by PITA ( 
a 7 mer 96-102 with one mismatch and one G-U wobble) 
 
 
PITA predicts 18 sites with an overall score -10.66.  
There is no site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
C-Allele 
hsa-miR-
519a-3p            96-102  7:1:1 -12.7 -20.64 7.94 
 
 
PITA predicts 18 sites with an overall score -10.66.  
There is no site covering the SNP position.  
The following site may cause the opening of the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
T-Allele 
hsa-miR-









STarMir predicts 37 seedless binding sites. The following are 








Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 




STarMir predicts 37 seedless binding sites and one seed site. 






Seed ΔGhybrid ΔGnucl ΔGopen ΔGtotal 
Site 
Access 
18 348-370 364-369 -21.300 -6.967 -5.051 -16.249 0.616 





STarMir Site 18 
 
    5'->3'        A   UUUUAU     UC  C    U 
    Target   348   UCU      CAUGA  CU CCUA   370 
                   |||      |||||  || ||||  
    miRNA     22   GGG      GUACU  GA GGAU   1 
    3'->5'            UUGUU      UU  U      
 
  
The bindings in green highlight positions predicted by PITA 
(364-369 a 6 seed match with one mismatch) 
 
 
STarMir Site 18 seed site 
 
    5'->3'        A   UUUUAU     UC       U 
    Target   348   UCU      CAUGA  CUACCUA   370 
                   |||      |||||  |||||||  
    miRNA     22   GGG      GUACU  GAUGGAU   1 
    3'->5'            UUGUU      UU         
  
The bindings in green highlight positions predicted by PITA 
(364-369 a perfect 6 seed match) 
 
 
STarMir Site 19 
 
    5'->3'        A   UUUUAU     UC     N  
    Target   348   UCU      CAUGA  CUACC    368 
                   |||      |||||  |||||   
    miRNA     22   GGG      GUACU  GAUGG    1 
    3'->5'            UUGUU      UU     AU 
  
PITA predicts 22 binding sites with an overall score -9.02.  
There is one binding site covering the SNP position: 
 




364-369 6:1:0 -12.5 -5.03 -7.46 
 
The following site may cause the opening of the SNP position: 
 




368-373 6:1:1 -9.4 -3.22 -6.17 
 
PITA predicts 22 binding sites with an overall score -12.08.  
There is one binding site covering the SNP position: 
 
Gene microRNA Position Seed dGduplex dGopen ddG 
A-
Allele 
hsa-miR-196a 364-369 6:0:0 -17.1 -5.04 -12.05 
 
The following site may cause the opening of the SNP position: 
 
Gene miRNA Position Seed dGduplex dGopen ddG 
A-
Allele 
hsa-miR-196a 368-373 6:1:1 -9.4 -3.22 -6.17 
 
 FindTar predictions:  there is only one binding site predicted for 
the C-Allele while there are 2 binding sites for the A-Allele; the 
additional one covers the SNP position: 
 
Position Structure Loop Score ΔG 
349-370 
3' GGGUUGUUGUACUUUGAUGGAU 5' 
   |::**:|*|||||**|||||||    
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1. LIG3 (L = 124) 
NM_002311.4 vs. rs4796030  
miRNA:  miR-221  
SNP Pos.  83  
 
 A-allele C-allele 
 Target Site:  77 - 98  80 - 98  
 
RNAsubopt and Barrier Setting 
 Offset  Barrier  A-allele  C-allele  A-allele  C-allele  
6.0  1.2  20,646  28,997  349  317  
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
A-allele  -20.30  -3.39  -11.77  -8.53  
C-allele  -24.60  -0.20  -15.96  -8.64  
 
Local Minima 
 MFE  A -allele  C-allele  
#Pairings  9  7  
Opening Energy  -10.48  -12.68  
Structure 
Energy  
-33.70  -35.90  
MFE Barrier  6.0  6.00  
Minima  
Less Pairings  28.4%        99  6.3%             20  
Equal Pairings  38.5%      134  10.4%           33  
Greater Pairings  33.0%      115  83.2%         263  
Identical to 
MFE  
4.0%          14  8.5%             27  
Minima (-MFE)  348  316  
Avg. Opening of 
All Local 
Minima  
(excluding MFE)  
-10.38  -12.33  
 
Less/Equal Pairings than MFE 







Approx. Avg.  
4  0.29%          1  -7.40  1.27%          4  -5.99  
5  1.15%          4  -10.49  2.22%          7  -6.98  
6  4.02%        14  -11.07  2.85%          9  -10.00  
7  8.62%        30  -8.36  10.44%     33  -12.41  
8  14.37%     50  -10.01  24.68%     78  -13.88  
9  38.51%   134  -9.79  16.77%     53  -11.50  
Total 66.95%   233 -9.73 58.23%   184 -12.31 
Avg. Barrier 1.78  1.72  
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Local Minima with Less Pairings 
 A-allele C-allele 
#LM Less Pairings:  28.4%        99 6.33%        20 
Avg. Target Site 
Energy  
-9.65  -8.14 
Less Pairings Avg. 
Barrier Height  
1.69  1.74 
 
Local Minima with Less or Equal Approx.  
Target Site Energy than the MFE 
 A -allele C-allele 
Less 61.5%    214 57.9%     183 
Equal 4.0%        14 4.4%         14 
Less or 
Equal  
65.5%    228  62.3%     197 
 
N+ Test 
A-allele Local Minima Distribution 






2*2.50, 2.30, 2.20, 
2*2.10, 2*1.80, 
5*1.30, 2*1.20 
1.75 -21.08, -16.28, -13.47, -11.96, -10.89, 
-10.56, -10.49, -10.06, -9.98, 2*-9.76,  







1.79 -11.53, -10.76, -7.08, -9.98, 2*-9.86,  
2*-10.48, 2*-10.59, -12.03, -6.85,  
-9.18, -22.36 
-10.83 
-30.40 2 2.20, 1.80 2.00 -10.36, -9.96 -10.16 
-30.50 7 
 
2*2.80, 2.70, 2.40, 
2.20, 2.10, 1.80 





2*2.90, 2.40, 2.20, 
1.80, 1.50, 2*1.30 
2.04 -11.06, -10.89, -10.56, -10.48, -10.46,  
-9.18, -5.85, -7.38 
-9.48 
-30.70 4 3.00, 1.80, 1.30, 
1.60 
1.93 -10.56, -10.48, -7.48, -9.18 -9.43 
-30.80 4 1.50, 1.30, 1.80, 
1.60 
1.55 -10.46, -7.58, -10.36, -10.48 -9.72 
-30.90 8 
 
2*3.20, 2.2, 1.90, 
1.80, 2*1.30, 1.40 





1.40, 3.30, 1.80 2.17 -7.78, -10.86, -10.56 -9.73 
-31.10 5 
 
2*2.30, 1.80, 1.60, 
1.30 
1.86 -11.53, -9.98, -9.18, 2*-7.88 -9.29 
-31.20 4 
 
1.31, 2.30, 3.50, 
1.60 
2.18 -12.43, -7.98, -14.47, -9.46 -11.09 
-31.30 4 2*1.80, 1.30, 2.60 1.43 -10.86, -9.38, -9.78, -8.08 -9.53 
-31.40 2 2.60, 1.90 2.25 2*-8.18 -8.18 
-31.50 4 2*1.30, 2.10, 2.30 1.43 -10.49, -11.96, -9.98, -9.76 -10.55 
-31.60 6 
(21) 
3.70, 3.90, 2*1.30, 
2.00, 3.20 
2.57 -12.03, -6.85, -10.48, -9.86, 2*-10.59 -10.06 
-31.70 2 2.30, 1.30 1.80 -9.96, -9.78 -9.87 
-31.80 1 2.30 2.30 -10.06 -10.06 
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-31.90 2 2.10, 1.80 1.95 -10.89, -9.98 -10.44 
-32.00 1 
(10) 
4.30 4.30 -10.48 -10.48 
-32.10 1 2.20 2.20 -10.36 -10.36 
-32.20 1 2.40 2.40 -10.46 -10.46 
-32.30 1 3.20 3.20 -10.56 -10.56 
-32.40 2 1.80, 1.60 1.70 -10.48, -9.18 -9.83 
-32.60 2 4.70, 3.70 4.20 -10.86, -9.38 -10.12 
-33.00 1 1.30 1.30 -9.78 -9.78 
-33.20 1 2.30 2.30 -9.98 -9.98 
MFE:  
-33.70 




106 220.81 2.08 -1073.4 -10.13 
 

































C-allele - Local Minima Distribution 






2* 2.50, 2*2.40, 
2*1.80, 1.60, 
2*1.20 
1.83 -16.20, 2*-15.30, -14.43, -12.76,  
-12.36, -10.88, -10.48, -6.30 
-12.67 
-32.50 7 2*2.60, 2.40, 2.10, 
1.80, 1.60, 1.20 
2.04 -15.30, -14.53, -12.46, 2*-12.68,  
-12.38, -12.36 
-13.20 
-32.60 9 3* 2.70, 2.40, 
3*2.10, 2.00, 1.80 
2.29 -15.87, -13.29, -12.46, -12.38, -11.59, 
-11.20, -10.86, -10.61, -6.80 
-11.67 
-32.70 8 2.80, 2.40, 2.30, 
2.10, 2*1.60, 
2*1.20 
1.90 -20.23, -16.20, -13.16, -12.38, -11.58, 
-10.96, -9.48, -7.95 
-12.37 
-32.80 8 2*2.90, 2.30, 1.90, 
2*1.80, 1.50, 1.40 





2* 3.00, 2.70, 
3*1.80, 1.30, 1.20 
2.08 -16.23, -13.50, -12.76, -12.68, -12.46,  
-11.78, -11.16, -9.68 
-12.53 
-33.00 7 2*3.10, 2.10, 1.80, 
1.60, 2* 1.30 
2.04 -13.60, -13.29, -12.68, -11.26,  
2*-9.78, -8.25 
-11.23 
-33.10 1 1.60  1.60 -11.58 -11.58 
-33.20 5 3.20, 1.80, 1.40, 1.78 -16.50, -15.46, -15.30, -12.76, -11.68 -14.34 
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1.30, 1.20 
-33.30 6 3.40, 2.20, 1.90, 
1.80, 1.40, 1.20 
1.98 -16.23, -13.50, -11.78, 3*-10.08 -11.96 
-33.40 4 2.10, 1.80, 1.30, 
1.20 
1.60 -18.16, -17.13, -16.23, -13.60 -16.28 
-33.50 4 3.60, 3.20, 1.80, 
1.60 
2.55 -13.93, -12.38, -11.58, -10.28 -12.04 
-33.60 3 3.70, 1.60, 1.40 2.23 -15.30, -11.86, -11.68 -12.95 
-33.70 6 3.80, 2.60, 2*1.80, 
2*1.20 





3.20, 1.80, 1.20 2.07 -14.53, -13.60, -12.68 -13.60 
-33.90 1 4.00 4.00 -12.38 -12.38 
-34.00 2 1.80, 1.20  1.50 -16.20, -15.30 -15.75 
-34.10 2 2*2.40  2.40 -12.36, -10.88 -11.62 
-34.20 2 4.30, 3.20  3.75 -12.68, -12.46 -12.57 
-34.30 2 2.10, 1.80 1.95 -13.29, -12.38 -12.84 
-34.50 1 
(10) 
4.60 4.60 -12.76 -12.76 
-34.60 1 1.80 1.80 -12.68 -12.68 
-34.80 1 1.60 1.60 -11.58 -11.58 
-34.90 1 1.40 1.40 -11.68 -11.68 
-35.00 3 4.20, 1.80, 1.20 2.40 -16.23, -13.50, -11.78 -13.84 
-35.10 1 2.10 2.10 -13.60 -13.60 
-35.30 1 5.40 5.40 -15.30 -15.30 
-35.60 1 5.20 5.20 -12.38 -12.38 
MFE: 
 -35.90 




108 237.7 2.20 1374.8 -12.73 
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Ordered by Deepest Local Minima 
A-allele 
Barrier #LM Opening 
Avg. 
Opening 
4.70 1 -10.86 -10.86 
4.30 1 -10.48 -10.48 
3.90 1 -6.85 -6.85 
3.70 2 -12.03, -9.38 -10.71 
3.50 1 -14.47 -14.47 
3.30 1 -10.86 -10.86 
3.20 4 (11) -9.38, -10.48, -10.56, -10.86 -10.32 
3.00 1 -10.56 -10.56 
2.90 2 -10.56, -10.48 -10.52 
2.80 2 -9.38, -10.86 -10.12 
2.70 1 -8.76 -8.76 
2.60 4 (21) -22.36, -8.08, -8.18, -11.53 -12.54 
2.50 2 -21.08, -10.56 -15.82 
2.40 5 4*-10.46, -5.35 -9.44 
2.30 14 -7.98, -8.26, 3*-9.96, 4*-9.98, 3*-10.06, -11.53, -20.88 -10.62 
2.20 9 -5.85, -6.85, -7.68, 4*-10.36, -12.03, -13.47 -9.70 
2.10 16 (67) -5.05, -6.68, -8.21, -8.51, -9.98, -9.09, 3*-10.89, -10.48, 3*-11.96,  
-15.31, -15.61, -22.36 
-11.24 
2.00 7 -8.18, -8.26, -10.06, 2*-10.59, -16.66, -21.08 -10.69 
1.90 8 -7.68, -8.08, 2*-8.18, -9.96, -10.86, -11.69, -15.98 -10.08 
1.80 42 
(124) 
2*-6.85, 2*-7.68, -7.76, 2*-7.88, 2*-7.98, -8.08, 2*-8.18, 3*-9.38,  
-9.96, 3*-9.98, -10.06, -10.36, -10.46, 3*-10.48, -10.56, 3*-10.59,  
-10.76, 4*-10.86, -10.89, -11.53, -11.96, 2*-12.03, 2*-14.47, -20.88 
-10.19 
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C-allele 
Barrier #LM Opening 
Avg. 
Opening 
5.40 1 -15.30 -15.30 
5.20 1 -12.38 -12.38 
4.60 1 -12.76 -12.76 
4.30 1 -12.68 -12.68 
4.20 1 -11.78 -11.78 
4.00 1 -12.38 -12.38 
3.80 1 -15.30 -15.30 
3.70 1 -15.30 -15.30 
3.60 1 -13.93 -13.93 
3.40 1 (10) -11.78 -11.78 
3.20 4 -12.38, -12.46, -12.68, -15.30 -13.21 
3.10 2 -8.25, -11.26 -9.76 
3.00 2 -11.78, -12.76 -12.27 
2.90 1 -12.68 -12.68 
2.80 1 (20) -20.23 -20.23 
2.70 4 -6.80, -11.16, -12.46, -15.87 -11.57 
2.60 3 -10.48, -12.38, -12.46 -11.77 
2.50 2 -6.30, -12.76 -9.53 
2.40 10 -6.86, -9.08, -10.86, 2*-10.88, -10.96, 3*-12.36, -15.30 -11.19 
2.30 4 -9.48, -11.20, -15.30, -20.23 -14.05 
2.20 4 -10.08, -10.73, -12.46, -15.13 -12.10 
2.10 18 (65) -7.20, -10.48, -10.61, -10.88, -11.59, -12.36, -12.38, -12.43, -12.68,  
-13.16, 3*-13.29, 4*-13.60, -17.71 
-12.54 
2.00 4 -10.16, -11.20, -11.78, -15.30 -12.11 
1.90 10 -6.00, 4*-8.58, -8.60, -9.33, -9.58, -10.08, -13.93 -9.18 
1.80 43 -6.95, -8.25, -8.88, -9.96, 2*-10.08, 3*-10.28, -10.48, -10.88, -11.26,  
2*-11.78, -12.36, 3*-12.38, -12.46, 3*-12.68, -12.76, -13.29,  
4*-13.60, -13.93, 4*-15.30, 9*-13.23, -20.23 
-12.47 
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Ordered by Opening Energy 
A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-4.15 1 1.20 1.20 
-4.35 1 1.30 1.30 
-4.55 1 1.60 1.60 
-5.05 1 2.10 2.10 
-5.35 2 2.40, 1.40 1.90 
-5.68 1 1.20 1.20 
-5.85 3 (10) 2.20, 1.60, 1.20 1.67 
-5.98 3  1.30, 1.40, 1.50 1.40 
-6.18 1 1.70 1.70 
-6.38 1 1.20 1.20 
-6.48 3 1.50, 1.30, 1.20 1.33 
-6.58 1 1.70 1.70 
-6.68 2 (21) 2.10, 1.50 1.80 
-6.85 4 3.90, 2.20, 2*1.80 2.43 
-6.88 1 1.50 1.50 
-6.98 1 1.20 1.20 
-7.01 1 1.30 1.30 
-7.08 3 1.70, 1.30, 1.20 1.40 
-7.16 1 1.20 1.20 
-7.26 1 1.30 1.30 
-7.38 3 2*1.30, 1.20 1.27 
-7.40 1 1.30 1.30 
-7.46 2 1.30 1.30 
-7.48 3 3*1.30 1.30 
-7.56 3 1.60, 1.50, 1.30 1.47 
-7.58 3 3*1.30 1.30 
-7.66 1 1.70 1.70 
-7.68 10 2.20, 1.90, 2*1.80, 2*1.50, 3*1.40, 1.30 1.62 
-7.76 1 (60) 1.80 1.80 
-7.78 4  3*1.40, 1.20 1.35 
-7.86 2 1.30, 1.20 1.25 
-7.88 8 2*1.80, 1.70, 5*1.30 1.48 
-7.91 1 1.60 1.60 
-7.96 1 1.30 1.30 
-7.98 4 2.30, 2*1.80, 1.40 1.83 
-8.06 1 1.30 1.30 
-8.08 4 2.60, 1.90, 1.80, 1.50 1.95 
-8.16 1 1.40 1.40 
-8.18 8 2.60, 2.00, 2*1.90, 2*1.80, 2*1.60 1.90 
-8.21 2 2.10, 1.20 1.65 
-8.26 2 2.30, 2.00 2.15 




1. LIG3 (L = 124) 




A-allele - Averages 
Test 
#LM-MFE 



















C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-5.50 1 1.70 1.70 
-5.66 1 1.20 1.20 
-6.00 1 1.90 1.90 
-6.06 1 1.60 1.60 
-6.30 2 2.50, 1.20 1.85 
-6.35 2 2*1.20 1.20 
-6.40 1 1.30 1.30 
-6.45 2 (11) 2*1.30 1.30 
-6.80 2 2.70, 1.40 2.05 
-6.86 1 2.40 2.40 
-6.95 1 1.80 1.80 
-7.20 1 2.10 2.10 
-7.88 1 1.20 1.20 
-7.95 1 1.20 1.20 
-7.98 1 1.30 1.30 
-8.08 1 (20) 1.30 1.30 
-8.25 3 3.10, 1.80, 1.40 2.10 
-8.28 1 1.30 1.30 
-8.58 4 4*1.90 1.90 
-8.60 1 1.90 1.90 
-8.68 1 1.50 1.50 
-8.88 1 1.80 1.80 
-8.93 1 1.40 1.40 
-8.98 1 1.70 1.70 
-9.08 1 2.40 2.40 
-9.30 1 1.70 1.70 
-9.33 1 1.90 1.90 
-9.48 2 2.30, 1.50 1.90 
-9.56 3 3*1.40 1.40 
-9.58 6 1.90, 1.60, 2*1.50, 2*1.20 2.23 
-9.60 1 1.20 1.20 
-9.66 1 1.50 1.50 
-9.68 3 3*1.30 1.30 
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-9.76 2 1.60, 1.30 1.45 
-9.78 6 (60) 6*1.30 1.30 
-9.86 2 2*1.30 1.30 
-9.96 2 1.80, 1.40 1.60 
-10.08 12 2.20, 1.90, 2*1.80, 2*1.70, 3*1.40, 3*1.30 1.60 
-10.13 1 1.20 1.20 
-10.16 1 2.00 2.00 
-10.23 1 1.30 1.30 
-10.28 4 3*1.80, 1.50 1.73 
-10.48 4 2.60, 2.10, 1.80, 1.70 2.05 
-10.61 2 2.10, 1.40 1.75 
-10.73 1 2.20 2.20 
-10.86 2 2.40, 1.40 1.90 
-10.88 6 2*2.40, 2.10, 1.80, 1.30, 1.20 1.87 
-10.96 3 (101) 2.40, 1.50, 1.20 1.70 
 
C-allele - Averages 
Test 
#LM-MFE 
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RNAsubopt and Barrier Setting 
Offset  Barrier  G-allele  A-allele  G-allele  A-allele  
6.0 1.4 10,987,436 16,209,366 7,457 11,187 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_disrupt dG_total 
G-allele -27.80 -5.36 -8.09 -19.72 



















Less/Equal Pairings than MFE Target Site 
#Pairings  #Minima  
G-Allele  
Target Site 




Approx. Avg.  
4  -  -  0.07%             8  -2.20  
6  0.28%           21  -4.39  0.61%           68  -4.62  
7  0.25%           19  -4.57  1.25%         140  -4.48  
8  0.15%           11  -5.86  3.22%         360  -5.68  
9  0.52%           39  -5.23  0.75%           84  -5.81  
10  1.44%         107  -5.64  8.31%         929  -7.10  
11  1.22%           91  -6.48  6.12%         685  -7.36  
12  24.75%   1,845 -7.64  30.67%   3,431  -8.25  
13  11.01%       821  -8.38  14.44%   1,615  -8.55  
14  18.58%   1,385  -10.68  3.41%         382  -9.00  
Total 
Minima  
58.19%   4,339  -8.62  68.85%   7,702  -7.88  
Avg. Barrier 1.83  1.82  
 
      NM_001757.2 vs.  rs9024 
miRNA:       miR-574-5p 
SNP Pos.       133 
Target site:       121 - 162 
MFE G-allele A-allele 
#Pairings 14  12  
Opening Energy -10.90  -9.90  
Structure Energy -52.10  -51.10  
MFE Barrier 6.00  6.00  
 
Minima 
Less Pairings 39.6%     2,954 20.3%     2,274 
Equal Pairings 18.6%     1,385  30.7%     3,431 
Greater Pairings 41.8%     3,117 49.0%     5,481 
Identical to MFE 12.8%         951 8.5%           951 
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Local Minima with Less Pairings 
 G-allele A-allele 
#LM Less 
Pairings:  
36.6%   2,954 20.3%   2,274 
Avg. Target Site 
Energy  
-7.66 -6.65 
Less Pairings Avg. 
Barrier Height  
1.82 1.82 
 
Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 G-allele A-allele 
Less  56.37%   4,203  58.04%   6,492  
Equal  13.37%      997  8.93%         999  
Less or 
Equal  
69.74%   5,200  66.97%   7,491  
 
N+ Test 
G-allele - Local Minima Distribution 







2.10, 2.30, 2*2.40, 
7*2.20, 2*1.70 
2.86 5*-18.70, 5*-12.75, -11.10,  
6*-10.90, 5*-8.20, 2*-7.30, -7.00 
-11.85 






2.46 5*-12.75, -12.00, -11.10, 5*-10.90,  
-9.20, 5*-8.20, 2*7.30, 3*-7.00 
-9.88 
-50.00 15 3*3.90, 3.80, 3.40, 
3.20, 2.40, 2*2.30, 
2.10, 2*2.20, 
3*1.80 
3.77 2*-18.70, 2*-12.75, 4*-10.90, 9.80,  




5*4.00, 3.90, 3.80, 
2*3.20, 3*2.10, 
1.90 
3.25 2*-12.75, -11.60, -11.10, 3*-8.20,  
-7.30, 3*-7.00, 2*-5.80 
-8.67 
-50.20 9 2*4.10, 3.70, 
2*2.90, 3*2.40, 
1.80 
2.97 2*-18.70, -12.75, -10.90, -9.00,  
-8.20, 3*-7.30 
-11.13 
-50.30 6 4.20, 3.90, 3.80, 
3.70, 2.90, 2.10 
3.43 2*-18.70, -12.75, -10.90, -8.20,  
-7.30 
-12.76 
-50.40 10 4*4.30, 2*3.80, 
3.40, 2*2.90, 2.10 
3.61 3*-12.75, -9.20, 3*-8.20, 3*-7.30 -9.40 
-50.50 6 
(22) 
2*4.40, 3.80, 2.90, 
2.30, 1.80 







3.73 3*-12.75, 3*-8.20, -10.90, -5.80 -9.94 
-50.70 1 1.90 1.90 -10.90 -10.90 
-50.80 4 4.70, 3.90, 2.30, 3.25 4*-10.90 -10.90 
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2.10 
-51.30 2 3.90, 2.30 3.10 2*-10.90 -10.90 








124 376.6 3.04 1323.55 -10.67 
 
































A-allele - Local Minima Distribution 










2.29 2*-17.70, -11.75, 3*-10.42, -9.90,  
-8.00, 2*-7.60, 3*-7.30, -7.20,  
4*-6.30, 2*-5.80 
-8.87 
-49.30 19 2*4.20, 3.90, 




2.74 2*-17.70, -11.75, -10.42, -9.90, 






3.40, 2*2.90, 2.20, 
3*2.00, 3*1.90, 
1.80 
2.84 3*-11.75, 3*-10.42, -8.20, -7.60, 
3*7.20, 3*6.30, 2*5.80 
-8.40 
-49.50 11 3*4.40, 3.80, 
2*3.10, 2.90, 2.30, 
2.20, 2.10, 1.80 
3.15 2*-17.70, -11.75, -10.55, -9.90, -7.60, 
3*-7.30, -7.20, -5.80 
-10.00 




3.24 3*11.75, 9.90, -7.60, 5*-7.30, 
3*7.20, -5.80 
-8.33 
-49.70 7 2.90, 2.40, 2*2.20, 
2.10, 1.90, 1.70 
2.20 -9.90, 5*-7.30, -5.80 -7.46 
-49.80 6 4.70, 2*3.90, 2.30, 
2.20, 2.10 
3.18 4*-9.90, 2*-7.30 -9.03 
-49.90 2 
(20) 
4.80, 2.10 3.45 2*-7.30 -7.30 
2. CBR1 (L = 284) 
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-50.00 3 2.40, 2*1.80 2.00 2*-7.60, -7.30 -7.50 
-50.10 3 2*5.00, 3.90 4.63 -7.30, 2*-5.80 -6.30 
-50.20 3 
(12) 
2*5.10, 2.90 4.36 3*-7.30 -7.30 
-50.30 3 5.20, 3.90, 2.30 3.80 2*-9.90, -7.30 -9.03 
-50.40 3 2*5.30, 2.10 4.23 3*-7.30 -7.30 
-50.50 1 1.80 1.80 -7.60 -7.60 
-50.60 2 2*5.50 5.50 -9.90, -5.80 -7.85 
MFE: 
-51.10 




114 340.2 2.98 -968.44 -8.57 
 
































Ordered by Deepest Local Minima 
G-allele 
Barrier #LM Opening 
Avg. 
Opening 
5.50 1 -10.90 -10.90 
4.70 1 -10.90 -10.90 
4.50 4 -5.80, -10.90, 2*-12.75,  -10.55 
4.40 2 -18.70, -12.75 -15.73 
4.30 4 (12) 2*-7.30, 2*-12.75 -10.02 
4.20 1 -7.30 -7.30 
4.10 2 2*-7.30 -7.30 
4.00 5 (20) 2*-5.80, -11.10, -11.60, -12.75 -9.41 
3.90 7 -7.30, 3*-10.90, 2*-12.75, -18.70 -12.03 
3.80 10 -7.30, 8*-8.20, -10.90 -8.38 
3.70 13 -7.30, 2*-8.20, 3*-10.90, 2*-11.10, 2*-12.75, 3*-18.70 -12.32 
3.60 4 4*-10.90 -10.90 
3.50 12 (66) 2*-7.30, 7*-10.90, -11.50, -11.60, -18.70 -11.06 
3.40 14 -5.80, -8.20, 3*-9.20, 2*-9.80, -10.00, -10.55, 2*-10.90, -12.75,  
2*-18.70 
-10.98 





-4.50, -5.80, 10*-7.00, -7.30, 5*-8.20, -9.10, -9.93, -10.00, 2*-10.90, -
11.60, 5*-12.75, 7*-18.70 
-10.71 
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Barrier #LM Opening 
Avg. 
Opening 
5.50 2 -5.80, -9.90 -7.85 
5.30 2 2*-7.30 -7.30 
5.20 1 -7.30 -7.30 
5.10 2 2*-7.30 -7.30 
5.00 2 2*5.80 -5.80 
4.80 1 (10) -7.30 -7.30 
4.70 1 -9.90 -9.90 
4.50 3 -9.90, 2*-11.75 -11.13 
4.40 3 -10.55, -11.75, -17.70 -13.33 
4.30 4 (21) -5.80, -7.30, 2*-11.75 -9.15 
4.20 2 -5.80, -7.30 -6.55 
4.10 1 -7.30 -7.30 
4.00 8 -5.80, 4*-7.30, -10.10, -10.60, -11.75 -8.43 
3.90 16 7*-7.30, -8.40, 3*-9.90, 2*-10.55, 2*-11.75, -17.70 -9.47 
3.80 15 (63) -4.50, 2*-5.80, 8*-7.20, 3*-7.30, -9.90 -7.03 
3.70 19 2*-4.50, 2*-7.20, 4*-7.30, -8.40, 3*-9.90, 2*-10.10, 2*-11.75,  
3*-17.70 
-9.87 
3.60 11 -4.90, -5.80, 4*-7.30, -8.40, 4*-9.90 -7.99 
3.50 13 
(106) 
-4.50, 2*-7.30, 7*-9.90, -10.50, -10.60, -17.70 -9.78 
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Ordered by Opening Energy 
 
G-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-2.20 1 1.60 1.60 
-2.90 1 1.60 1.60 
-3.40 4 3*1.50, 1.40 1.48 
-3.50 4 
(10) 
1.90, 2*1.70, 1.50 1.70 
-3.90 10 
(20) 
4*1.70, 3*1.60, 1.50, 2*1.40 1.59 
-4.00 9 2*1.70, 1.50, 6*1.40 1.48 
-4.10 12 2.80, 2*2.30, 1.90, 1.80, 1.70, 2*1.60, 2*1.50, 2*1.40 1.82 
-4.50 26 
(67) 
3.20, 2*2.70, 2.50, 2.30, 2.20, 2.10, 4*2.00, 1.90, 3*1.80, 2*1.70, 
2*1.60, 3*1.50, 4*1.40 
1.91 
-4.70 6 2.40, 2*1.90, 2*1.50, 1.40 1.77 
-4.90 8 2.60, 2*2.10, 1.70, 1.60, 1.50, 2*1.40 1.80 
-5.00 10 2.70, 2*2.20, 1.80, 1.70, 1.60, 2*1.50, 2*1.40 1.80 
-5.20 3 3*1.50 1.50 
-5.30 18 
(112) 
1.80, 8*1.60, 2*1.50, 7*1.40 1.52 
 
G-allele - Averages 
Test 
#LM-MFE 



















A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-2.20 8 5*1.60, 1.50, 2*1.40 1.36 






3*1.90, 5*1.70, 3*1.60, 2*1.50, 4*1.40 1.62 
-3.00 6 6*1.40 1.40 
-3.40 8 2.40, 2*1.90, 1.50, 4*1.40 1.66 
-3.50 26 
(67) 
4*1.40, 3*1.50, 2*1.60, 2*1.70, 3*1.80, 12*1.90 1.73 
-3.60 1 1.40 1.40 
-3.70 1 1.50 1.50 
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-3.90 16 2.60, 2*2.10, 3*1.90, 2*1.70, 2*1.60, 2*1.50, 4*1.40 1.73 
-4.00 26 
(111) 
5*1.40, 5*1.50, 6*1.60, 2*1.70, 2*1.80, 3*1.90, 2*2.20, 2.70 1.69 
 
A-allele - Averages 
Test 
#LM-MFE 
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 G-allele A-allele 
Target Site: 50 - 80 50 - 80 
 
RNAsubopt and Barrier Setting 
Offset  Barrier  G-allele  A-allele  G-allele  A-allele  
6.0  1.4  260,869 239,418 1,174 997 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_disrupt dG_total 
G-allele -28.70 -5.505 -12.645 -16.055 



















Less/Equal Pairings than MFE 
#Pairings  #Minima  
G-allele  
Target Site 




Approx. Avg.  
6 0.09%          1 -5.40 0.10%          1 -2.20 
7 - - 0.50%          5 -5.04 
8 1.02%        12 -9.42 6.93%        69 -6.03 
9 0.34%          4 -10.58 24.3%      242 -9.43 
10 0.68%          8 -7.90 22.5%      224 -6.67 
11 1.71%        20 -10.50 4.82%        48 -7.44 
12 2.30%        27 -9.68 7.13%        71 -8.73 
13 1.36%        16 -17.29 9.84%        98                      -10.88
14 3.41%        40 -21.63 20.38%   203 -18.10 
Total: 10.91%   128 -14.35 96.5%      961 -10.34 
Avg. Barrier:  1.79  1.79  
 
NM_001256614.1 vs. rs56109847 
miRNA:       miR-510-5p 
SNP Pos.       76 
MFE  G -allele A-allele 
#Pairings  15 9 
Opening Energy  -24.47 -10.96 
Structure Energy  -66.90 -63.90 
MFE Barrier  6.00 6.00 
Minima  
Less Pairings  10.91%       128 7.53%           75 
Equal Pairings  78.86%       925 24.29%       242 
Greater Pairings  10.23%       120 68.17%       679 
Target Site 
Identical to MFE  
13.73%       161 13.05%       130 
Minima (- MFE)  1,173 996 
Avg. Opening of 
All Local Minima 
(excluding MFE) 
-21.74 -10.56 
3. HTR3E (L = 302) 
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Local Minima with Less Pairings 
 G-allele A-allele 
#LM Less Pairings:  10.91%    128 7.53%        75 




Local Minima with Less or Equal Approx.  
Target Site Energy than the MFE 
 G-allele A-allele 
Less 36.15%  424 595 
Equal 27.54%  323 130 
Less or 
Equal  
63.68%  747 725 
 
N+ Test 
G-allele Local Minima Distribution 








1.77 4*-25.40, 8*-21.37 -22.71 
-64.50 14 4*2.10, 2*1.90, 
4*1.60, 4*1.50 
1.76 8*-21.47, 6*-21.37 -21.43 
-64.60 10 4*2.10, 4*1.60, 
2*1.90 
1.86 6*-21.47, 4*-21.37 -21.43 
-64.70 4 4*2.10 2.10 4*-21.47 -21.47 
-64.80 4 4*2.30 2.30 4*-21.37 -21.37 
-64.90 10 
(64) 
4*2.90, 6*2.30 2.54 4*-21.47, 6*-21.37 -21.41 
-65.00 6 6*2.60 2.60 6*-21.47 -21.47 
-65.10 8 4*2.30, 4*1.70 2.00 4*-25.30, 4*-21.37 -23.44 
-65.20 8 4*2.60, 4*1.70 2.15 4*-25.40, 4*-21.47 -23.44 
-65.30 4 4*2.30 2.30 4*-21.37 -21.37 
-65.40 4 4*2.50 2.50 4*-21.47 -21.47 
-65.80 4 4*1.70 1.70 4*-25.30 -25.30 
-65.90 4 
(20) 
4*1.70 1.70 4*-25.40 -25.40 
-66.10 4 4*2.10 2.10 4*-21.37 -21.37 
-66.20 4 
(12) 
4*2.10 2.10 4*-21.47 -21.47 
-66.80 4 4*2.30 2.30 4*-21.37 -21.37 
MFE:  
-66.90 
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A-allele - Local Minima Distribution 







2.50, 2.30, 2*2.20, 
2*2.00, 1.60, 
4*1.40 
2.22 6*-17.47, 3*-10.96, 2*-10.00,  
2*-8.06, -7.90, 3*-7.20, -6.20, -5.80 
-11.33 
-61.10 9 2.10, 2*1.90, 
2*1.80, 2*1.70, 
2*1.60 
1.79 2*-13.40, 3*-10.96, -8.86, 3*-7.20 -10.02 




2.27 4*-21.40, 4*-17.47, 4*-10.96, 2*-
7.90, 4*-7.20, 2*-6.90, -6.20, -5.50 
-12.25 
-61.30 6 2*3.40, 2.80, 2.60 
2*2.10 





2.06 4*-17.47, 2*-10.40, -8.30, -6.20,  
2*-5.40 
-11.60 
-61.50 6 2*3.60, 2*2.10, 
2*1.50 
2.40 3*-10.96, 3*-7.20 -9.08 
-61.60 5 3.70, 2.70, 2.10, 
2*1.60 
2.34 -10.96, -8.66, 2*-8.30, -7.20 -8.68 
-61.70 6 3*2.10, 3*1.40 1.75 -10.96, 2*-10.00, -8.10, -7.90, -7.20 -9.03 
-61.80 2 2.30, 2.10 2.20 -8.86, -5.80 -7.33 
-61.90 6 4*1.70, 2*2.90 2.10 4*-21.40, -10.96, -7.20 -17.29 
-62.00 3 2*2.60, 1.40 2.20 -10.96, 2*-7.70 -8.79 





2.14 4*-17.47, -10.96, -7.20, -6.20 -13.46 
-62.40 3 4.50, 2*2.50 3.17 -10.96, -8.10, -7.20 -8.75 
-62.50 1 
(10) 
4.60 4.60 -5.80 -5.80 
-62.90 5 5.00, 4.70, 2*2.90, 
1.40 
3.38 4*-17.47, -6.20 -15.22 
-63.20 2 2*2.10 2.10 -10.96, -7.20 -9.08 
MFE: 
-63.90 
2 6.00, 5.70 5.85 -10.96, -7.20 -9.08 
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118 277.5 2.35 1284.53 -10.89 
 
































Ordered by Deepest Local Minima 
G-Allele 
Barrier  #LM  Opening  Avg. 
Opening  
4.70 1 -21.47 -21.47 
3.30 2 2*-21.47 -21.47 
3.20 2 -23.35, -11.16 -17.26 
3.10 3 2*-21.47, -17.70 -20.21 
3.00 4 
(12) 
2*-21.47, -10.96, -7.20 -15.27 
2.90 12 
(24) 
-23.35, 10*-21.47, -17.70 -21.31 
2.80 7 4*-23.35, 2*-21.47, -10.83 -21.02 
2.70 6 2*-22.5, 4*-21.47 -21.81 
2.60 14 10*-21.47, 4*-10.20 -18.25 
2.50 32 
(83) 
4*-23.55, 26*-21.47, 2*-20.21 -21.65 
2.40 5 2*-21.47, 2*-19.71, -10.83 -18.64 
2.30 82 
(170) 
8*-23.45, 2*-23.25, 2*-22.75, 62*-21.37,  
2*-20.11, 2*-20.01, 2*-19.61, 2*-10.83 
-21.29 
 
G-Allele - Averages 
Test  
#LM-MFE  





















3. HTR3E (L = 302) 
Page 22 of 75 
 
A-Allele 
Barrier  #LM  Opening  Avg. 
Opening  
5.70 1 -7.20 -7.20 
5.00 1 -17.47 -17.47 
4.70 1 -17.47 -17.47 
4.60 1 -5.80 -5.80 
4.50 1 -8.10 -8.10 
4.20 2 2*-10.40 -10.40 
3.70 1 -8.30 -8.30 
3.60 2 
(10) 
-10.96, -7.20 -9.08 
3.40 2 2*-10.40 -10.40 
3.30 5 2*-10.96, 2*-7.20, -6.90  -8.64 
3.10 2 -7.20, -10.96 -9.08 
3.00 4 
(23) 
-8.10, -8.03, -7.60, -7.10 -7.71 
2.90 8 6*-17.47, -10.96, -7.20 -15.37 
2.80 5 -9.00, 2*-7.50, -6.90, -6.83 -7.60 
2.70 6 -10.96, 2*-8.30, -7.60, -7.50, -7.20 -8.31 
2.60 25 
(67) 
10*-17.47, -11.90, 4*-10.96, -9.00, 2*-8.10,  




4*-17.47, 7*-10.96, 4*-10.40, 3*-8.30,  




A-Allele - Averages 
Test  
#LM-MFE  
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Ordered by Opening Energy 
G-Allele 
Opening  #LM  Barrier  Avg. 
Barrier  
-5.40 1 1.70 1.70 
-5.50 2 2.10, 1.40 1.75 
-5.80 2 2*1.60 1.60 
-6.20 2 2.00, 1.40 1.70 
-7.20 3 
(10) 
3.00, 2.10, 1.50 1.87 
-7.60 1 1.40 1.40 
-8.10 2 2*1.50 1.50 
-8.50 2 1.90, 1.40 1.65 
-9.10 2 2*1.50 1.50 
-9.20 6 
(23) 
2*1.60, 4*1.40 1.47 
-9.40 2 2*1.80 1.80 
-9.43 1 1.40 1.40 
-9.60 4 4*1.40 1.40 
-9.70 8 4*2.10, 4*1.40 1.75 
-10.13 5 2.10, 1.70, 2*1.60 ,1.40 1.68 
-10.20 8 4*2.60, 4*1.90 2.25 
-10.80 3 1.70, 2*1.60 1.63 
-10.83 8 
(62) 
2.80, 2.40, 2*2.30, 2.10, 1.70, 2*1.60 2.10 
-10.96 3 3.00, 2.10, 1.50 2.20 
-11.16 4 3.20, 2.10, 1.70, 1.50 2.13 
-11.70 3 2.20, 1.70, 1.50 1.80 
-16.30 2 2*1.70 1.70 
-16.70 2 2*1.40 1.40 
-17.27 2 2*1.80 1.80 
-17.70 8 3.10, 2.90, 2*2.10, 2*1.60, 2*1.40 2.03 
-18.07 4 4*1.60 1.60 
-18.17 4 4*1.70 1.70 
-18.37 6  
(100) 
4*1.90, 2*1.40 1.73 
 
G-Allele - Averages 
Test  
#LM-MFE  
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A-Allele 
Opening  #LM  Barrier  Avg. 
Barrier  
-2.00 1 1.50 1.50 
-2.20 1 1.40 1.40 
-2.30 1 1.90 1.90 
-2.60 2 2*1.40 1.40 
-2.70 1 1.40 1.40 
-3.00 1 1.80 1.80 
-3.10 1 1.90 1.90 
-3.30 5 
(13) 
2.10, 1.80, 3*1.40 1.62 
-3.40 1 1.40 1.40 
-3.70 1 1.40 1.40 
-3.80 2 2.60, 1.90 2.25 
-3.90 2 2*1.90 1.90 
-4.00 4 
(23) 
2*1.50, 2*1.40 1.45 
-4.10 3 2*1.50, 1.40 1.47 
-4.30 2 2*1.40 1.40 
-4.40 2 2*1.40 1.40 
-4.50 1 1.50 1.50 
-5.00 1 1.40 1.40 
-5.10 3 1.70, 2*1.50 1.57 
-5.40 32 
(67) 
16*1.50, 16*1.40 1.45 
-5.50 4 4*1.40 1.40 
-5.70 2 1.60, 1.50 1.55 
-5.80 31 
(104) 
4.60, 3*2.60, 2*2.50, 2.20, 3*2.10, 2.00, 




A-Allele - Averages 
Test  
#LM-MFE  
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RNAsubopt and Barrier Setting 
Offset  Barrier  C-allele  G-allele  C-allele  G-allele  
4.0 1.4 9,718,256 8,406,185 11,957 10,473 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
C-allele -23.90 -4.55 -9.28 -14.62  
G-allele -30.50 -3.24 -11.01 -19.49 
 
Local Minima 
MFE  C-allele  G-allele  
#Pairings  9  11  
Opening Energy -12.30  -13.10  
Structure Energy  -86.70  -87.50  
MFE Barrier  4.00  4.00  
Minima  
Less Pairings  18.8%           2,248  21.0%           2,201  
Equal Pairings  46.9%           5,613  55.9%           5,853  
Greater Pairings  34.3%           4,095  23.1%           2,418  
Identical to MFE  38.1%           4,554  45.0%           4,714  
Minima (- MFE)  11,956  10,472  
Avg. Opening of 




Less/Equal Pairings than MFE Target Site 
#Pairings  #Minima  
C-allele  
Target Site 




Approx. Avg.  
6  3.00%           359  -6.88  0.72%           75  -6.30  
7  7.89%           943  -5.15  7.26%         760  -5.79  
8  7.91%           946  -7.19  7.65%         801  -8.08  
9  46.95%     5,613  -10.96  1.48%         155  -7.49  
10  2.18%           261  -4.80  3.92%         410  -7.29  
11  0.92%           110  -6.56  55.89%   5,853  -11.78  
Total 
Minima  
68.85%     8,232  -9.43  76.91%   8,054  -10.48  







      NM_002127.5 vs. rs1063320 
miRNA:       miR-148a-3p 
SNP Pos.       233 
Target site:      221 - 239 
4. HLA_G (L = 386) 
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Local Minima with Less Pairings 
 C-allele G-allele 
#LM Less Pairings:  18.8%     2,248 21.0%     2,201 
Avg. Target Site 
Energy  
-6.28 -7.04 
Less Pairings Avg. 
Barrier Height  
1.75 1.77 
 
Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 C-allele G-allele 
Less  18.8%     6,448  48.8%     5,112  
Equal  35.7%     4,272  41.7%     4,372  
Less or 
Equal  
89.7%   10,720  90.6%     9,484  
 
N+ Test 
C-allele - Local Minima Distribution 















3.40, 2.90, 2*2.70, 
4*2.50, 8*2.30, 
8*1.40 
2.14 12*-12.30, 8*-6.90, 2*-4.80,  
2*-4.10 
-9.19 
-86.20 17 3*3.50, 3.30, 
2*3.00, 2*2.90, 
8*2.30, 2.70 
2.75 12*-12.30, 3*-4.80, 2*-4.10 -10.01 
-86.30 13 2*3.60, 2*3.30, 
2.90, 8*2.80 





3.10 8*-12.30, -4.80, 2*-4.10 -10.13 
-86.50 10 
(14) 
2*3.80, 4*2.30,  
4*1.40 
2.24 8*-12.30, -4.80, -4.10 -10.73 
-86.60 1 3.90 3.90 -4.10 -4.10 
-86.70 3 4.00, 2*3.00 3.33 3*-12.30 -12.30 
MFE: 
-86.70 
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G-allele - Local Minima Distribution 






3*3.30, 2.90,  
2*2.70, 4*2.30, 
8*2.50, 8*2.80,  
4*1.40 
2.51 16*-13.10, -11.60, -11.20, 8*-7.70, 
2*-5.50, 2*-4.80 
-10.49 
-86.90 27 3*3.40, 3.30,  
2*2.90, 2.70,  
4*2.50, 8*2.30, 
8*1.40 



























2.07 8*-13.10, -4.80 -12.18 
-87.50 3 4.00, 2*3.00 3.50 3*-13.10 -13.10 
MFE: 
-87.50 




119 303.00 2.55 1279.5 -10.75 
 































4. HLA_G (L = 386) 
Page 28 of 75 
 
Ordered by Deepest Local Minima 
C-allele 
Barrier #LM Opening 
Avg. 
Opening 
4.00 1 -12.30 -12.30 
3.90 1 -4.10 -4.10 
3.80 2 -4.10, -4.80 -4.45 
3.70 4 -4.10, -4.80, 2*-12.30 -8.38 
3.60 2 (10) -4.10, -4.80 -4.45 
3.50 3 -4.80, 2*-12.30 -9.80 
3.40 1 -4.10 -4.10 
3.30 8 (22) 3*-4.10, 3*-4.80, 2*-11.60 -6.24 
3.20 16 6*-4.10, -4.80, 9*-12.30 -8.76 
3.10 11 4*-4.10, 4*-4.0, -7.20, 2*-18.00 -6.87 
3.00 37 (86) -4.10, 4*-4.80, -7.20, 4*-9.80, 6*-11.60, 19*-12.30, 2*-18.00 -11.05 
2.90 30 
(116) 
6*-4.10, 5*-4.80, 4*-6.30, 3*-7.20, 12*-12.30 -8.10 
 








Barrier #LM Opening 
Avg. 
Opening 
4.00 1 -13.10 -13.10 
3.80 1 -4.80 -4.80 
3.70 4 -4.80, -5.50, 2*-13.10 -9.13 
3.60 3 (9) -4.80, -5.50, -11.60 -7.30 
3.50 6 -4.80, -5.50, -11.20, -11.60, 2*-13.10 -9.88 
3.40 3 -5.50, -11.20, -11.60 -9.43 
3.30 7 (25) 3*-4.80, 2*-5.50, -11.20, -11.60 -6.88 
3.20 15 -4.80, -5.50, -11.20, 2*-12.30, 9*-13.10, -15.71 -11.98 
3.10 8 6*-4.80, -5.50, -15.71 -6.25 
3.00 33 (81) 4*-4.80, 4*-5.50, -6.80, 2*-12.30, 19*-13.10, 3*-15.71 -11.17 
2.90 40 
(121) 
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Ordered by Opening Energy 
C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-3.10 4 2*1.60, 2*1.50 1.55 
-3.30 29 (33) 2.10, 2.00, 3*1.90, 4*1.80, 4*1.70, 4*1.60, 4*1.50, 8*1.40 1.63 
-4.00 21 (65) 2.00, 1.90, 3*1.80, 4*1.70, 4*1.60, 4*1.50, 4*1.40 1.62 
-4.10 495 
(560) 
81*1.40, 112*1.50, 39*1.60, 61*1.70, 29*1.80, 30*1.90, 17*2.00, 
14*2.10, 29*2.20, 11*2.30, 10*2.40, 9*2.50, 8*2.60, 19*2.70, 2.80, 
6*2.90, 3.00, 4*3.10, 6*3.20, 3*3.30, 3.40, 3.60, 3.70, 3.80, 3.90 
1.84 
 
C-allele - Averages 
Test 
#LM-MFE 



















G-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-3.80 4 2*1.50, 2*1.40 1.45 
-4.00 21  2.00, 1.90, 3*1.80, 4*1.70, 4*1.60, 4*1.50, 4*1.40 1.62 
-4.70 17 1.90, 1.80, 3*1.70, 4*1.60, 4*1.50, 4*1.40 1.58 
-4.80 418 3.80, 3.70, 3.60, 3.50, 3*3.30, 3.20, 6*3.10, 4*3.00, 5*2.90, 2*2.80, 
10*2.70, 10*2.60, 10*2.50, 7*2.40, 10*2.30, 26*2.20, 14*2.10, 
14*2.00, 24*1.90, 23*1.80, 58*1.70, 32*1.60, 88*1.50, 67*1.40 
1.85 
 
G-allele - Averages 
Test 
#LM-MFE 
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RNAsubopt and Barrier Setting 
Offset  Barrier  U-allele  C-allele  U-allele  C-allele  
6.0 1.4 10,610,542 1,582,333 14,281 1,709 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
U-allele -19.70 0.93 -12.19 -7.51 
C-allele -19.20 -0.65 -20.90 1.70 
 
Local Minima 
MFE  U-allele  C-allele  
#Pairings  11  22  
Opening Energy -18.10  -31.12  
Structure Energy  -186.90  -188.70  
MFE Barrier  3.00  3.00  
Minima  
Less Pairings  79.1%         11,295  12.3%               210  
Equal Pairings  7.9%              1,226  87.7%           1,499  
Greater Pairings  12.3%           1,760  0.0%                     0 
Identical to MFE  8.6%              1,226  42.2%               807  
Minima (- MFE)  14,281  1,709  
Avg. Opening of 




Less/Equal Pairings than MFE Target Site 
#Pairings  #Minima  
U-allele  
Target Site 




Approx. Avg.  
6 52.06%   7,434 -8.75 - - 
7 21.70%   3,099 -10.19 - - 
10 5.34%         762 -17.90 - - 
11 8.58%     1,226 -18.10 - - 
12 0.01%             1 -19.20 - - 
17 0.01%             2 -22.40 - - 
20 1.56%         223 -27.98 12.17%      208 -30.46 
21 0.01%             2 -25.50 0.12%             2 -27.40 
22 10.73%   1,532 -28.97 87.71%   1,499 -30.87 
Total 
Minima 





NM_001618.3 vs.  rs8679 
miRNA: miR-145-5p 
SNP Pos. 607 
Target site: 592-614 
5. PARP1 (L = 769) 
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Local Minima with Less Pairings 
 U-allele C-allele 
#LM Less Pairings:  79.1%   11,295 12.29%      210 
Avg. Target Site 
Energy  
-9.76 -30.43 
Less Pairings Avg. 
Barrier Height  
1.42 1.51 
 
Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 U-allele C-allele 
Less  79.1%   11,295  12.3%      902  
Equal  8.6%        1,226  42.2%      807  
Less or 
Equal  
87.7%   12,521  100%    1,709  
 
N+ Test 
U-allele - Local Minima Distribution 













12*2.50, 2*2.00 2.43 8*-18.10, 6*-17.90 -18.01 
-186.50 18 10*2.60, 4*2.40, 
4*2.00 







2.32 4*-29.22, 6*-18.10, 2*-17.90 -12.77 
-186.70 6 
(11) 
2*2.80, 4*2.40 2.53 4*29.22, 2*-17.90 -25.45 
-186.80 4 2.90, 2.70, 2*2.60 2.70 4*-29.22 -29.22 
-186.90 1 3.00 3.00 -18.10 -18.10 
MFE: 
-186.90 




104 238 2.29 1867.36 -17.96 
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N+ Test 
C-allele - Local Minima Distribution 













2.10 4*-30.52, 16*-31.12, 12*-30.62 -30.86 
-188.10 24 12*2.40, 4*2.10, 
4*1.70, 4*1.50 





1.90 12*-30.62 -30.62 
-188.40 4 4*2.40 2.40 4*-31.12 -31.12 
-188.50 4 
(11) 
2.80, 2.70, 2*2.60 2.68 4*-31.12 -31.12 
-188.60 4 4*2.40 2.40 4*-31.12 -31.12 
-188.70 3 2.70, 2*2.60 2.63 3*-31.12 -31.12 
MFE: 
-188.70 




124 262.8 2.12 3827.68 -30.87 
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Ordered by Deepest Local Minima 
U-allele  
Barrier #LM Opening 
Avg. 
Opening 
3.00 1 -18.10 -18.10 
2.90 1 -29.22 -29.22 
2.80 2 2*-17.90 -17.90 
2.70 7 (11) 4*-18.10, 3*-29.22 -22.87 
2.60 14 (25) 4*-8.80, 4*-10.20, 2*-18.10, 4*-29.22 -16.36 
2.50 12 4*-17.90, 8*-18.10 -18.03 
2.40 32 (69) 6*-8.80, 6*-10.20, 2*-17.90, 6*-18.10, 4*-28.72, 8*-29.22 -18.97 
2.30 54 
(123) 
4*-8.50, 12*8.80, 12*-10.20, 8*-17.90, 6*-18.10, 4*-28.72, 8*-29.22 -15.97 
 










Barrier #LM Opening 
Avg. 
Opening 
2.80 1 -31.12 -31.12 
2.70 2 2*-31.12 -31.12 
2.60 4 4*-31.12 -31.12 
2.50 4 (11) 4*-30.62 -30.62 
2.40 20 (31) 16*-31.12, 4*30.62 -31.02 
2.30 20 16*-31.12, 4*-30.62 -31.02 
2.20 20 (71) 16*-31.12, 4*-30.62 -31.02 
2.10 64 
(135) 
16*-30.52, 48*-31.12 -30.97 
 
C-allele - Averages 
Test 
#LM-MFE 


































135 301/135 -4183.60/116 
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Ordered by Opening Energy 
 
U-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-8.50 1,300 4*2.30, 6*2.10, 16*2.00, 13*1.90, 48*1.80, 109*1.70, 64*1.60, 
161*1.50, 183*1.40, 213*1.30, 483*1.20 
1.39 
-8.80 6,134 4*2.60, 6*2.40, 12*2.30, 10*2.20, 32*2.10, 172*2.00, 166*1.90, 




U-allele - Averages 
Test 
#LM-MFE 



















C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-27.40 2 2*1.30 1.30 
-27.50 4 2*1.40, 2*1.30 1.35 
-30.02 24 16*1.50, 8*1.30 1.43 
-30.12 40 16*1.50, 8*1.40, 16*1.30  1.40 
-30.52 184 40*2.10, 24*1.60, 40*1.50, 44*1.40, 36*1.30 1.58 
 
C-allele - Averages 
Test 
#LM-MFE 
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RNAsubopt and Barrier Setting 
Offset  Barrier  G-allele  A-allele  G-allele  A-allele  
2.7 0.8 11,404,145 11,362,245 79,577 79,273 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
G-allele -26.60 -4.421 -10.641 -15.959 



















Less/Equal Pairings than MFE 
#Pairings  #Minima  
G-allele  
Target Site 




Approx. Avg.  
10 0.34%      272 -7.56 0 - 
Total: 0.34%      272 -7.56 0 - 
Avg. Barrier:  1.01  -  
 
Local Minima with Less or Equal Approx.  
Target Site Energy than the MFE 
 G-allele A-allele 
Less 7%            5,600 6.7%        5,328 
Equal 92.9%    73,943 93.3%    73,943 
Less or 
Equal  




NM_001145853.1 vs.   rs1046322 
miRNA: miR-668-3p 
SNP Pos. 253 
Target site: 234 - 258 
MFE  G -allele A-allele 
#Pairings  12 12 
Opening Energy  -15.72 -15.72 
Structure Energy  -290.70 -290.70 
MFE Barrier  2.70 2.70 
Minima  
Less Pairings  0.34%         272 0% 
Equal Pairings  92.9%   73,943 93.3%   73,943 
Greater Pairings  6.74%     5,360 6.7%       5,328 
Target Site 
Identical to MFE  
92.9%   73,943 93.3%   73,943 
Minima (- MFE)  79,575 79,271 
Avg. Opening of 
All Local Minima 
(excluding MFE) 
-15.64 -15.67 
6. WFS1 (L = 797) 
Page 37 of 75 
 
N+ Test 
G-allele Local Minima Distribution 




-290.50 96 16*2.50, 16*2.30, 
32*1.90, 32*1.30 
1.87 96*-15.72 -15.72 
-290.60 64 32*2.60, 16*1.90, 
16*1.30 
2.10 64*-15.72 -15.72 
MFE: 
-290.70 
16 16*2.70 2.70 16*-15.72 -15.72 
 







10 -290.70 2.70 -15.72 
20 -290.68 2.50 -15.72 
60 -290.63 2.44 -15.72 
100 -290.59 2.15 -15.72 
 
N+ Test 
A-allele Local Minima Distribution 




-290.50 96 16*2.50, 16*2.30, 
32*1.90, 32*1.30 
1.87 96*-15.72 -15.72 
-290.60 64 32*2.60, 16*1.90, 
16*1.30 
2.10 64*-15.72 -15.72 
MFE: 
-290.70 
16 16*2.70 2.70 16*-15.72 -15.72 
 







10 -290.70 2.70 -15.72 
20 -290.68 2.50 -15.72 
60 -290.63 2.44 -15.72 
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Ordered by Deepest Local Minima 
G-Allele 
Barrier  #LM  Opening  Avg. 
Opening  
2.70 15 -15.72 -15.72 
2.60 32 -15.72 -15.72 
2.50 16 -15.72 -15.72 
2.40 16 -15.72 -15.72 
2.30 80 -15.72 -15.72 
 






Barrier  #LM  Opening  Avg. 
Opening  
2.70 15 -15.72 -15.72 
2.60 32 -15.72 -15.72 
2.50 16 -15.72 -15.72 
2.40 16 -15.72 -15.72 
2.30 80 -15.72 -15.72 
 























Avg. Barrier Avg. Opening 
Energy 
10 2.70 -15.72 
20 2.68 -15.72 
60 2.65 -15.72 
100 2.50 -15.72 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening 
Energy 
10 2.70 -15.72 
20 2.68 -15.72 
60 2.65 -15.72 
100 2.50 -15.72 
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Ordered by Opening Energy 
G-allele 






-7.30 32 32*0.90 0.90 -288.90 -288.90 










G-allele - Averages 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening Energy 
10 0.90 -7.30 
20 0.90 -7.30 
60 0.90 32*-7.30, 28*-7.60 
Avg. -7.44 
































A-allele - Averages 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening 
Energy 
10 0.90 -14.92 
20 0.90 -14.92 
60 0.90 -14.92 
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 C-allele A-allele 
Target Site: 291 - 310 291 - 308 
 
RNAsubopt and Barrier Setting 
Offset Barrier C-allele A-allele C-allele A-allele 
2.0 1.2 396,014 756,122 964 1,080 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
C-allele -24.70 0.00 -25.82 1.12 
A-allele -20.70 -0.05 -21.40 0.70 
 
Local Minima 
MFE  C-allele A-allele 
#Pairings  17 15 
Opening Energy -25.90 -21.70 
Structure Energy  -228.40 -224.60 
MFE Barrier  2.00 2.00 
Minima  
Less Pairings  0.0%                     0 35.6%               384 
Equal Pairings  100%                963 64.4%               695 
Greater Pairings  0.0%                     0 0.0%                     0 
Identical to MFE  100%                963 64.4%               695 
Minima (- MFE)  963 1,079 
Avg. Opening of 




#Pairings  #Minima  
C-allele  
Target Site 




Approx. Avg.  
12  -  -  29.7%      320 -12.50 
13  -  -  5.9%          64 -13.10 
14  -  -  - - 
15  -  -  64.4%      695 -21.70 
16  -  -  - - 
17  100%       963  -25.90  - - 
Total 
Minima  
100%       963  -25.90  100%   1,079 -18.46 






NM_144701.2 vs. rs10889677 
miRNA: let-7e 
SNP Pos. 309 
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Local Minima with Less Pairings 
 C-allele A-allele 
#LM Less Pairings:  0.0% 35.6%         384 
Avg. Target Site 
Energy  
- -12.60 
Less Pairings Avg. 
Barrier Height  
- 1.40 
 
Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 C-allele A-allele 
Less  0.0%               0 35.6%      384 
Equal  100%          963 64.4%      695 
Less or 
Equal  
100%          963 100%    1,079 
 
N+ Test 
C-allele - Local Minima Distribution 






40*1.70 1.70 40*-25.90 -25.90 
-228.20 32 32*1.70 1.70 32*-25.90 -25.90 
-228.30 32 
(63) 
32*1.90 1.90 32*-25.90 -25.90 
-228.40 31 
(31) 
31*2.00 2.00 31*25.90 -25.90 
MFE 
-228.40 




136 247.2 1.80 3522.4 -25.90 
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N+ Test 
A-allele - Local Minima Distribution 






40*1.70 1.70 40*-21.70 -21.70 
-224.40 32 32*1.70 1.70 32*-21.70 -21.70 
-224.50 32 
(63) 
32*1.90 1.90 32*-21.70 -21.70 
-224.60 31 
(31) 
31*2.00 2.00 31*-21.70 -21.70 
MFE: 
-224.60 




136 247.2 1.82 2951.2 -21.70 
 
































Ordered by Deepest Local Minima 
C-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.00 31 31*-25.90 -25.90 
1.90 32 32*-25.90 -25.90 
1.80 72 72*-25.90 -25.90 
 






























7. IL23R (L = 851) 





Barrier #LM Opening 
Avg. 
Opening 
2.00 31 31*-21.70 -21.70 
1.90 32 32*-21.70 -21.70 
1.70 72 72*-21.70 -21.70 
 










Ordered by Opening Energy 
C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-25.90 963 31*2.00, 32*1.90, 72*1.70, 56*1.50, 232*1.40, 200*1.30, 340*1.20 1.37 
 
C-allele - Averages 
Test 
#LM-MFE 



















A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-12.50 320 128*1.30, 64*1.40, 64*1.50, 64*1.60 1.42 
 
A-allele - Averages 
Test 
#LM-MFE 
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 A-allele G-allele 
Target Site: 835 - 857 830 - 857 
 
RNAsubopt and Barrier Setting 
Offset Barrier A-allele G-allele A-allele G-allele 
2.3 1.2 13,569,252 5,006,010 19,936 2,628 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
A-allele -14.80 -1.22 -11.42 -3.38 
G-allele -15.30 -0.19 -19.65 4.35 
 
Local Minima 
MFE A-allele G-allele 
#Pairings 7 14 
Opening Energy -10.85 -11.60 
Structure Energy -186.60 -188.40 
MFE Barrier 2.30 2.30 
 
Minima 
Less Pairings 1.6%                 324  0.0%                      0 
Equal Pairings 56.3%         11,227  96.6%            2,537 
Greater Pairings 42.1%            8,384  3.4%                   90 
Identical to MFE 56.2%         11,203  90.6%            2,379 
Minima (- MFE) 19,935  2,627 
Avg. Opening of 













6 1.6%           324 -9.19 - -  
7 56.3%   11,227 -10.85 - -  
8 36.7%      7,322  -11.09 - -  
9 5.3%        1,062  -11.28 - -  
10 - - - - 
11 - - - - 
12 - - - - 
13 - - - - 
14 - - 2,537 -11.57 
Total 
Minima 
19,935 -10.93 2,537 -11.57 
Avg. Barrier 1.42  1.44  
NM_001036.3 vs. rs1044129 
miRNA: miR-367 
SNP Pos: 839 
9. RYR3 (L = 880) 
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Local Minima with Less Pairings 
 A-allele G-allele 
#LM Less Pairings: 1.6%           324 0 
Avg. Target Site 
Energy 
-9.19 - 




Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 A-allele G-allele 
Less 19.1%     3,816 5.3%           140 
Equal 56.2%   11,203 90.6%      2,379 
Less or Equal 73.3%   15,019 95.9%     2,519 
 
N+ Test 
A-allele - 100 Local Minima Distribution 















1.79 12*-11.58, 60*-10.85 -10.97 
-186.60 23 
(23) 
15*2.30, 8*1.40 1.99 23*-10.85 -10.85 
MFE: 
-186.60 




186 332.8 1.79 2048.76 -11.01 
 





































9. RYR3 (L = 880) 





G-allele - Local Minima Distribution 












4*1.60, 16* 1.40 





1.76 18*-11.60 -11.60 
-188.30 6 4*2.20, 2*1.40  1.93 6*-11.60 -11.60 
-188.40 5 3*2.30, 2*1.40  1.94 5*-11.60 -11.60 
MFE: 
-188.40 




140 245.4 1.75 -1624 -11.60 
 
































Ordered by Deepest Local Minima 
A-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.30 15 15*-10.85 -10.85 
2.20 24 24*-10.85 -10.85 
2.10 24 24*-10.85 -10.85 
2.00 136 104*-10.85, 32*-11.58 -11.02 
 
A-allele - Averages 
Test 
#LM-MFE 














9. RYR3 (L = 880) 





Barrier #LM Opening 
Avg. 
Opening 
2.30 3 3*-11.60 -11.60 
2.20 4 4*-11.60 -11.60 
2.10 8 8*-11.60 -11.60 
2.00 24 24*-11.60 -11.60 
1.90 34 34*-11.60 -11.60 
1.80 62 62*-11.60 -11.60 
 










Ordered by Opening Energy 
A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-8.39 24 24*1.30 1.30 
-9.19 324 16*1.60, 40*1.50, 88*1.40,  180*1.30  1.37 
 
A-allele - Averages 
Test 
#LM-MFE 



















G-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
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G-allele - Averages 
Test 
#LM-MFE 
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 A-allele C-allele 
Target Site: 57 - 90 57 - 90 
 
RNAsubopt and Barrier Setting 
Offset Barrier A-allele C-allele A-allele C-allele 
2.3 0.8 546,284 2,147,815 2,309 14,944 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
A-allele -20.90 -0.577 -28.561 7.661 



















Less/Equal Pairings than MFE 
#Pairings  #Minima  
A-allele  
Target Site 




Approx. Avg.  
18 8.1%        186 -17.90 0 - 
22 91.9%  2,122 -18.60 0 - 
24 0 - 100% 14,943 -21.30 
Total: 2,308 -18.54 14,943 -21.30 









NM_032049.3 vs.  rs5186 
miRNA: miR-155-5p 
SNP Pos: 86 
MFE  A -allele C-allele 
#Pairings  22 24 
Opening Energy  -18.60 -21.30 
Structure Energy  -188.00 -188.80 
MFE Barrier  2.30 2.30 
Minima  
Less Pairings  8.1%           186 0% 
Equal Pairings  91.9%     2,122 100%    14,943 
Greater Pairings  0% 0% 
Target Site 
Identical to MFE  
45.8%     1,058 25%         3,735 
Minima (- MFE)  2,308 14,943 
Avg. Opening of 
All Local Minima 
(excluding MFE) 
-18.54 -21.30 
9. AGTR1 (L = 888) 
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Local Minima with Less Pairings 
 A-allele C-allele 
#LM Less Pairings:  8.1%        186 0% 
Avg. Target Site 
Energy  
-17.90 - 
Less Pairings Avg. 
Barrier Height  
0.97 - 
 
Local Minima with Less or Equal Approx.  
Target Site Energy than the MFE 
 A-allele C-allele 
Less 8.3%           191 0% 
Equal 91.7%     2,117 100%    14,943 
Less or 
Equal  
100%      2,308 100%    14,943 
 
N+ Test 
A-allele Local Minima Distribution 








1.49 44*-18.60 -18.60 





1.49 22*-18.60 -18.60 
-187.41 6 3*1.71, 2*1.60 1.39 6*-18.60 -18.60 
-187.50 14 10*1.80, 2*1.60, 
2*1.40 
1.71 14*-18.60 -18.60 
-187.51 2 2*1.81 1.81 2*-18.60 -18.60 
-187.60 10 4*1.90, 6*1.40 1.60 110*-18.60 -18.60 





1.75 8*-18.60 -18.60 
-187.71 2 2*2.01 2.01 2*-18.60 -18.60 
-187.80 4 
(10) 
2*2.10, 2*1.40 1.75 4*-18.60 -18.60 
-187.90 4 2*2.20, 2*1.40 1.80 4*-18.60 -18.60 
-188.00 
MFE 
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C-allele Local Minima Distribution 








1.72 48*-21.30 -21.30 




















120 191.4/120 1.60 -2556/120 -21.30 
 




























Ordered by Deepest Local Minima 
A-Allele 
Barrier  #LM  Opening  Avg. 
Opening  
2.30 2 2*-18.60 -18.60 
2.20 2 2*-18.60 -18.60 
2.10 2 2*-18.60 -18.60 
2.01 2 2*-18.60 -18.60 
9. AGTR1 (L = 888) 





1.91 2 2*-18.60 -18.60 




1.80 10 10*-18.60 -18.60 
1.71 4 4*-18.60 -18.60 
1.70 10 10*-18.60 -18.60 
1.61 2 2*-18.60 -18.60 
1.60 36 
(82) 
34*-18.60, 2*-17.90 -18.56 
1.51 10 10*-18.60 -18.60 
1.50 30 
(122) 
28*-18.60, 2*-17.90 -18.55 
 
A-Allele - Averages 
Test  
#LM-MFE  





24  40.26/20 
2.01 
-18.60 
83  125.92/82 
1.54 
-18.58 





Barrier  #LM  Opening  Avg. 
Opening  







2.01 8 -21.30 -21.30 
2.00 16 -21.30 -21.30 









C-Allele - Averages 
Test  
#LM-MFE  





9. AGTR1 (L = 888) 












Ordered by Opening Energy 
A-Allele 
Opening  #LM  Barrier  Avg. 
Barrier  
-17.30 5 1.00, 2*0.90, 2*0.80 0.88 
-17.90 186 2*1.60, 2*1.50, 6*1.40, 2*1.31, 8*1.30, 
2*1.21, 10*1.20, 2*1.11, 14*1.10, 




A-allele - Averages 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening 
Energy 
10 1.19 -17.60 
20 1.28 -17.90 
60 1.20 -17.90 
100 1.10 -17.90 
 
C-Allele 
Opening  #LM  Barrier  Avg. 
Barrier  
-21.30 14,943 8*2.30, 8*2.20, 8*2.10, 8*2.01, 
16*2.00, 8*1.91, 20*2.00, 8*1.81, 
92*1.80, 24*1.71, 76*1.70, 16*1.61, 
196*1.60, 52*1.51, 132*1.50, 64*1.41, 
704*1.40, 104*1.31, 520*1.30, 96*1.21, 
600*1.20, 204*1.11, 1696*1.10, 
220*1.01, 2204*1.00, 428*0.91, 
3092*0.90, 592*0.81, 3748*0.80 
1.00 
 
C-allele - Averages 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening 
Energy 
10 2.15 -21.30 
20 1.94 -21.30 
60 1.80 -21.30 
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10. FGF20 (L = 903) 
 
 
 C-allele U-allele 
Target Site: 166 - 187 166 - 187 
 
RNAsubopt and Barrier Setting 
Offset  Barrier  C-allele  U-allele  C-allele  U-allele  
2.3 0.8 1,213,806 2,514,455 5,937 7,784 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
C-allele -14.50 -2.356 -9.274 -5.226 



















Less/Equal Pairings than MFE 
#Pairings  #Minima  
C-allele  
Target Site 




Approx. Avg.  
6 0.1%                6 -5.80 1.7%        132 -5.80 
7 0.5%              28 -6.80 5.8%        450 -6.79 
9 51.3%      3,048 -4.10 0 - 
10 30.4%      1,804 -7.66 92.5%  7,201 -9.11 
Total: 82.3%      4,886 -5.43 100%   7,783 -8.92 
Avg. Barrier:  0.97  1.05  
 
Local Minima with Less Pairings 
 C-allele U-allele 
#LM Less Pairings:  0.6%          34 7.5%        582 
Avg. Target Site 
Energy  
-6.62 -6.57 
NM_019851.2 vs. rs12720208 
miRNA:       miR-433-3p 
SNP Pos.       182 
MFE  C -allele U-allele 
#Pairings  9 10 
Opening Energy  -4.10 -7.30 
Structure Energy  -159.50 -158.90 
MFE Barrier  2.30 2.30 
Minima  
Less Pairings  0.6%             34 7.5%           582 
Equal Pairings  51.3%     3,048 92.5%     7,201 
Greater Pairings  48.1%     2,854 0% 
Target Site 
Identical to MFE  
50.9%     3,020 89%         6,927 
Minima (- MFE)  5,936 7,783 
Avg. Opening of 
All Local Minima 
(excluding MFE) 
-6.40 -8.92 
10. FGF20 (L = 903) 
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Less Pairings Avg. 
Barrier Height  
0.88 1.03 
 
Local Minima with Less or Equal Approx.  
Target Site Energy than the MFE 
 C-allele U-allele 
Less 0.7%            42 11%           856 
Equal 50.9%    3,020 44.5%    3,463 
Less or 
Equal  
51.6%    3,062 55.5%    4,319 
 
N+ Test 
C-allele Local Minima Distribution 















1.59 4*-11.10, 2*-10.60, -8.10, -7.30,  
37*-4.10 
-5.17 
-159.00 23 18*1.80, 3*1.20, 
2*0.90 





1.70 -11.10, 11*-4.10  -4.68 
-159.20 7 
(13) 
6*2.00, 1.20 1.88 7*-4.10 -4.10 
-159.30 3 3*2.10 2.10 3*-4.10 -4.10 
-159.40 2 2*2.20 2.20 2*-4.10 -4.10 
MFE: 
-159.50 




163 259.9 1.59 -841.1 -5.16 
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N+ Test 
U-allele Local Minima Distribution 














1.68 14*-11.10, 14*-7.30 -9.20 
-158.70 16 
(22) 
14*2.00, 2*1.20 1.90 8*-11.10, 8*-7.30 -9.20 
-158.80 4 4*2.20 2.20 2*-11.10, 2*-7.30 -9.20 
MFE: 
-158.90 




101 173.4 1.71 926.8 -9.20 
 


























Ordered by Deepest Local Minima 
C-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.20 2 2*-4.10 -4.10 






8*-4.10, 1*-11.10 -4.88 
1.80 18 15*-4.10, 1*-10.60, 2*-11.10 -5.24 
1.70 35 
(73) 
26*-4.10, 1*-4.30, 1*-8.10, 1*-7.30, 2*-10.60, 4*-11.10  -5.25 
1.60 55 
(128) 
38*-4.10, 2*-4.30, 2*-7.30, 2*-8.10, 3*-10.60, 8*-11.10 -5.74 
 
C-allele - Averages 
Test 
#LM-MFE 
Avg. Barrier Avg. Opening 
Energy 
11 2.06 -4.10 
20 1.99 -4.45 
73 1.80 -5.14 
10. FGF20 (L = 903) 




Barrier  #LM  Opening  Avg. 
Opening  
2.30 1 -11.10 -11.10 
2.20 4 2*-11.10, 2*-7.30 -9.20 
2.10 6 
(11) 
3*-11.10, 3*-7.30 -9.20 
2.00 14 
(25) 
7*-11.10, 7*-7.30 -9.20 
1.90 18 9*-11.10, 9*-7.30 -9.20 
1.80 39 
(82) 
19*-11.10, 19*-7.30, -6.80 -9.14 
1.70 66 
(148) 
32*-11.10, 32*-7.30, 2*-6.80, -9.13 
 
U-Allele - Averages 
Test  
#LM-MFE  
Avg. Barrier  Avg. Opening 
Energy  







148 1.81 -9.16 
 
Ordered by Opening Energy 
C-Allele 
Opening  #LM  Barrier  Avg. 
Barrier  
-3.70 14 1.10, 2*1.00, 3*0.90, 8*0.80 0.87 
-3.80 28 6*1.00, 8*0.90, 14*0.80 0.87 
-4.10 3,020 2*2.20, 3*2.10, 6*2.00, 8*1.90, 
15*1.80, 26*1.70, 38*1.60, 53*1.50, 
80*1.40, 104*1.30, 302*1.20, 1.14, 
278*1.10, 2*1.04, 408*1.00, 3*0.94, 




Opening  #LM  Barrier  Avg. 
Barrier  
-2.90 1 0.90 0.90 
-5.80 132 1.60, 2*1.50, 3*1.40, 6*1.30, 11*1.20, 
18*1.10, 33*1.00, 58*0.90 
1.02 
 
128 1.72 -5.40 
11. HOXB5 (L = 952) 
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RNAsubopt and Barrier Setting 
Offset Barrier G-allele A-allele G-allele A-allele 
2.0 0.8 1,383,237 480,436 6,481 3,746 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
G-allele -21.90 -0.49 -13.61 -8.29 
A-allele -22.40 -1.39 -11.20 -11.20 
 
Local Minima 
MFE G-allele A-allele 
#Pairings 15 15 
Opening Energy -17.60 -18.30 
Structure Energy -302.70 -302.40 
MFE Barrier 2.00 2.00 
 
Minima 
Less Pairings 0.2%          16 1.4%          54 
Equal Pairings 99.8%   6,464 98.6%  3,691 
Greater Pairings 0 0 
Identical to MFE  84.9%   5,504 98.6%  3,691 
Minima (- MFE) 6,480 3,745 
Avg. Opening of 












9 - - 1.44%        54 -12.20 
12 0.2%              16 -13.95 - - 
15 99.8%      6,464 -17.65 98.6%  3,691 -18.30 
Total 
Minima 
6,480  3,745  
Avg. Barrier 1.00  0.94  
 
Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 G-allele A-allele 
Less 4.0%           262 1.4%          54 
Equal 84.9%      5,504 98.6%   3,691 
Less or Equal 88.98%   5,766 100%    3,745 
 
 
NM_002147.3 vs. rs9299 
miRNA: miR-7 
SNP Pos: 141 
Target site: 126 - 154 
11. HOXB5 (L = 952) 
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N+ Test 
G-allele - Local Minima Distribution 






58*1.60 1.60 4*-18.30, 54*-17.60 -17.65 
-302.40 22 
(51) 
22*1.70 1.70 4*-18.30, 18*-17.60 -17.73 
-302.50 12 
(29) 
12*1.80 1.80 12*-17.60 -17.60 
-302.60 12 
(17) 
12*1.90 1.90 12*-17.60 -17.60 
-302.70 5 5*2.00 2.00 5*-17.60 -17.60 
MFE: 
-302.70 
1 2.00 2.00 -17.60 -17.60 
 
































A-allele - Local Minima Distribution 


















1.35 12*-18.30 -18.30 
-302.20 12 
(19) 
10*1.80, 2*1.40 1.73 12*-18.30 -18.30 
-302.30 4 4*1.90 2.00 4*-18.30 -18.30 
-302.40 3 3*2.00 2.00 3*-18.30 -18.30 
MFE: 
-302.40 
1 2.00 2.00 -18.30 -18.30 
 













31 -9368/31 50.6/31 -567.3/31 
11. HOXB5 (L = 952) 
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Ordered by Deepest Local Minima 
G-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.00 5 5*-17.60 -17.60 
1.90 12 12*-17.60 -17.60 
1.80 12 12*-17.60 -17.60 
1.70 22 22*-17.60 -17.60 
1.60 54 54*-17.60 -17.60 
 










Barrier #LM Opening 
Avg. 
Opening 
2.00 3 3*-18.30 -18.30 
1.90 4 4*-18.30 -18.30 
1.80 10 10*-18.30 -18.30 
1.70 6 6*-18.30 -18.30 
1.60 38 38*-18.30 -18.30 
1.50 32 32*-18.30 -18.30 
1.40 114 114*-18.30 -18.30 
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Ordered by Opening Energy 
G-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-13.95 16 2*1.10, 6*1.00, 8*0.90 0.96 
-17.00 246 6*1.40, 12*1.30, 12*1.20, 18*1.10, 54*1.00, 102*0.90, 42*0.80 0.97 
 
G-allele - Averages 
Test 
#LM-MFE 



















A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-12.20 54 6*1.10, 12*1.00, 12*0.90, 24*0.80 0.90 
-18.30 3691 3*2.00, 4*1.90, 10*1.80, 6*1.70, 38*1.60, 32*1.50, 114*1.40, 
96*1.30, 246*1.20, 222*1.10, 522*1.00, 680*0.90, 1718*0.80 
0.94 
 
A-allele - Averages 
Test 
#LM-MFE 
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RNAsubopt and Barrier Setting 
Offset Barrier G-allele A-allele G-allele A-allele 
2.2 1.2 9,020,624 11,874,784 3,850 6,291 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
G-allele -28.60 -0.56 -14.30 -14.31 
A-allele -22.00 -1.20 -15.00 -7.00 
 
Local Minima 
MFE G-allele A-allele 
#Pairings 6 6 
Opening Energy -6.60 -4.70 
Structure Energy -285.90 -284.00 
MFE Barrier 2.20 2.20 
 
Minima 
Less Pairings 0.0%                      0 0.0%                      0 
Equal Pairings 100%             3,849 93.9%            5,907 
Greater Pairings 0.0%                      0 6.1%                 383 
Identical to MFE 100%             3,849 93.3%            5,867 
Minima (- MFE) 3,849 6,290 
Avg. Opening of 




Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 G-allele  A-allele  
Less 0.0%                0 0.6%             40 
Equal 100%       3,849 93.3%      5,867 
Less or Equal 100%       3,849 93.9%     5,907 
 
N+ Test 
G-allele - Local Minima Distribution 
















1.83 33*-6.60 -6.60 
NM_002875.4 vs. rs7180135 
miRNA: miR-197-3p 
SNP Pos: 718 
Target site: 707 - 725 
12. RAD51 (L = 978) 
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-285.70 2 2.00, 1.80 1.90 2*-6.60 -6.60 
-285.90 3 2*2.10, 1.80 2.00 3*-6.60 -6.60 
MFE: 
-285.90 




377 655.10 1.74 -2488.19 -6.60 
 
































A-allele - Local Minima Distribution 


















1.83 33*-4.70 -4.70 
-283.80 2 2.00, 1.80 1.90 2*-4.70 -4.70 
-283.90 3 2*2.10, 1.80 2.00 3*-4.70 -4.70 
MFE: 
-284.00 




380 659.20 1.73 1786.89 -4.70 
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Ordered by Deepest Local Minima 
G-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.10 2 2*-6.60 -6.60 
2.00 1 -6.60 -6.60 
1.90 24 24*-6.60 -6.60 
1.80 101 101*-6.60 -6.60 
 










Barrier #LM Opening 
Avg. 
Opening 
2.10 2 2*-4.70 -4.70 
2.00 1 -4.70 -4.70 
1.90 24 24*-4.70 -4.70 
1.80 101 101*-4.70 -4.70 
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Ordered by Opening Energy 
G-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-6.60 3,849 2*2.10, 2.00, 24*1.90, 101*1.80, 243*1.70, 238*1.60, 446*1.50, 
914*1.40, 1306*1.30, 574*1.20 
1.39 
 
G-allele - Averages 
Test 
#LM-MFE 



















A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-3.70 1 1.20 1.20 
-4.00 39 1.50, 3*1.40, 2*1.30, 33*1.20  1.23 
-4.70 5867 2*2.10, 2.00, 24*1.90, 101*1.80, 243*1.70, 238*1.60, 446*1.50, 
914*1.40, 1306*1.30, 2592*1.20 
1.33 
 
A-allele - Averages 
Test 
#LM-MFE 

























13. ORA1 (L = 1034) 
Page 67 of 75 
 





 C-allele U-allele 
Target Site: 69 - 88 81 - 102 
 
RNAsubopt and Barrier Setting 
Offset Barrier C-allele U-allele C-allele U-allele 
2.0 0.9 223,532 559,335 577 1,332 
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
U-allele -17.90 -0.02 -23.42 5.62 
C-allele -16.70 -4.32 -9.49 -7.21 
 
Local Minima 
MFE C-allele U-allele 
#Pairings 6 16 
Opening Energy -5.40 -27.21 
Structure Energy -403.50 -405.20 
MFE Barrier 2.00 2.00 
 
Minima 
Less Pairings 0.0%                     0 1.4%                   18 
Equal Pairings 100%                576 98.6%           1,313 
Greater Pairings 0.0%                     0 0.0%                     0 
Identical to MFE 100%                576 49.3%              656 
Minima (- MFE) 576 1,331 
Avg. Opening of 




#Pairings  #Minima  
C-allele  
Target Site 




Approx. Avg.  
5 100%       576 -5.40 - - 
... - - - - 
15  - - 1.4%          18 -26.29 
16  - - 98.65   1,313 -27.21 
Total 
Minima  
100%       576 -5.40 100%   1,331 -27.20 







NM_032790.3 vs. rs76753792 
miRNA: miR-519a-3p 
SNP Pos: 86 
13. ORA1 (L = 1034) 
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Local Minima with Less Pairings 
 C-allele U-allele 
#LM Less Pairings: 0.0% 1.4%             18 
Avg. Target Site 
Energy 
- -26.29 




Local Minima with Less/Equal Approx.  
Target Site Energy than the MFE 
 C-allele U-allele 
Less 0.0%                0 1.4%             18 
Equal 100%          576 98.6%      1,313 
Less or Equal 100%          576 100%       1,331 
 
C-allele - Local Minima Distribution 








1.27 35*-5.40 -5.40 
-403.00 32 18*1.50, 4*1.10, 
10*1.00 
1.29 36*-5.40 -5.40 
-403.10 26 
(65) 
22*1.60, 4*1.00 1.51 26*-5.40 -5.40 
-403.20 22 
(39) 
12*1.70, 10*0.90 1.34 22*-5.40 -5.40 
-403.30 4 4*1.80 1.80 4*-5.40 -5.40 
-403.40 10 
(13) 
10*1.90 1.90 10*-5.40 -5.40 
-403.50 3 3*2.00 2.00 3*-5.40 -5.40 
MFE: 
-403.50 




133 188.6 1.42 -718.20 -5.40 
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U-allele - Local Minima Distribution 






44*1.60, 8*1.00 1.51 52*-27.21 -27.21 
-404.90 24 
(59) 
24*1.70 1.70 24*-27.21 -27.21 
-405.00 8 8*1.80 1.80 8*-27.21 -27.21 
-405.10 20 
(27) 
20*1.90 1.90 20*-27.21 -27.21 
-405.20 7 7*2.00 2.00 7*-27.21 -27.21 
MFE: 
-405.20 




112 187.6 1.68 -3047.52 -27.21 
 


























Ordered by Deepest Local Minima 
C-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.00 3 3*-5.40 -5.40 
1.90 10 10*-5.40 -5.40 
1.80 4 4*-5.40 -5.40 
1.70 12 12*-5.40 -5.40 
1.60 22 22*-5.40 -5.40 
1.50 18 18*-5.40 -5.40 
1.40 21 21*-5.40 -5.40 
1.30 38 38*-5.40 -5.40 
 
C-allele - Averages 
Test 
#LM-MFE 














128 193.6/128 -691.19/100 
13. ORA1 (L = 1034) 





Barrier #LM Opening 
Avg. 
Opening 
2.00 7 7*-27.21 -27.21 
1.90 20 20*-27.21 -27.21 
1.80 8 8*-27.21 -27.21 
1.70 24 24*-27.21 -27.21 
1.60 44 44*-27.21 -27.21 
 








Ordered by Opening Energy 
C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-5.40 576 3*2.00, 10*1.90, 4*1.80, 12*1.70, 22*1.60, 18*1.50, 21*1.40, 
38*1.30, 4*1.20, 131*1.10, 181*1.00, 83*1.20, 49*0.90 
1.16 
 
C-allele - Averages 
Test 
#LM-MFE 



















U-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-26.31 18 4*1.10, 14*1.00 1.02 
-27.21 1313 7*2.00, 20*1.90, 8*1.80, 24*1.70, 44*1.60, 36*1.50, 42*1.40, 
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U-allele - Averages 
Test 
#LM-MFE 
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RNAsubopt and Barrier Setting 
Offset Barrier C-allele A-allele C-allele A-allele 
2.0  0.9  1,689,428  1,689,428  238  238  
 
STarMir Target Site Energies 
 dG_hybrid dG_nucl dG_open dG_total 
C-allele -16.70 -3.97 -5.40 -11.30 
A-allele -21.30 -6.97 -5.05 -16.25 
 
Local Minima 
MFE C-allele A-allele 
#Pairings 12 12 
Opening Energy -5.10 -5.10 
Structure Energy -197.80 -197.80 
MFE Barrier 2.00 2.00 
 
Minima 
Less Pairings 0.0% 0.0% 
Equal Pairings 100%                237 100%                237 
Greater Pairings 0.0% 0.0% 
Identical to MFE 100%                237 100%                237 
Minima (- MFE) 237 237 
Avg. Opening of 




C-allele - Local Minima Distribution 






46*1.10 1.10 46*-5.10 -5.10 
-197.00 30 30*1.20 1.20 30*-5.10 -5.10 
-197.10 28 
(67) 
22*1.30, 6*0.90 1.21 28*-5.10 -5.10 
-197.20 12 10*1.40, 2*1.30 1.38 12*-5.10 -5.10 
-197.30 10 
(27) 
10*1.50 1.50 10*-5.10 -5.10 
-197.40 8 6*1.60, 2*1.50 1.58 8*-5.10 -5.10 
-197.50 6 6*1.70 1.70 6*-5.10 -5.10 
-197.70 2 2*1.90 1.90 2*-5.10 -5.10 
-197.80 1 2.00 2.00 -5.10 -5.10 
MFE: 
-197.80 
1 2.00 2.00 -5.10 -5.10 
NM_02884.2 vs. rs6573 
miRNA: miR-196a 
SNP Pos: 366 
Target Site: 348 - 370 
14. RAP1 (L = 1078) 





144 182.8 1.27 -734.4 -5.10 
 


























A-allele - Local Minima Distribution 






46*1.10 1.10 46*-5.10 -5.10 
-197.00 30 30*1.20 1.20 30*-5.10 -5.10 
-197.10 28 
(67) 
22*1.30, 6*0.90 1.21 28*-5.10 -5.10 
-197.20 12 10*1.40, 2*1.30 1.38 12*-5.10 -5.10 
-197.30 10 
(27) 
10*1.50 1.50 10*-5.10 -5.10 
-197.40 8 6*1.60, 2*1.50 1.58 8*-5.10 -5.10 
-197.50 6 6*1.70 1.70 6*-5.10 -5.10 
-197.70 2 2*1.90 1.90 2*-5.10 -5.10 
-197.80 1 2.00 2.00 -5.10 -5.10 
MFE: 
-197.80 




144 182.8 1.27 -734.4 -5.10 
 


























Ordered by Deepest Local Minima 
C-allele 
Barrier #LM Opening 
Avg. 
Opening 
2.00 1 -5.10 -5.10 
14. RAP1 (L = 1078) 
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1.90 2 2*-5.10 -5.10 
1.70 6 6*-5.10 -5.10 
1.60 6 (15) 6*-5.10 -5.10 
1.50 12 (27) 12*-5.10 -5.10 
1.40 10 10*-5.10 -5.10 
1.30 24 (61) 24*-5.10 -5.10 















Barrier #LM Opening 
Avg. 
Opening 
2.00 1 -5.10 -5.10 
1.90 2 2*-5.10 -5.10 
1.70 6 6*-5.10 -5.10 
1.60 6 6*-5.10 -5.10 
1.50 12 12*-5.10 -5.10 
1.40 10 10*-5.10 -5.10 
1.30 24 24*-5.10 -5.10 
1.20 30 30*-5.10 -5.10 
1.10 46 46*-5.10 -5.10 
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Ordered by Opening Energy 
 
C-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-5.10 237 2.00, 2*1.90, 6*1.70, 6*1.60, 12*1.50, 10*1.40, 24*1.30, 30*1.20, 




C-allele - Averages 
Test 
#LM-MFE 



















A-allele - Opening Energy 
Opening #LM Barrier 
Avg. 
Barrier 
-5.10 237 2.00, 2*1.90, 6*1.70, 6*1.60, 12*1.50, 10*1.40, 24*1.30, 30*1.20, 
46*1.10, 77*1.00, 22*0.90 
1.45 
 
A-allele - Averages 
Test 
#LM-MFE 






















.5 microRNA Target Prediction Based upon




Wild type A allele is expected to be weaker when binding with microRNA-124. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -17.69 -4.59   -20.22   -7.12    -84.789      -5.98    
Variant -29.19 -8.76   -35.13   -13.28    -99.072   -7.45   
Δ (stronger – weaker) -11.5 -4.17 -14.91 -6.16 -14.283 -1.47 
 
MSLN/mir611 
Wild type G allele is expected to be stronger when binding with microRNA-611. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -6.61   -5.45 (opening 
-20.9)   
-8.64 -8.64 (opening 
-16.61) 
-121.0 -8.47 
Variant -4.39 -1.37 (opening 
-17.96 )   
-4.74  -4.74 
(opening -14) 
-145.9   -7.84 
Δ (stronger – weaker) -2.22 -4.08 -3.9 -3.9 24.9 -0.63 
 
CGA/mir1302 
Wild type T allele is expected to be weaker when binding with microRNA-1302. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -12.10    -4.37 (opening 
-20.01) 
-22.85 -7.62 (opening 
-12.8) 
-23.57 -7.87 
Variant -17.65 -6.36 (opening 
-19.71) 
-28.88 -9.63 (opening 
-10.65) 
-27.61 -8.99 
Δ (stronger – weaker) -5.55 -1.99 -6.03 -2.01 -4.04 -1.12 
 
CBR1/mir-574 
Wild type G allele is expected to be weaker when binding with microRNA-284. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -31.95    -12.96   -40.75 -16.88   -156.19 -17.94 
Variant -37.96   -16.06   -42.61 -17.08   -176.74 -19.21 
Δ (stronger – weaker) -6.01 -3.1 -1.86 -0.2 -20.55 -1.27 
 
HTR3E/mir-510 
Wild type G allele is expected to be stronger when binding with microRNA-302. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -13.45   -1.71 -27.67    -11.9    -83.24 -16.41 
Variant -19.74 -3.40   -30.26   -10.54    -80.94 -12.28 
Δ (stronger – weaker) 6.29 1.69 2.59 -1.36 -2.31 -4.13 
 
KRT81/mir17b 
Wild Type G allele is expected to be the stronger allele and the weaker allele is the variant C allele. 
Variant: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -13.92 -10.74 -16.21 -13.11 -45.69 -7.25   
Variant -3.58 NA NA NA -46.26 -5.65 




Wild Type G allele is expected to be the stronger allele and the weaker allele is the variant C allele. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.32 -13.34   -18.47 -15.5 -36.72 -8.14 
Variant -10.20   -9.02    -11.77   -8.8 -36.62 -7.45 
Δ (stronger – weaker) -6.12 -4.32 -6.7 -6.7 -0.1 -0.69 
 
SPI1/mir-569 /369 
Wild type C allele is expected to be stronger when binding with microRNA-569. 
 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.56   NA NA NA -26.43 -5.75      
Variant -16.56   NA NA NA -25.32 -3.98 
Δ (stronger – weaker) 0 NA NA NA -1.11 -1.77 
 
HLA_G/mir-148a 
Wild type C allele is expected to be weaker when binding with microRNA-148a. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -21.62 -10.47   -28.94    -14.56 -41.40     -1.16 
Variant -41.22 -15.44   -50.50   -20.40    -53.22 -6.49 
Δ (stronger – weaker) -19.6 -4.97 -21.56 -5.84 -11.82 -5.33 
 
MTHFD1/mir-197 
Wild type A allele is expected to be weaker when binding with microRNA-197. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.58   + -16.58   + -81.87 -8.43    
Variant -23.88 -3.5   -23.88 -3.5   -80.44 -11   
Δ (stronger – weaker) -7.3 -3.6+ -7.3 -3.6+ 1.43 -2.57 
 
NFKBIA/mir-449a  
Wild type G allele is expected to be the weaker allele while the variant A allele to be the stronger. 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -7.45 NA NA NA -61.21 -9.73   
Variant -12.15   NA NA NA -83.11 -10.17   




Wild type A allele is expected to be weaker when binding with microRNA-1248. 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -10.10 NA NA NA -113.72 -8.51 
Variant -10.30 + (opening -
16.79 ) 
-10.30 + (opening -
16.79 ) 
-112.08 -8.43 
Δ (stronger – weaker) -0.20 NA NA NA 1.64 0.08 
CCNE1/mir-151a 
Wild type C allele is expected to be stronger when binding with microRNA-151a. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -9.22 +(opening -
58.64) 
-10.1   +(opening -
57.46) 
-87.15 -3.64 
Variant  -9.22 +(opening -
53.64) 
-10.1   +(opening -
52.46) 
-86.77 -3.64 
Δ (stronger – weaker) 0 0 0 0 -0.38 0 
 
NPM1-mir337   
The variant delT allele is expected to have stronger binding with miR-337. 
Wild type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -10.6 NA NA NA -90.68 -3.72 
Variant -32.9 -10.6 -32.9 -10.6 -96.49 -4.87 
Δ (stronger – weaker) -22.3 -10.6+ NA NA -5.81 -1.15 
 
AGT-mir31  
The wild type C allele is expected to be the stronger allele while the A allele is the weaker. 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -8.2 NA NA NA -12.62 -5.17 
Variant -8.2 NA NA NA -12.68 -5.16 
Δ (stronger – weaker) 0 0 0 0 0.06 -0.01 
AGT-mir584  
The wild type C allele is expected to be the stronger allele while the A allele is the weaker. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -6.1 + -8.38 -2.85 -129.89 -6.22 
Variant -6.1 NA NA NA -129.68 -2.87 
Δ (stronger – weaker) 0 NA NA NA -0.21 -3.35 
 
NCSTN-mir455 
Wild type allele is expected to be stronger when binding with microRNA-455. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type + +(opening -
18.12)   
+ + (opening -
17.40) 
-18.23      -7.59 
Variant + + (opening -
44.34)   
+ + (opening -
44.34)   
-10.40 -2.73 
Δ (stronger – weaker) 0 0 0 0 -7.83 -4.86 
 
SMUG1-mir770  
The variant T allele is expected to be the stronger allele. The G allele is the wild type. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -14.1   + -14.1   + -231.58  -12.66 
Variant -19.49 -4.7   -20.9 -4.7 -233.88 -13.25 
Δ (stronger – weaker) -5.39 -4.7+ -6.8 -4.7+ -2.3 -0.59 
 
PARP1/mir-145a  
Wild type T allele is expected to be stronger when binding with microRNA-145a. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -25.2   2.94   -38.46    -7.8   -137.71     -2.53    
Variant -22.84   12.68 -24.20    11.8 -103.37 -2.51 
Δ (stronger – weaker) -2.36 -9.74 -14.26 -7.8+ -34.34 -0.02 
 
WFS1/mir-668 
Wild type G allele is expected to be stronger when binding with microRNA-668. 
 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -26.4   -4.3   -26.4 -4.3   -221.57       -16.47   
Variant -18.1 NA NA NA -200.81 -12.13 
Δ (stronger – weaker) -8.3 NA NA NA -20.76 -4.34 
 
MSX1/mir-3649 
Wild type A allele is expected to be stronger when binding with microRNA-3649. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 














Δ (stronger – weaker) -12.2 -3.1 -12.2 -3.1 6.63 -1.7 
 
EFNA1/mir-200c  
Wild type G allele is expected to be stronger when binding with microRNA-200c. 
 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -13.38 -4.44  -16.6   -6 -86.29      -6.28 
Variant -11.04 NA NA NA -99.35 -2.93 
Δ (stronger – weaker) -2.34 NA NA NA 13.06 -3.35 
 
IL23R/mir-7e 
Wild type C allele is expected to be stronger when binding with microRNA-72. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -36.5 + -36.5 + -185.39 -14.23 
Variant -36.5 + -36.5 + -186.15 -12.11    
Δ (stronger – weaker) 0 0 0 0 0.76 -2.12 
 
RYR3/mir-367 
Wild type A allele is expected to be stronger when binding with microRNA-367. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -2.4   + -2.1 + -43.42    -6.97   
Variant -1.4   + -1.4   + -32.60 -6.97   




Wild type A allele is expected to be stronger when binding with microRNA-155. 
 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -20.5   + -20.5   + -81.05    -5.40   
Variant -16.20 NA NA NA -63.47 -5.19 
Δ (stronger – weaker) -4.3 NA NA NA -17.58 -0.21 
 
FGF20/mir-433 
Wild type C allele is expected to be stronger when binding with microRNA-433. 
 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -21.44   NA NA NA -304.83      -11.08 
Variant -21.62 NA NA NA -313.92 -11.08 
Δ (stronger – weaker) 0.18 NA NA NA 9.10 0 
 
DROSHA/mir-27b 
Wild type T allele is expected to be stronger when binding with microRNA-27b. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.8    + ( opening 
-20.5)   
-20.4 + (opening -
17.15) 
-28.56 -6.10   
Variant -16.8    + ( opening 
-20.5)   
-19.08 + (opening -
17.13) 
-38.69 -6.01 
Δ (stronger – weaker) 0 0 -1.32 0 10.13 -0.09 
HOXB5/mir-7 
Wild type G allele is expected to be weaker when binding with microRNA-7. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -6.8 + -6.8 + -96.95 -8.39   
Variant -26.22 + -26.22 + -95.20 -10.25 
Δ (stronger – weaker) -19.42 0 -19.42 0 1.751 -1.86 
 
RAD51/mir-197 
Wild type G allele is expected to be stronger when binding with microRNA-197. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -39.7     -15.9   -39.7    -15.9 -58.205 -12.50   
Variant -30.1 -11.1   -30.1 -11.1   -70.83 -12.48 
Δ (stronger – weaker) -9.6 -4.8 -9.6 -4.8 12.625 -0.02 
 
REV3L/mir-25  
Wild type C allele is expected to be weaker when binding with microRNA-25. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -37.52    -3.3   -45.74   -4.6   -72.74   -8.24 
Variant -37.98   -6.14   -49.62    -9.02    -79.16  -8.26 




Wild type C allele is expected to be stronger when binding with microRNA-519a 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -0.3   + -0.3   + -58.00 -10.66    
Variant -0.3   + -0.3   + -50.44 -10.66    
Δ (stronger – weaker) 0 0 0 0 -7.558 0 
 
RAP1A/mir-196a 
Wild type C allele is expected to be weaker when binding with microRNA-196a. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.2 -7.6 -16.2   -7.6 -112.26 -9.02 
Variant -29.5 -12.3 -29.5 -12.3 -131.05 -12.08 
Δ (stronger – weaker) -13.3   -4.7 -13.3   -4.7 -18.79 -3.06 
 
APP/mir-147 
Wild type T allele is expected to be stronger when binding with microRNA-147. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -56.68   + -56.68   + -141.242 -12.63 
Variant -45.45 + -45.45 + -134.564 -11.45 




IL1A/mir-122    
The Variant TTCA insertion is expected be the weaker allele. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -11.01 + -11.01 + -269.45 -11.81           
Variant -11.01 + -11.01 + -266.21 -11.07 
Δ (stronger – weaker) 0 0 0 0 -3.24 -0.74 
 
CD133/mir-135b 
Wild type A allele is expected to be weaker when binding with microRNA-135b. 
 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -5.36   + -5.36   + -89.73   -6.97   
Variant -9.26   -2.1   -9.26   -2.1   -101.29 -10.22 
Δ (stronger – weaker) -3.9 -2.1+ -3.9 -2.1+ -11.56 -3.25 
 
PDCD1/mir-4717 
Wild type G allele is expected to be stronger when binding with microRNA-4717. 
Wild Type: no sites with SNP position inside, therefore no Su for Case A and no Case B. 
Variant:  no sites with SNP position inside, therefore no Su for Case A and no Case B. 
 Case A Case B STarMir 
Linear Sum 
PITA 
score  Ssum Su Ssum Su 
Wild Type -16.6 NA NA NA -486.86 -11.85   
Variant -14.3 NA NA NA -487 -10.33 
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